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CHAPTER 1
General introduction
This thesis is aimed at gaining insight into the genetic underpinnings and brain correlates 
of the highly heritable disorder Attention-Deficit/Hyperactivity Disorder (ADHD), the latter 
serving as possible links between genetic risk factors and the clinical phenotype. In the 
following sections, I will describe the clinical manifestation of ADHD, brain phenotypes 
linked with ADHD, and the “state of affairs” in the search for genetic risk factors associ-
ated with ADHD. Subsequently, I present the aims of this thesis and outline how each 
chapter of this thesis relates to my aims.
Clinical aspects of ADHD
Epidemiology
ADHD is a common neurodevelopmental disorder characterized by developmentally in-
appropriate inattentiveness, and/or increased impulsivity and hyperactivity (American 
Psychiatric Association, 2000). The world-wide prevalence of ADHD in childhood is about 
5% (Polanczyk et al., 2007; Polanczyk et al., 2014; Willcutt, 2012). More boys than girls receive 
the diagnosis (Ramtekkar et al., 2010), with estimated ratios ranging from 3:1 (Arnold, 1996) to 
9:1 (Gaub and Carlson, 1997). Although ADHD starts in childhood, it can persist into adult-
hood with estimations on persistence rates varying between 15% to 64%, depending 
on the defin ition of persistence (Barkley et al., 2002; Biederman et al., 2000; Biederman et al., 
2010;  Faraone et al., 2006; Kessler et al., 2005). Prevalence of ADHD in adulthood is around 
3% (Fayyad et al., 2007; Kessler et al., 2005; Simon et al., 2009), with a sex distribution around 
1:1 (Biederman et al., 1994). In general, ADHD symptoms decline with age, with hyper-
activity/impulsivity symptoms declining more rapidly than the inattention symptoms over 
adolescence into adulthood (Biederman et al., 2000; Spencer et al., 2007). 
Diagnosis 
The diagnosis of ADHD is established based on information on the presence of symptoms 
and impairment of functioning. This information is gathered by open or structured psy-
chiatric interviews conducted by clinicians as well as by questionnaires filled in by the 
parents and teachers for children or self reported by adults. No biomarkers for ADHD are 
currently available as a diagnostic tool. Based on the Diagnostic and Statistical Manual of 
Mental Disorders (DSM), the classification system for psychiatric disorders used in most 
countries, ADHD can be diagnosed if at least 6 out of 9 symptoms of inattention and/or 
hyperactivity/impulsivity are present. These symptoms should be present in at least two 
settings (for example home and school), be present for 6 months or longer, and should 
have a significant impact on social, academic or occupational functioning. The DSM 
 undergoes updates if additional knowledge is gained on psychiatric disorders. Versions 
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that have been used in this thesis are the DSM-IV (DSM-IV, 1994) and the DSM-5 (DSM-5, 2013). 
The most important differences between DSM-IV and DSM-5 regarding ADHD are that in the 
former, ADHD could only be diagnosed if some symptoms were present before the age of 7 
years, whereas in the latter, this has been changed to the age of 12 years. Additionally, in 
DSM-IV ADHD could not be diagnosed if Autism Spectrum Disorder was present, whereas 
DSM-5 allows to classify ADHD and comorbid Autism Spectrum Disorder (see Figure 1).
Symptoms
Inattention symptoms in ADHD refer to distractibility, forgetfulness, daydreaming, and 
difficulty in sustaining attention. The hyperactivity symptoms comprise restlessness, ex-
cessive talking and fidgeting, the impulsivity symptoms capture behaviors like difficulty 
in awaiting one’s turn, frequently interrupting others, and blurting out answers before the 
question has been completed (Figure 1). Factor analyses of the ADHD symptoms demon-
strate that ADHD is multidimensional (Toplak et al., 2012). Studies of teacher and parent rat-
ings of ADHD symptoms found support for a two-factor structure in children (Collett, 2000; 
Toplak et al., 2012), separating an inattention factor and a hyperactivity/impulsivity factor 
(Willcutt et al., 2012). Although some studies of adult ADHD split the hyperactivity/impul-
sivity dimension into separate factors, making a three-factor model for ADHD symptoms 
(Burns et al., 2001; Gomez et al., 1999; Kooij et al., 2005), the two-factor model has been most 
widely accepted. DSM (DSM-IV and DSM-5) diagnostic criteria make sub-classifications 
based on the two-factor model, distinguishing an inattentive presentation (predominantly 
inattentive symptoms), a hyperactive/impulsive presentation (predominantly hyperactive/
impulsive symptoms) and a presentation with symptoms in both domains (DSM-5, 2013; 
DSM-IV, 1994) (see Figure 1). Even though the diagnostic threshold for ADHD is only reached 
if the number of symptoms is high enough, ADHD traits are continuously distributed in 
the general population, and ADHD is often seen as the (behavioral) extreme end of this 
continuum in the general population (Larsson et al., 2012; Lubke et al., 2009).
Neuropsychology
ADHD is characterized by neuropsychological deficits (van Lieshout et al., 2013). The main 
neuropsychological deficits in ADHD have been subdivided into three domains: cognitive 
control, reinforcement processing, and temporal processing (de Zeeuw et al., 2012; Durston et 
al., 2011; Sonuga-Barke et al., 2010). Cognitive control (also known as executive functioning) 
refers to the higher order cognitive functions that are needed to flexibly adjust to chang-
ing circumstances. Such functions consist of set shifting, working memory, fluency, and 
response inhibition (Alderson et al., 2008; Kasper et al., 2012; Sergeant et al., 2002; Slaats-Willemse 
et al., 2003; Willcutt et al., 2005). Reinforcement processing refers to motivational mechanisms 
that influence task performance. A well-known example in ADHD literature is the effect 
of the anticipation of receiving a reward on cognitive performance, which is altered in 
participants with ADHD compared to healthy controls. Compared to controls, participants 
with ADHD show a larger positive effect of reinforcement on cognitive performance. They 
also have a stronger preference for responses that provide immediate rewards, even if 
they might be unfavorable in the future, and prefer immediate small rewards over larger 
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delayed rewards (Luman et al., 2005; Plichta and Scheres, 2014; Scheres et al., 2007). Temporal 
processing refers to the ability to order and predict serial events in time, but also to the 
temporal stability in responding. Examples of tasks that require temporal processing in-
clude the perception and estimation of time intervals. Suboptimal performance in timing 
ability has been reported reproducibly in ADHD (Noreika et al., 2013). Not all neuropsycho-
logical impairments observed in ADHD are (completely) covered by these three domains, 
for example, other neuropsychological deficits related to ADHD are a somewhat lower 
general intelligence at group level (Frazier et al., 2004), problems in basic information pro-
cessing (Salum et al., 2014), problems in emotion processing (Shaw et al., 2014), perception 
(Nazari et al., 2010) and attention (Wang et al., 2013).
Comorbidities
ADHD is clinically a highly heterogeneous disorder. Next to the multitude of possible com-
binations of the 9 symptoms of hyperactivity/impulsivity and the 9 inattention symptoms 
used for diagnostic purposes, and the different neuropsychological profiles, comorbidity 
is a common feature of ADHD. Frequent comorbidities seen in ADHD are oppositional 
defiant and conduct disorder, autism spectrum disorder, tic disorders, sleep disorders, 
specific learning disorders like dyslexia, motor coordination problems, depression, anx-
iety, and substance use disorder (Biederman and Faraone, 2005; Gillberg et al., 2004; Lycett et 
al., 2014; Rappley, 2005; Reinhardt and Reinhardt, 2013). 
Treatment
Treatment of ADHD is mostly multimodal, with in particular psycho-education, psycho-
logical interventions, and medication being used for patients with ADHD (Feldman and 
Reiff, 2014; Heilskov Rytter et al., 2014; Sonuga-Barke et al., 2013; National Institute for Health and 
Clinical Excellence (NICE clinical guideline), 2008). Stimulants are the medication of first choice, 
which control core behavioral symptoms in a substantial proportion of cases. None of 
the pharmacological treatment options used so far cure ADHD. Learning more about the 
biological mechanisms and other underlying molecular processes involved in ADHD may 
help us to improve the prognosis and/or treatment of this disorder.  
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DSM-IV 
Three Subtypes:
Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type: This subtype is used if six (or 
more) symptoms of inattention (but fewer than six symptoms of hyperactivity-impulsivity) have persisted for 
at least six months.
Attention-Deficit/Hyperactivity Disorder Predominantly Hyperactive-Impulsive Type: This subtype should 
be used if six (or more) symptoms of hyperactivity-impulsivity (but fewer than six of inattention) have 
persisted for at least six months.
Attention-Deficit/Hyperactivity Disorder Combined Type: This subtype should be used if six (or more) 
symptoms of inattention and six (or more) symptoms of hyperactivity-impulsivity have persisted for at least 
six months. 
Diagnostic Criteria for the three subtypes of Attention-Deficit/Hyperactivity Disorder according to DSM-IV:
A  “Persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequently displayed and 
is more severe than is typically observed in individuals at comparable level of development.” Individual 
must meet criteria for either (1) or (2):
(1)  Six (or more) of the following symptoms of inattention have persisted for at least six months to a 
degree that is maladaptive and inconsistent with developmental level:
Inattention 
(a)  often fails to give close attention to details or makes careless mistakes in schoolwork, work or 
other activities
(b) often has difficulty sustaining attention in tasks or play activities
(c) often does not seem to listen when spoken to directly
(d)  often does not follow through on instructions and fails to finish schoolwork, chores or duties in 
the workplace (not due to oppositional behavior or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f)  often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort 
(such as schoolwork or homework)
(g)  often looses things necessary for tasks or activities (e.g., toys, school assignments, pencils, 
books or tools)
(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2)  Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least six 
months to a degree that is maladaptive and inconsistent with developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which remaining seated is expected
(c)  often runs about or climbs excessively in situations in which it is inappropriate (in adolescents 
or adults, may be limited to subjective feelings of restlessness)
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(d) often has difficulty playing or engaging in leisure activities quietly
(e) is often “on the go” or often acts as if “driven by a motor”
(f) often talks excessively
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often has difficulty awaiting turn
(i) often interrupts or intrudes on others (e.g., butts into conversations or games) 
B  Some hyperactive-impulsive or inattentive symptoms must have been present before age 7 years.
C  Some impairment from the symptoms is present in at least two settings (e.g., at school [or work] and at 
home).
D  There must be clear evidence of interference with developmentally appropriate social, academic or 
occupational functioning.
E  The disturbance does not occur exclusively during the course of a Pervasive Developmental Disorder, 
Schizophrenia, or other Psychotic Disorders and is not better accounted for by another mental disorder 
(e.g., Mood Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder).
DSM-5 Changes in DSM-5 compared to DSM-IV: 
–  Adult ADHD: For many years, the diagnostic criteria for ADHD stated that it was children who were 
diagnosed with the disorder. That meant that for older adolescents and adults with symptoms of the 
disorder, and who may have been struggling for many years but didn’t know why, couldn’t officially be 
diagnosed with ADHD. The DSM-5 has changed this; older adolescents and adults can now be officially 
diagnosed with the disorder. The diagnostic criteria mentions and gives examples of how the disorder 
appears in older adolescents and adults. 
–  In diagnosing ADHD in adults, clinicians now look back to middle childhood (age 12) when making a 
diagnosis for the beginning of symptoms, not all the way back to early childhood (age 7). 
–  In the previous edition, DSM-IV, the three types of ADHD were referring to as “subtypes.” This has 
changed; subtypes are now referred to as “presentations.” Furthermore, a person can change “presen-
tations” during their lifetime. 
– Severity is now specified as mild, moderate or severe ADHD. This is based on the impairment. 
– A person can now be diagnosed with ADHD and Autism Spectrum Disorder. 
–  In making the diagnosis, children still should have six or more symptoms of the disorder. In older teens 
and adults the DSM-5 states they should have at least five symptoms.
 
Figure 1  DSM-IV and DSM-5 diagnostic criteria for Attention-Deficit/Hyperactivity Disorder
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Brain abnormalities in ADHD
Brain volume
ADHD has been recognized as a neurobiological disorder. Previous studies have indicated 
structural and functional differences between the brains of patients with ADHD and controls. 
Structural magnetic resonance imaging (MRI) has pointed to total brain volume reductions 
up to 3-5% for ADHD cases compared to controls (Castellanos et al., 2002; Valera et al., 2007). To 
investigate whether these reductions are global or regional, several brain regions of interest 
(ROIs) have been studied. A meta-analysis reported significant volume differences in cere-
bellar regions, total and right cerebral volume, right caudate and frontal brain areas (Valera 
et al., 2007). Although many studies have investigated and reported on structural brain ab-
normalities in ADHD, the field has not yet arrived at a consensus (Dennis and Thompson, 2013).
Next to region of interest (ROI) studies that rely on a priori definitions of the structures in-
vestigated, structural whole-brain analyses have been performed that have the advantage 
of serving hypothesis-generating, as no prior assumptions are made. One of the methods 
that uses this approach is voxel-based morphometry (VBM), which investigates differen-
ces in grey matter intensity (Ashburner and Friston, 2000; Friston et al., 2006). Individual VBM 
 studies in ADHD have been based on small samples and show considerable heterogeneity 
in their findings (Brieber et al., 2007; Onnink and Zwiers, 2013; Seidman et al., 2011). To investigate 
the most prominent differences between ADHD cases and controls, three meta-analyses 
have been performed that combined the individual studies and compared their results 
(the samples used in these individual meta-analyses partly overlap) (Ellison-Wright et al., 
2008; Frodl and Skokauskas, 2012; Nakao et al., 2011). The meta-analysis of Ellison-Wright and 
colleagues integrated data from 7 studies, which in total consisted of 114 children with 
ADHD and 143 controls. They found grey matter differences in right putamen and globus 
pallidus (Ellison-Wright et al., 2008). The meta-analyis of Nakao and colleagues included 14 
datasets, which comprised of 202 children and adolescents and 176 adults with ADHD and 
344 controls. They found reduced localized grey matter in right globus pallidus, putamen 
and caudate nucleus. In the left posterior cingulate cortex they reported larger local grey 
matter volume (Nakao et al., 2011). The meta-analysis of Frodl and Skokauskas studied 11 
datasets, which were comprised of 175 children and adolescents and 145 adults with ADHD 
and 288 controls. They reported reduced right globus pallidus and putamen volumes in 
children with ADHD, whereas the adult samples showed reductions in anterior cingulate 
cortex volume (Frodl and Skokauskas, 2012). The results presented by the meta-analyses still 
show considerable heterogeneity, and reliability analysis revealed differences in findings 
in 50% to 75% of the studies (Nakao et al., 2011). As meta-analyses are limited by the limita-
tions of the single studies, investigating volume differences within a single large sample 
has substantial added value over existing meta-analyses.
Cortical thickness
Another approach to investigate whole-brain structural differences in ADHD is to investi-
gate cortical thickness. Cortical thickness analyses can map differences in laminar thick-
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ness between (diagnostic) groups. The approach is based on the estimation of the distance 
between the grey-white matter border and the pial surface. Compared to region of interest 
volumetric studies and VBM studies, cortical thickness studies are less susceptible to 
positional variance (Kim et al., 2005; MacDonald et al., 2000). Differences in cortical thickness 
have been reported between patients with ADHD and healthy controls in the superior and 
inferior parietal cortex, the (pre)frontal cortex, and in anterior cingulated cortex (Almeida 
et al., 2010; Batty et al., 2010; Hoekzema et al., 2012; Makris et al., 2007; Narr et al., 2009).
White matter
Next to the volumetric differences observed in brain grey matter, white matter has also 
been found to be altered in ADHD, leading to a potential disorganization of the brain’s 
connectivity. Studies investigating white matter volume showed an overall reduction of 
total cerebral white matter (Castellanos et al., 2002; McAlonan et al., 2007; Mostofsky et al., 2002), 
which appeared to be localized mostly to the inferior longitudinal fasciculi (connecting 
the temporal lobe with the cerebellum) and occipitofrontal fasciculi (connecting frontal 
and occipital lobes) (McAlonan et al., 2007). Another way to study changes in white matter 
is diffusion tensor imaging (DTI), a method that measures the directionality of water 
molecules. In pure water or grey matter, water molecules can diffuse in every direction, 
however, in white matter the water molecules are restricted e.g. by the myelin sheets of 
the axon bundles. Therefore, the water molecules will diffuse more readily in the direction 
of the axon bundles than other directions (Alexander et al., 2007; Beaulieu, 2002). Findings 
in individual DTI studies have been inconsistent, but a recent meta-analysis highlight-
ed five areas with disturbed white matter in participants with ADHD, located in white 
matter tracts subserving the fronto-striatal-cerebellar neurocircuitry (van Ewijk et al., 2012). 
Investigation of white matter structure in the family-based sample used in the current 
thesis showed that the decreases observed in individuals with ADHD were widespread 
and associated with impairment (van Ewijk et al., 2014).
Functional MRI
In the studies discussed above, an altered structure of the brain is often assumed to lead 
to altered brain functioning. Although not investigated in the current thesis, I would 
shortly like to mention a neuroimaging method used to more directly investigate potential 
changes in brain function, which is functional magnetic resonance imaging (fMRI). In 
fMRI alterations in blood flow after a task/stimulus/change in environment are measured. 
This is measured by measuring the blood-oxygen-level dependent (BOLD) contrast. As 
cerebral blood flow and neuronal activation are coupled, one can infer conclusions about 
acute brain activity. Studies using fMRI in ADHD showed slight functional abnormalities 
in patients (both children and adults) in many different regions of the brain, like the 
fronto-parietal executive control network, putamen, and ventral attentional network. 
Such findings are consistent with one of the classical hypotheses about ADHD etiology, 
i.e. that ADHD is linked to dysfunctioning of the fronto-striatal areas of the brain (Cortese 
et al., 2012; Hart et al., 2012; Hart et al., 2013). Next to support for the classical models, re-
cent studies also point out differences in other areas of the brain, like the default mode 
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network and visual areas, leading to the conclusion that ADHD is a disorder with brain 
dysfunctioning in multiple large-scale brain networks (Castellanos and Proal, 2012; Cortese 
et al., 2012; Makris et al., 2013). In summary, neuroimaging data from different sources (grey 
matter, white matter, connectivity, and activity) suggest differences in ADHD to be present 
in several areas of the brain, like the frontal areas of the brain, the striatal areas of the 
brain, and the cerebellum.  
Developmental delay
Some studies suggest the brain differences observed in ADHD to be partly attributable 
to a delay in maturational processes. A cross-sectional volumetric study of Castellanos 
and colleagues (Castellanos et al., 2002) showed that cerebrum, cerebellum, grey and white 
matter of the four major lobes were smaller in participants with ADHD. However, as 
the developmental trajectories of these areas ran roughly parallel for participants with 
ADHD and controls during childhood and adolescence, this might indicate that ADHD 
subjects of older ages have brain volumes more comparable to controls of younger ages. 
The exception was the caudate nucleus that had a smaller volume in participants with 
ADHD compared to controls only in childhood. The developmental growth curve of the 
caudate did not remain parallel for ADHD and control subjects, and this was driven by a 
normalization of caudate volume for patients with ADHD by late adolescence (Castellanos 
et al., 2002). Support for the developmental delay hypothesis in ADHD comes from the 
findings described in one of the meta-analyses of VBM studies, which indicated that 
increasing age is associated with more normal grey matter values in affected areas (Nakao 
et al., 2011). For cortical thickness measures, Shaw and coworkers investigated the growth 
trajectories of different points of the cortex in a sample of participants with ADHD and 
healthy controls. They reported a general childhood increase in cortical thickness fol-
lowed by an adolescent decrease in cortical thickness. From these analyses they extract-
ed the peak cortical thickness which they describe as the point of cortical maturation. 
They compared the peak cortical thickness as well as the ordered sequence of regional 
development between participants with ADHD and healthy controls. They reported that 
cortical thickness maturation in participants with ADHD lagged behind that of healthy 
controls approximately 3 years through most of the cerebrum. The most prominent delay 
was found in the prefrontal cortex (Shaw et al., 2007). 
Next to grey matter volume and cortical thickness results supporting the developmental 
delay hypothesis, such delay has also been suggested for white matter abnormalities 
reported in ADHD (Silk et al., 2009). These results are in line with fMRI studies that report 
brain activity at rest and in response to stimuli to be similar between participants with 
ADHD and their somewhat younger but healthy peers (El-Sayed et al., 2003; Fernandez et al., 
2009; Rubia, 2002). Altogether several studies on neurobiological findings in ADHD supports 
a potential delay in (brain) maturation as a key characteristic of ADHD, but there are also 
studies that do not support this hypothesis.
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Dimensionality
The view that ADHD is the extreme end of a continuum in the population, as mentioned 
earlier in this thesis, has also been investigated with neuroimaging methods. A study 
by Hoogman and colleagues (Hoogman et al., 2012) investigated the relationship between 
ADHD symptoms and brain volume in a large population sample of healthy young adults. 
They showed that an increased number of current ADHD symptoms was associated with 
a smaller total brain volume. In addition, when they grouped their population sample 
based on DSM-IV diagnostic criteria for ADHD (based on self-reports), the group difference 
was also significant, indicating that the reduction in total brain volume coincides with 
impairment and is likely important in ADHD. Another study investigated the relationship 
between cortical thickness and ADHD symptoms and reported similar findings (Shaw et al., 
2011). Investigating healthy children and adolescents these authors showed an association 
between a thinner cortex and more symptoms of ADHD. A similar relationship between 
symptomatology and white matter volume has also been reported (Mackie et al., 2007), 
as has an increase in abnormal DTI findings in individuals with higher levels of ADHD 
symptoms (van Ewijk et al., 2014). These findings support the dimensionality of ADHD in 
its biological substrates. 
Neuropsychology and the brain
I would also shortly like to mention the hypothesis on the neuropsychological dysfunc-
tions in ADHD in the brain. As described in section Neuropsychology of this introduc-
tion, the main neuropsychological deficits in ADHD have been subdivided into three 
domains: cognitive control, reinforcement processing, and temporal processing. These 
neuro psychological abnormalities have been linked to specific neurobiological substrates, 
which are hypothesized to be the main neurobiological systems involved in ADHD (de 
Zeeuw et al., 2012; Durston et al., 2011). Cognitive control has been linked to dorsal fronto- 
striatal circuits in the brain (Badre, 2008), reinforcement processing to orbitofronto-striatal 
circuits (Scheres et al., 2007), and temporal processing to fronto cerebellar circuits (Durston et 
al., 2007). Subtyping of ADHD has been proposed, based on dorsal frontal-striatal, orbito-
frontal-striatal and fronto-cerebellar circuits (Durston et al., 2011; Hart et al., 2012), which 
would take into account the option of multiple biological pathways leading to ADHD.  
Genetics of ADHD
Familiality
Familial transmission of ADHD has been consistently reported (Biederman and Faraone, 
2005; Faraone et al., 1994). Having a first degree family member (e.g. parent, sibling, child) 
affected with ADHD increases the risk for also having ADHD in a child approximately 5 
times compared to the population risk, and having a second degree family member (e.g., 
grandparent, aunt, uncle) affected with ADHD increases the risk approximately 1.5-2 times 
(Faraone et al., 2005). Familial aggregation can point to genetic influences on ADHD, as 
family members share some of their genetic material (e.g., full siblings on average share 
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50% of their genetic material). However, it can also point to shared environmental influ-
ences on ADHD, as family members share their entire family-wide environment. Together, 
shared genetic and shared environmental factors are referred to as ‘familial’ factors, but 
the two types of factors cannot be teased apart using standard family-based study designs. 
Adoption studies
One way to separate the genetic and environmental factors that could contribute to ADHD 
is through adoption research. Some adoption studies have been performed in ADHD 
(Alberts-Corush et al., 1986; Cantwell, 1975; Morrison and Stewart, 1973; Sprich et al., 2000; van der 
Valk et al., 1998). In these studies biological parents share genetic factors with the adopt-
ed child, and adoptive parents share family-wide environments with the adopted child; 
hence, similarities between the child and biological parents point to genetic influences or 
those of prenatal environment, where similarity between the child and adoptive parents 
points to shared postnatal environmental influences. The above-mentioned adoption 
studies in ADHD showed that genetic factors play a role in ADHD. For example, ADHD 
was more likely to be present in the biological parents of children with ADHD compared 
to the adoptive parents (Sprich et al., 2000).
Twin studies
Another way to separate the genetic and shared environmental factors is through twin 
studies. Twin studies can provide useful insights as we know that monozygotic twins share 
100% of their genetic material as well as their family environments, whereas dizygotic 
twins share on average 50% of their genetic material as well as 100% of their family 
environments. Therefore, if concordance rates of ADHD are higher in monozygotic twins 
compared to dizygotic twins, this would indicate genetic factors to play a role. Twin studies 
investigating ADHD concordance in monozygotic and dizygotic twins showed strong ge-
netic influences for ADHD, as concordance for ADHD was higher in monozygotic twins 
compared to dizygotic twins (Faraone et al., 2005). Twin studies in the general population 
found similar results based on individual differences in ADHD traits, with higher similar-
ities for monozygotic twins (Levy et al., 1997). Twin studies make it possible to estimate the 
genetic contribution to a specific trait. Meta-analyses of twin studies in ADHD showed 
that the genetic contribution to ADHD in childhood is high, with a mean estimate of .76 
(Burt, 2009; Burt et al., 2012; Faraone et al., 2005). Heritability estimates in adult ADHD have 
been hypothesized to be similar, or even higher than those of ADHD in children, with 
the hypothesis that ADHD that persists into adulthood is the most severe form of ADHD 
and therefore might have stronger genetic influences (Faraone et al., 2000; Franke et al., 2012). 
However, several studies reporting on heritability estimates in adult ADHD showed lower 
heritability estimates (Franke et al., 2012a), potentially due to the different measures used to 
classify adult ADHD (self-reports compared to parent and teacher reports in childhood) 
(Posthuma and Polderman, 2013). Indeed, different heritabilities have been reported for ratings 
from different informants, with higher estimates for teacher and parent reports than for 
self-reports (Merwood et al., 2013), indicating the importance of reliable measurements in 
genetic analyses. A large twin study investigating clinical diagnose of ADHD showed that 
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the heritability of clinically diagnosed ADHD is high across the lifespan and also substan-
tial in adults (heritability of 0.72) (Larsson et al., 2013). When the two symptom domains 
of ADHD were investigated separately in population twin studies, heritabilities for both 
symptom domains were high (0.71 for inattention symptoms and 0.73 for hyperactivity/
impulsivity symptoms) (Nikolas and Burt, 2010). Twin studies also showed that although 
the two symptom domains of ADHD show genetic overlap, there is also a clear genetic 
specificity of the separate domains (Greven et al., 2011a; Greven et al., 2011b).
Challenges in finding genetics risk factors
Although the heritability estimates for ADHD are high, identifications of the specific gen-
etic risk factors have been difficult. One of the likely reasons for the complications in the 
identification of these genetic risk factors is the clinical heterogeneity of ADHD. Different 
presentations of ADHD might link to quantitatively or qualitatively different underlying 
genetic risk factors, for example ADHD in combination with conduct disorder has been 
shown to potentially capture higher genetic loadings (Faraone et al., 2000; Hamshere et al., 
2013), and variants in the gene DAT1 only seem to be associated with ADHD in the absence 
of conduct disorder (Zhou et al., 2008b). Another reason why finding genetic risk factors 
for ADHD is challenging is the fact that ADHD is a polygenic disorder (Cross-Disorder Group 
of the Psychiatric Genomics et al., 2013). Multiple genetic variants play a role in the genetics 
of ADHD, most of them only showing small effect sizes on their own, and – moreover – 
 different combinations of genetic variants can lead to similar phenotypes (Franke et al., 
2009). However, next to the support for the polygenic model of multiple common variants 
with small effect, there are also hypotheses about rare variants with larger effects playing 
a role in ADHD, and options for involvement of epigenetics, epistasis, and gene-environ-
ment interactions (Buitelaar, 2005; Thapar et al., 2013). 
Candidate gene approaches
Several methods have been used to study the genetics of ADHD. The search for genetic 
variants in ADHD started from the hypothesis that a common disorder like ADHD would 
most likely be linked to common genetic variants. Early studies investigated single candi-
date genes and variants the researchers suspected to potentially play a role in ADHD. The 
main focus in candidate gene studies of ADHD has been on genes related to catecholami-
nergic function, like dopamine, noradrenaline and serotonin. Alterations in these systems 
have been hypothesized to play a role in ADHD, for several reasons (Biederman and Spencer, 
1999; Staller and Faraone, 2007). Most of the medication that is used in ADHD and attenuates 
the behavioral symptoms of the disorder, works on dopamine and/or noradrenaline (Del 
Campo et al., 2011; Volkow et al., 2002). Although serotonin is not a direct target for ADHD 
medication, the serotonin and dopamine transmitter systems have been shown to interact, 
therefore, medication affecting the dopamine system might influence serotonin signaling 
as well (Oades, 2008). In addition, the projection sites of these neurotransmitter systems in 
the brain regulate ADHD-related cognitive processes, attention and motor behavior, and 
in addition structural alterations in these brain areas have been reported in ADHD (Bush 
et al., 2005; Frodl and Skokauskas, 2012; Nakao et al., 2011). A meta-analysis of candidate gene 
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studies performed in ADHD showed 6 genes that reached at least nominal significance 
for association with ADHD: three dopaminergic genes, DAT1/SLC6A3, DRD4, DRD5, two 
serotonergic genes, 5-HTT/SLC6A4 and HTR1B, and one gene involved in vesicle transport 
and membrane fusion, SNAP25 (Gizer et al., 2009). Currently over 300 candidate genes have 
been investigated in ADHD at least once (http://adhd.psych.ac.cn/) (Franke et al., 2012; 
Thapar et al., 2013; Zhang et al., 2012).
Linkage
Next to candidate gene approaches, which rely on a priori (theoretical) biological hypoth-
eses, there are also methods that circumvent this need for prior selection by studying the 
complete genome using a hypothesis-free approach. The first genome-wide hypoth esis-
free approaches to be used in ADHD were the linkage analyses, which are family-based 
approaches. In linkage studies, multiple variants over the genome are measured and 
tested for the odds of being shared between affected family-members compared to the 
odds of not being shared. Linkage studies rely on the notion that parts of the DNA are 
inherited together, a concept known as linkage disequilibrium (LD). Therefore, if a vari-
ant is assessed that is in close proximity to the causal variant, a significant signal can 
still be found. Eleven linkage studies have been performed in ADHD (Amin et al., 2009; 
Arcos-Burgos et al., 2004; Asherson et al., 2008; Bakker et al., 2003; Faraone et al., 2008; Fisher et 
al., 2002; Hebebrand et al., 2006; Ogdie et al., 2003; Romanos et al., 2008; Saviouk et al., 2011; Vegt 
et al., 2010); for a review see (Banaschewski et al., 2010). The results from these studies show 
very little overlap, most of the findings are study-specific. A meta-analysis on seven of 
the linkage studies showed a genome-wide significant peak on chromosome 16 (Zhou et 
al., 2008c). However, the area captured by this peak still contains multiple genes, making 
this a rather unspecific finding. There is one success story in linkage studies for ADHD, 
which is the identification of LPHN3 as a candidate gene for ADHD (Arcos-Burgos et al., 
2010). The investigators of this study worked out that the linkage peak they observed 
on chromosome 4 was driven by LPHN3. LPHN3 encodes a G-protein-coupled receptor 
and this gene is expressed in key brain regions for attention and activity. Additionally, a 
significant association was found for variants in LPHN3 with the response to stimulant 
medication (Arcos-Burgos et al., 2010). Linkage studies have also been used to investigate 
quantitative measures in ADHD, in line with the reasoning that ADHD symptoms can be 
viewed dimensionally on a continuum, which might increase the power of the analyses 
as more variability is present in the data (compared to the binary ADHD diagnosis [yes-
no]). Using this approach, significant linkage was found on chromosome 1p36 for both 
ADHD symptoms at home settings and at school settings (Zhou et al., 2008a). Another 
study investigating ADHD symptoms reported a suggestive peak on chromosome 3q13 for 
inattentive symptoms (Doyle et al., 2008).
Genome-wide association study (GWAS)
A second genome-wide hypothesis-free approach to gene-finding is a genome-wide associ-
ation study (GWAS). The variants measured are Single Nucleotide Polymorphisms (abbre-
viated as SNPs), which are common (e.g. present in at least one percent of the population) 
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one-nucleotide variations in the genome sequence. Because many thousands of variants 
are measured (usually between 200,000 and 1,000,000), GWASs can be performed in un-
related individuals . However, as the number of variants tested in genome-wide analysis 
is very high, it is important to take into account the multiple comparison problem that 
arises. Therefore, to reach genome-wide significance, a stringent p-value threshold of 
5*10-8 needs to be reached (Hoggart et al., 2008; McCarthy et al., 2008). 
In total, eight GWASs have been performed in ADHD (Hinney et al., 2011; Lesch et al., 2008; 
Mick et al., 2010; Neale et al., 2008; Neale et al., 2010b; Stergiakouli et al., 2012; Yang et al., 2013b). 
So far, none of the SNPs in the single GWASs in ADHD have reached the threshold for 
significance. A meta-analysis did not find genome-wide significant associations for ADHD 
diagnostic status either (Neale et al., 2010a). From this, it was concluded that the common 
variants studied with GWAS approaches in ADHD have very small individual effect sizes, 
and therefore large(r) sample sizes are needed to find them. To be able to obtain these 
large data sets, (international) collaborations are necessary, and are being realized for 
psychiatric disorders by the Psychiatric Genomics Consortium (PGC; http://www.med/
unc.edu/pgc). Data is still being collected to be able to reach large sample sizes, but with 
optimism, as other psychiatric disorders reached the genome-wide significance threshold 
for multiple variants when very large samples had been collected (Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). While the published meta-analysis contained 2,064 
trios, 896 cases, and 2,455 controls, an additional sample of 15,000 cases is currently 
being genotyped, and is expected to become available for association testing later this 
year. Quantitative approaches, investigating potential association to symptoms of ADHD 
have also been used in the GWAS framework (Ebejer et al., 2013; Lasky-Su et al., 2008). Again, 
this is in line with the reasoning that quantitative measures might increase the power 
of the analyses as more variability is present in the data (compared to the binary ADHD 
diagnosis [yes-no]). This approach indeed was shown to pay-off, as Lasky-Su and col-
leagues were able to identify genome-wide significant associations for a variant in the 
CDH13 gene associated with ADHD symptoms and for a variant in GFOD1 with inattentive 
symptoms (Lasky-Su et al., 2008). CDH13 codes for cadherin-13, belonging to the family of 
cell-cell adhesion proteins (Patel et al., 2003) and regulates neuronal cell growth. GFOD1 
codes for glucose-fructose oxidoreductase-domain containing 1 and possibly plays a role 
in electron transport (Lasky-Su et al., 2008).
Beyond GWAS
Although the lack of genome-wide significant results in GWAS for ADHD might seem dis-
couraging, the data collected so far can also be used in different ways to investigate the 
genetics of ADHD. One option is to use a hypothesis-based approach, and only investigate 
SNPs within genes or genetic pathways one might expect to be influencing ADHD, thus 
decreasing the number of statistical tests in the analyses along with the multiple testing 
burden (Elia et al., 2009; Payton et al., 2001). Another approach is to investigate whether the 
top results of GWAS (albeit not reaching genome-wide significance) have certain similar-
ities, for example if the genes work in a common process. This approach has been used in 
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work by Poelmans and colleagues, where bioinformatics as well as systematic literature 
searches showed that 45 of the 85 genes from the top results reported in five ADHD GWASs 
fell into a network involved in neurite outgrowth, suggesting neurite outgrowth to be an 
important process in ADHD (Poelmans et al., 2011). This approach was also used by Yang 
and colleagues, who implicated neuron projections and synaptic components in ADHD 
through bioinformatic analyses tools, suggesting a neurodevelopmental pathophysiology 
for ADHD (Yang et al., 2013b). Another approach that uses genome-wide genetic data in a 
different way is the polygenic risk score approach (International Schizophrenia et al., 2009). 
In polygenic score analyses, a combined risk score is made based on the aggregation of 
genetic effects of which genetic effect sizes are coming from an independent data set, for 
example a case-control study for ADHD. The composite score that is built based on the 
effect size of such an independent data set for the different genetic variants can be tested 
for association with one’s phenotype of interest (Martin et al., 2014).
Genetic overlap
As ADHD is often seen in combination with psychiatric comorbidities, and overlap  exists 
between symptoms and characteristics of different psychiatric disorders, studies have 
investigated whether there might also be a genetic overlap between psychiatric  dis orders. 
The Psychiatric Genomics Consortium (PGC), which combines and integrates genome-wide 
association data on ADHD, autism, major depressive disorder, schizophrenia, and bipolar 
disorder from many international research groups, had the opportunity to investigate 
this. Based on the common variants, that were genotyped for single GWASs of the five 
disorders, they investigated their shared genetic etiology. Through genetic correlation 
analyses, they reported several disorders to show significant shared genetic etiology, 
for ADHD a moderate genetic correlation with major depressive disorder was shown 
(Cross-Disorder Group of the Psychiatric Genomics and others 2013a). These results encouraged 
them to investigate potential common pathophysiologies of these disorders, which they 
realized by combining the GWASs of the five psychiatric disorders in one analysis. In total, 
their dataset consisted of 33,332 cases and 27,888 controls, increasing the power to find 
genome-wide significant associations. They found genome-wide significant associations 
for four independent regions. One for a SNP in the intronic region of ITIH3, although the 
linkage disequilibrium around this region encompasses several genes. That was also 
the case for the significant variant in the intron of AS3MT. The other two significant 
variants were located within CACNA1C (although the best fitting model included only 
schizophrenia and bipolar disorder for this finding) and in an intron of CACNB2, both 
genes are involved in calcium-channel activity (Cross-Disorder Group of the Psychiatric Genomics 
and others 2013b). Next to the identification of calcium activity being a potential important 
process in different psychiatric disorders, these findings also indicate that diagnostic 
criteria might not necessarily coincide with the underlying genetic components. Further 
research is needed to be able to elaborate on this, as it can potentially have a high impact 
on psychiatric diagnostics in the long term.
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Rare variants
Data collected by GWAS has been used to estimate the contribution of common genetic 
variants using genomic heritability estimate tools (Yang et al., 2013a). The SNP heritability 
estimate for ADHD based on common genetic variants captured in GWAS is 0.28, which 
is significantly lower than the heritability estimates based on family studies (Cross-Disorder 
Group of the Psychiatric Genomics et al., 2013). While part of this might be due to the relatively 
small number of samples available for such analyses yet, it also suggested that the com-
mon genetic variants captured by GWAS are most probably not the complete story for 
ADHD. Another interesting contribution to ADHD might come from rare genetic variants 
(less than 1% frequency in the population) (Thapar et al., 2013). Results of studies investiga-
ting rare variants in ADHD indeed suggest increased burden of big rare variants in ADHD 
(Yang et al., 2013b). The findings point to genes involved in the disruption of neurodevelop-
mental pathways (Elia et al., 2010; Lesch et al., 2011), and glutamatergic neurotransmission 
(Elia et al., 2012). Overlap with chromosomal regions found in autism and schizophrenia 
has been observed (Stergiakouli et al., 2012; Williams et al., 2012; Williams et al., 2010), as has 
overlap of these regions with regions of common genetic variants associated with ADHD 
(Stergiakouli et al., 2012).
Imaging genetics
As the search for genetic risk factors for ADHD turned out to be difficult, studies have 
tried to simplify this complex phenotype. This is attempted by using endophenotypes. 
Endophenotypes are phenotypes that lie on the pathway from gene to disorder and are 
 hypothesized to be genetically less complex than the disorder. The prerequisites for an 
endo phenotype are that the trait is heritable, associated with the disorder in the popula-
tion, cosegregates with the disorder in families, is also found in non-affected family mem-
ber, and can be measured reliably (Gottesman and Gould, 2003). Structural brain measures 
have been opted as endophenotypes for ADHD, as they fulfill these criteria for ADHD (Frodl 
and Skokauskas, 2012; Peper et al., 2007; Valera et al., 2007). Investigating the genetic influences 
on neuroimaging measures is also known as imaging genetics, which has been suggested 
to be useful in the investigation of psychiatric disorders (Meyer-Lindenberg & Zink, 2007). 
People have argued that brain volume may be closer to a gene then a clinical phenotype, 
indicating the possibility that genetic effects on brain volume are larger compared to the 
genetic effects on diagnostic status. Later in this thesis, I will come back to this point, as 
this reasoning is currently under discussion. Another advantage of imaging genetics is 
its potential to give us more insight into the underlying biological mechanisms of genetic 
risk factors for ADHD. Imaging genetics studies performed in ADHD have been reviewed 
in (Durston, 2010) and (Dresler et al., 2014). Although some of these studies reported gene-
brain associations, some limitations reduce the enthusiasm for the findings in imaging 
genetics of ADHD so far. The first limitation is that reported findings have been inconsist-
ent, making their results inconclusive. The second limitation is that all studies started 
from one or a few candidate genes, still requiring a priori hypotheses on the potential 
role of genetic variants. And the third limitation is that the findings in ADHD combining 
structural brain measures and genetics are based on small sample sizes, limiting the 
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representativeness of the sample for the population and making it almost impossible to 
find associations with limited effect sizes. 
The next steps
Regarding the challenges we face in the (imaging) genetics of ADHD, there are several 
routes that can be taken. A first route is that we can profit greatly from finding traits that 
are associated to the familial risk of ADHD and can subsequently be used for molecular 
genetic analysis. Next to the possibility of these traits guiding us to novel genetic risk 
factors for ADHD, they can be used for elucidating the underlying biological processes 
involved in ADHD. An important way to do this is to use large(r) samples of participants 
with ADHD and controls. Trying to investigate large samples for this purpose was done in 
the current thesis, but also by a research consortium known as the ENIGMA consortium 
(Enhancing Neuro Imaging Genetics through Meta-Analysis; http://enigma.ini.usc.edu/; Thompson et 
al. 2014). ENIGMA brings together scientists all around the world contributing imaging 
and/or genome-wide genetic data sets. The aim of this consortium is to understand brain 
structure, function, and disorders, based on brain imaging and genetic data, by perform-
ing meta-analyses of genetic association studies with brain measures. Brain scans and 
genetic data of both healthy individuals as well as subjects with diseases or disorders 
are allowed in ENIGMA. In their first study the researchers investigated the relationship 
between common genetic variants and hippocampus volume and intracranial volume. 
Through collaborations of more than 100 centers world-wide, this study was able to reach 
a sample size of more than 20,000 individuals, and was the first to find two SNPs that 
reached the threshold of being genome-wide significantly associated to hippocampus 
volume and intracranial volume, respectively (Stein et al. 2012). ENIGMA continued after 
this success with genetic association analyses for other subcortical structures (Hibar et 
al., under review in Nature), and by initiating working groups for psychiatric disorders 
and imaging techniques present in their data set (i.e. Schizophrenia, Bipolar disorder, 
ADHD, depression, DTI, see http://enigma.ini.usc.edu/). 
Next to increasing sample sizes for (imaging) genetic studies in ADHD, a second route the 
field can also profit from is the use of more advanced genetic analyses, that go beyond the 
search for association of single genetic variants to the binary diagnose [yes/no]. Here, the 
research field could benefit from knowledge on biological processes or previously indica-
ted gene sets already indicated to potentially play a role in ADHD. Another approach is to 
let the data guide your analyses, by investigating if there is common underlying variance 
to be explained by different measures, and by aggregating multiple measures into a single 
measure that potentially has more power to detect genetic association.
Finally, multivariate methods may also be a useful route to advance the field of (imaging) 
genetics in ADHD. As the number of data points of our genetic data (around 3 billion base 
pairs of which approximately 13 million are variable as SNPs) and the number of data 
points of our imaging data (e.g. around 230,000 grey matter voxels used in brain imaging, 
dependent on the voxel size) is high, the correction for the huge number of statistical tests 
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makes it difficult to detect effects of reasonable effect sizes with practical sample sizes. 
Multivariate methods can help by simultaneously assessing multiple variables for a com-
bined effect. To identify these aggregated effects several multivariate methods have been 
developed (Liu and Calhoun, 2014). One of these methods is independent component analysis 
(ICA) (Xu et al., 2009). ICA is a technique that extracts a set of underlying components from 
a set of variables. The assumption is that the underlying components are independent 
and linearly mixed into the observations you see in your data. The ICA algorithm extracts 
these underlying components, thereby reducing data tremendously, as well as searching 
for independent sources, which potentially capture underlying biological processes (al-
though noise will also be captured in some components). Considering the large amount 
of data we collect, and the need to handle these data in a biologically interesting way, 
we believe that multivariate methods, with the ICA approach as an example, can help to 
get the most out of one’s data (Liu & Calhoun, 2014). Trying to associate this clustered data 
to ADHD can provide new knowledge about this disorder. 
The aim and structure of this thesis
The overall aim of this thesis is to improve our understanding of the genetic underpin-
nings of ADHD and use cognitive and brain phenotypes relevant for ADHD as possible 
sources to search for genetic risk factors for ADHD.
This thesis is divided in three parts, according to three sub-questions:
–  Part 1, ‘Structural brain variation in ADHD’, tries to answer the question, which 
brain phenotypes show familial links with ADHD and can therefore be useful in the 
search for genetic mechanisms involved in ADHD risk.
–  Part 2, ‘Genetics of ADHD’, addresses the question, which and how molecular genetic 
mechanisms are involved in ADHD.
–  Part 3, ‘Brain Imaging Genetics in ADHD’, explores if the use of brain imaging gen-
etics in ADHD research can be useful to understand the genetic effects involved in 
ADHD.
PART 1 Structural brain variation in ADHD (Chapters 2-3)
In this part of my thesis I explore the possibility, that brain-derived phenotypes can help 
in our search for the genetic underpinnings (partially) explaining the biological mech-
anisms involved in the disorder. Single studies reporting on brain variation observed in 
ADHD usually have limited sample sizes, and results have been inconsistent. Even though 
meta-analyses have been conducted to summarize the main results, these are restricted 
by the limitations of the single studies. In Chapter 2, I describe our findings on the dif-
ferences in total and subcortical brain volumes in participants with ADHD compared to 
controls in a large well-characterized sample. In Chapter 3, I report on a hypothesis-free 
whole-brain analysis investigating local volume differences between participants with 
ADHD and controls. Both chapters describe analyses within the family-based sample of 
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the NeuroIMAGE sample (www.neuroimage.nl (von Rhein et al., 2014)), which includes 
 siblings of both participants with ADHD and controls (see also ‘study cohorts’). This 
made it possible to divide our group in three subgroups, i.e. participants with ADHD, un-
affected siblings, and controls. This set-up enabled us to investigate familial components 
by comparing the brain volumes of the unaffected siblings to those of the individuals 
with ADHD and controls. 
PART 2 Genetics of ADHD (Chapters 4-6)
As the search for genetic risk factors in ADHD has proven to be difficult, the aim of 
the second part of this thesis was to work on methods that could help with identifying 
and unraveling genetic mechanisms involved in ADHD. Strategies we used go beyond 
the commonly used univariate association to case-control status, to try to increase the 
power of gene-finding. In Chapter 4, neuropsychological measures were used to inves-
tigate involvement of dopaminergic and serotonergic candidate genes in ADHD, taking 
into account the possible influence of developmental stages. In Chapter 5, a common 
intra-individual variability construct, extracted from multiple neuropsychological tasks, 
was used as the outcome of interest for a linkage analysis. The aim was to discover new 
chromosomal areas that potentially harbor genes important for neuropsychological per-
formance relevant for ADHD. ADHD has been shown to have a polygenic nature (multiple 
genes, which may interact, are involved in the risk/onset of the disorder), and it shows 
genetic heterogeneity (different genes having an effect on the same outcome, i.e. the 
disorder). Therefore, in Chapter 6, I describe an attempt to address these challenges by 
performing candidate genetic pathway analysis in ADHD, simultaneously associating 
multiple genetic variants to ADHD symptoms.   
PART 3 Brain Imaging Genetics in ADHD (Chapter 7)
Here, I describe an imaging genetics approach, in which I aimed to combine the know-
ledge gained from parts 1 and 2 and go beyond more traditional imaging genetics ap-
proaches to evaluate the usefulness of a multivariate approach. Chapter 7 describes the 
ICA analysis we performed and the attempt to identify gene-brain correlations in ADHD.
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Study cohorts
I would like to shortly address, which data sets were used in the current thesis.
IMAGE cohort
The first cohort that was used is the International Multicenter ADHD Genetics (IMAGE) study (Brookes et al., 
2006; Kuntsi et al., 2006). The IMAGE study was conducted by a consortium of seven European countries 
and Israel, which aimed to identify genetic risk factors for ADHD. Families with at least one child with 
ADHD as well as at least one biological sibling (irrespective of ADHD diagnostic status) were recruited. Pro-
bands were required to be between 5 and 17 years of age, have an IQ above 70, and could not suffer from 
autistic disorder or Asperger syndrome, epilepsy, or other disorders associated to ADHD. IMAGE collected 
extensive phenotypic, endophenotypic (neuropsychological) and genotypic information of these families. 
Data collection in the Netherlands was performed between 2004 and 2007, and the Dutch database 
also included phenotypic and cognitive data from healthy control children. To enable molecular genetic 
studies the IMAGE project participated in the Genetic Association Information Network (GAIN) (Manolio 
et al., 2007), which provided the genotyping of more than 600,000 SNPs to perform a GWAS in 958 trios 
(315 from the Netherlands) of ADHD-affected children and their parents (Neale et al., 2008). Data of the 
IMAGE cohort was used for chapters 4,5,6 and 7.
NeuroIMAGE cohort
The second cohort that was used is the one from the NeuroIMAGE project. NeuroIMAGE was performed be-
tween 2009 and 2012, and is the follow-up study of the Dutch part of the IMAGE project (www.neuroimage.
nl (von Rhein et al., 2014)). NeuroIMAGE aimed to enrich the database of the Dutch IMAGE samples. Newly 
added measures are structural and functional MRI data in probands and siblings, follow-up data on clin ical 
status using questionnaires and semi-structured interviews (both ADHD as well as relevant comorbid ities), 
neuropsychological measures in both probands and siblings, additional DNA collection of individuals 
that did not contribute DNA in IMAGE (for example all control families), and comparable phenotypic and 
neuropsychological measures of the parents. Data of the NeuroIMAGE cohort was used in chapters 
2,3,4,5 and 7.  
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ABSTRACT
Importance: Attention-deficit/hyperactivity disorder (ADHD) is a heritable neurodevel-
opmental disorder. Whole brain volume is reportedly reduced in ADHD, as well as 
 early-emerging, persistent sub-cortical abnormalities. However, due to heterogeneity within 
and between studies and limited sample sizes, findings on the neuroanatomical substrates 
of ADHD have shown considerable variability. Moreover, potential familial underpinnings 
that may underlie these findings remain underexplored. 
Objective: To examine whether ADHD is linked to alterations in whole brain and subcortical 
volumes; and to examine familial underpinnings of brain volumetric alterations in ADHD.
Design, setting and participants: We included participants from the large and careful-
ly-phenotyped Dutch NeuroIMAGE sample (collected between 2009-2012) consisting of 
307 participants with ADHD, 169 of their unaffected siblings and 196 typically-developing 
controls (mean age=17.21 years, age range: 8-30 years). 
Main outcome measures: Whole brain volumes (total brain, gray and white matter vol-
umes) and volumes of subcortical regions (nucleus accumbens, amygdala, caudate  nucleus, 
 globus pallidus, hippocampus, putamen, thalamus and brainstem) were derived from 
 structural magnetic resonance imaging (MRI) scans using automated tissue-segmentation. 
Results: Regression analyses revealed that, relative to controls, participants with ADHD 
had a 2.5% smaller total brain (p=0.0027) and a 3% smaller total gray matter volume 
(p=0.0005)while total white matter volume was unaltered. Unaffected siblings had total 
brain and total gray matter volumes intermediate to participants with ADHD and controls. 
Significant age by diagnosis interactions showed that increasing age was linked to de-
creasing caudate (p<0.0001) and putamen (p=0.0101) volumes in controls, but not in 
participants with ADHD nor their unaffected siblings. ADHD was not significantly related 
to the other subcortical volumes.
Conclusions and Relevance: Global reductions in gray matter volume may be due to alter-
ations in general mechanisms underlying normal brain development in ADHD. The age-de-
pendent findings in the caudate and putamen indicate the relevance of different brain 
developmental trajectories in participants with ADHD versus controls, and support the 
role of subcortical basal ganglia alterations in the pathophysiology of ADHD. Alterations 
in whole brain, caudate and putamen volumes in unaffected siblings suggest that these 
volumes are linked to familial risk for ADHD and may be useful in molecular genetic studies.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental dis-
order characterized by symptoms of inattention and/or hyperactivity/impulsivity (Polanczyk 
and Rohde, 2007). Anatomical magnetic resonance imaging (MRI) studies have associated 
ADHD with a reduction in total brain size of 3-5% compared to controls (Castellanos et al., 
1996; Castellanos et al., 2002; Durston et al., 2004). Total brain size has been reported to be 
negatively correlated with ADHD symptoms in an adult population sample (Hoogman et al., 
2012). Meta-analyses have documented volume reductions in ADHD across several brain 
regions, most consistently in basal ganglia volumes; right globus pallidus, right putamen 
and caudate (Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011; Valera et 
al., 2007). Abnormalities in basal ganglia regions are in accordance with a neurodevel-
opmental theory which hypothesizes ADHD to be caused by early-emerging persistent 
sub-cortical abnormalities (Halperin and Schulz, 2006).
Existing studies on brain volumetric alterations in ADHD have come with limitations. 
First, child and adult literature have largely been kept separate ignoring the transition 
from adolescence into early adulthood in studying age effects. Hyperactivity/impulsivity 
symptoms of ADHD more than inattention symptoms tend to decrease with age (Bieder-
man et al., 2000; Greven et al., 2011b; Larsson et al., 2006). Moreover, cross-sectional evidence 
suggests that some aspects of brain volumetric alterations observed in childhood may 
normalise with increasing age (Frodl and Skokauskas, 2012; Nakao et al., 2011). Second, findings 
have been variable, e.g. one meta-analysis reported that only 25-50% of included studies 
revealed similar results (Frodl and Skokauskas, 2012). Heterogeneity in sample composition 
within and between studies and small samples sizes may explain inconsistencies; in-
dividual studies included in the meta-analyses ranged from 17 to 291 participants with 
ADHD and controls, with only four studies exceeding a sample size of 100 (Ellison-Wright 
et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011; Valera et al., 2007). Third, ADHD is 
more common in boys than girls (Greven et al., 2011a; Polanczyk and Rohde, 2007), and brain 
volumetric alterations in ADHD may be hemisphere-specific (Ellison-Wright et al., 2008; Frodl 
and Skokauskas, 2012; Nakao et al., 2011; Valera et al., 2007). However, the majority of previous 
work used small samples to study gender or lateralisation effects or revealed inconsistent 
findings (Frodl and Skokauskas, 2012; Nakao et al., 2011; Onnink et al., 2014; Valera et al., 2007). 
ADHD runs in families (Faraone et al., 2000; Levy et al., 2006; Sprich et al., 2000), and its herit-
ability is estimated around 76% (Faraone and Mick, 2010). As brain volumes are also heritable 
(total brain volume around 66-97% (Peper et al., 2007); subcortical volumes around 44-88% 
(den Braber et al., 2013)), associations between ADHD and brain volumetric alterations may 
be influenced by shared genetic influences. Two studies showed alterations in prefrontal 
gray matter and occipital gray and white matter (Durston et al., 2004), as well as inferior 
frontal gyrus gray matter and inferior fronto-occipital fasciculus white matter (Pironti et al., 
2013) not only in participants with ADHD, but also in their unaffected siblings relative to 
controls. Because first degree relatives on average share 50% of their genetic information 
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as well as all family-wide environmental influences, these findings suggest familial (i.e. 
shared genetic and/or shared environmental) underpinnings to associations between 
ADHD and brain volumes. Studying genetic or familial underpinnings will provide further 
clarification of mechanisms underlying ADHD-brain associations.
The present cross-sectional study aimed to examine brain volumetric correlates of ADHD 
in a large well-characterized sample of adolescents and young adults with ADHD, their un-
affected siblings and typically-developing controls. First, we investigated whether ADHD 
would be linked to whole brain and subcortical volumes, and whether results would be 
influenced by age, gender or lateralisation. Second, familial underpinnings of brain vol-
umetric alterations in ADHD were examined. The focus on whole brain and subcortical 
volumes was based on evidence for reductions in these volumes (Castellanos et al., 1996; 
Castellanos et al., 2002; Durston et al., 2004; Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; 
Nakao et al., 2011; Valera et al., 2007) and the neurodevelopmental theory that ADHD is caused 
by early emerging non-cortical alterations (Halperin and Schulz, 2006). Subcortical volumes 
of the nucleus accumbens, amygdala, caudate nucleus, globus pallidus, hippocampus, 
putamen, thalamus and brainstem were selected, all of which demonstrated heritable 
underpinnings (den Braber et al., 2013). 
Method
Sample
Participants came from the NeuroIMAGE project, a follow-up (2009-2012) (von Rhein et 
al., submitted) of the Dutch part of the International Multicenter ADHD Genetics (IMAGE) 
study performed between 2003-2006 (Muller et al., 2011; Nijmeijer et al., 2009; Rommelse et al., 
2008a). IMAGE recruited ADHD families with at least one child with combined type ADHD 
and at least one biological sibling (regardless of ADHD diagnosis), as well as control 
families with at least one child and one biological sibling with no formal or suspected 
ADHD diagnosis in first-degree family members. Inclusion criteria were: age between 8-30 
years, Caucasian descent, IQ ≥ 70 and no diagnosis of autism, epilepsy, general learning 
difficulties, brain disorders and known genetic disorders. Dutch participants of IMAGE 
were invited for follow-up measurement and (re)assessed in NeuroIMAGE between 2009 
and 2012 (follow-up rate ADHD families 75.6%, controls 75.1%). Time between the IMAGE 
and NeuroIMAGE measurements was 5.9 years (SD=0.74). Inclusion criteria were largely 
consistent with IMAGE, except that inclusion of children with any ADHD subtype was 
allowed . Following exclusion of participants with contra-indications for MRI scanning 
and quality control of MRI scans (described below), the final sample consisted of 307 par-
ticipants with ADHD, 169 unaffected siblings and 196 control subjects (siblings from 389 
families) (Table 1). Ethical approval was obtained (CMO Regio Arnhem – Nijmegen; 2008/163; 
ABR: NL23894.091.08), and all participants provided written informed consent.
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Table 1  Participant characteristics
 
ADHD
(N=307)
Siblings
(N=169)
Control
(N=196)
% male 68% 43% 49%
Mean age in years (SD) 17.06 (3.42) 17.52 (4.11) 16.66 (3.07)
Mean / median total ADHD (SD) 69.99 / 70.00 (12.88) 47.60 / 46.00 (6.58) 45.74 / 45.00 (5.24)
Mean / median INATT (SD) 66.10 / 66.00 (11.16) 47.72 / 45.00 (6.56) 46.27 / 45.00 (5.61)
Mean / median HYP-IMP (SD) 69.85 / 68.00 (14.48) 48.29 / 46.00 (7.11) 46.27 / 44.00 (4.93)
Mean IQ (SD) 97.08 (15.18) 102.19 (14.54) 106.61 (13.70)
Note Siblings = unaffected siblings of participants with ADHD. Total ADHD, INATT and HYP-IMP refer to t-scores on the 
DSM total, inattentive behaviour and hyperactive-impulsive behaviour scales of the Conners’ Parent Rating Scale-Revised 
(scales N, L and M; CPRS-R:L; (Conners et al., 1998a)). T-scores ≥ 63 are regarded clinically elevated.
Diagnostic assessment of ADHD  
Each participant was assessed with a Conners parent-rated questionnaire (CPRS-R:L) (Con-
ners et al., 1998a) combined with either a teacher-rating (CTRS-R:L) (Conners et al., 1998b) or 
self-report (CAARS-S:L) (Conners et al., 1999). In addition, all participants were interviewed 
by trained professionals on the Schedule for Affective Disorders and Schizophrenia for 
School-Age Children – Present and Lifetime Version (Kaufman et al., 1997) (K-SADS). A diag-
nostic algorithm was applied to combine symptom counts on the K-SADS and Conners’ 
questionnaires (American Psychiatric Association, 2000). See Methods S1 in the Supplement 
for details.
Image acquisition and segmentation
Imaging was conducted at two sites (Amsterdam and Nijmegen) using two comparable 1.5 
Tesla scanners and scan protocols (Siemens Sonata/Avanto), the same product 8-channel 
head-coil and closely matched scan protocols. The protocol included two high-resolution 
T1-weighted MP-RAGE anatomical scans (176 sagittal slices, TR = 2730 msec, TE = 2.95 
msec, TI = 1000 ms, flip angle = 7 deg, GRAPPA 2, voxel size = 1.0 x 1.0 x 1.0 mm, field of 
view = 256 mm). MRI scans which yielded relevant incidental findings, or in which manual 
ratings revealed poor quality or motion artifacts were excluded from analysis (Blumenthal 
et al., 2002). In participants with two good quality scans, volume estimates were averaged 
across scans thereby improving signal-to-noise ratio. If only one good quality scan was 
available, a single scan was used. 
Whole brain volumes. Normalisation, bias-correction and segmentation into gray matter, 
white matter and cerebrospinal fluid were performed using the unified procedure of the 
VBM 8.1 toolbox (http://dbm.neuro.uni-jena.de/vbm/) in SPM (default settings). Total 
gray and white matter volumes were calculated by summation of their tissue probability 
maps. Total brain volume was taken as the sum of total gray and white matter volume. 
Subcortical volumes. Automated FIRST subcortical segmentation was applied to estimate 
total, left and right volumes of eight regions: amygdala, caudate nucleus, hippocampus, 
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nucleus accumbens, globus pallidus, putamen, thalamus and brain stem. FIRST is part 
of FMRIB’s Software Library (FSL) and performs registration and shape modelling of the 
above regions in MNI152 standard space (Patenaude et al., 2011). FIRST-based segmentation 
includes the hippocampus as a subcortical region although it is not usually considered 
subcortical (Patenaude et al., 2011).
Assessment of IQ and medication use
Participant’s full-scale IQ was estimated using the Vocabulary and Block Design subtests 
of the Wechsler Intelligence Scale for Children (WISC-III) or Wechsler Adult Intelligence 
Scale (WAIS-III; for participants ≥ 17 years). These subtests show high correlations with 
full-scale IQ scores (0.88 for WISC and 0.90 for WAIS) (Silverstein, 1975, 1982). Participants 
self-reported lifetime use of psychoactive medication. The current study classified indi-
viduals who never took medication as medication-naïve.
Analyses 
Comparisons between participants with ADHD and controls. Brain volumetric meas-
ures were normally distributed and outliers more than three standard deviations above 
or below the mean were removed. Associations between ADHD and brain volumes were 
examined using regression analyses that included brain volumes as outcome measures, 
and scanner location (Amsterdam, Nijmegen), age, age2 and gender as covariates (Brain 
Development Cooperative, 2012; den Braber et al., 2013; Reiss et al., 1996). Total brain volume 
was included as an additional covariate for regressions of subcortical volumes, to enable 
inferences about subcortical alterations unconfounded by total brain volume (Mechelli et 
al., 2005). Analyses were repeated without total brain volume as a covariate (same pattern 
of results; results not shown). The regression model included binary ADHD diagnosis 
(ADHD, control) as a main effect, as well as the 2-way interaction effects between binary 
ADHD diagnosis and age, age2 and gender (ADHD by age; ADHD by age2; ADHD by gen-
der). Interaction effects not reaching nominal significance (p< 0.05) were dropped from 
the final model. Centering of variables was used (Bradley and Srivastava, 1979) before creating 
interaction terms and multicollineary statistics were examined. Observations were not 
independent within families, hence we accounted for the correlation structure of the data 
by calculating robust standard errors using the ‘cluster’ command in STATA (StataCorp, 
2007; Williams, 2000). This was merely a correction to account for the underlying assumption 
in regression that observations are independent and does not preclude examination of 
familiality effects on brain-ADHD associations.
Correction for multiple testing. A multiple testing correction was applied which adjusts 
correlated tests based on an effective number (Meff) of independent comparisons (Li and Ji, 
2005) derived from the Eigenvalues of a correlation matrix between the included outcome 
measures adjusted for covariates. The multiple-testing adjusted p-value was determined 
to be 0.003 (see Table S1) and applied to analyses comparing participants with ADHD and 
controls. Any follow-up analyses of effects surviving multiple-testing correction used the 
nominal significance level (0.05) and should be seen as exploratory. 
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Comparisons of unaffected siblings to participants with ADHD and controls. For re-
sults surviving multiple testing correction, the regression models were repeated including 
a three-level group membership variable (ADHD, unaffected sibling, control). Familiality 
was considered to be present if unaffected siblings differed in brain volumes from controls 
but not from participants with ADHD, or differed from both groups showing intermediate 
brain volumes. 
Potential effects of IQ and medication use. Based on previous evidence, stimulant use 
(Frodl and Skokauskas, 2012; Nakao et al., 2011) and IQ (Hulshoff-Pol et al., 2006; Kuntsi et al., 2004; 
Rushton and Ankney, 2009) were treated as potential confounders. First, for any volumes 
surviving multiple testing correction, the regression models comparing participants with 
ADHD to controls were repeated including IQ as an additional covariate. Second, they 
were repeated excluding participants with ADHD who ever took psychoactive medication 
thereby comparing controls only to the small sample of medication-naive participants 
with ADHD (N=35).
Results
Comparisons between participants with ADHD and controls
Whole brain volumes. Compared to controls, participants with ADHD had smaller total 
brain (p=0.0027) and total gray matter volumes (p=0.0005). Total brain volume was 2.5% 
(32 ml) smaller and total gray matter volume 3% (22 ml) smaller (Figure 1; Tables 2-3). 
No significant group differences were found for total white matter volume. None of the 
interactions between ADHD diagnosis and gender, age and age2 were significant (Table 3).
 
Figure 1  Mean total brain and total gray matter volumes in participants with ADHD, unaffected siblings 
and controls. Y-axis shows brain volumes in ml. Siblings = unaffected siblings of participants with ADHD. 
Means based on estimated marginal means corrected for age, age2, gender, and scanner location. Error bars 
represent standard errors.
1275
1250
1225
1200
Controls
775
750
725
700
ControlsSiblings
Total Brain Volume Gray Matter Volume
SiblingsADHD ADHD
48 Chapter 2
Table 2  Mean brain volumes in ml (± SE) for participants with ADHD, unaffected siblings and controls
ADHD (N=307) Siblings (N=169) Control (N=196)
M ±SE M ±SE M ±SE
1 Total Brain 1230.59 6.08 1250.72 8.27 1262.31 8.15
2 Gray Matter 724.49 3.49 737.32 4.97 746.82 5.07
3 White Matter 505.59 3.21 513.11 4.17 515.52 4.15
4 Accumbens (t) 1.15 0.01 1.11 0.01 1.11 0.01
5 Accumbens (l) 0.61 0.01 0.60 0.01 0.59 0.01
6 Accumbens (r) 0.54 0.01 0.51 0.01 0.52 0.01
7 Amygdala (t) 2.67 0.02 2.67 0.03 2.63 0.03
8 Amygdala (l) 1.30 0.01 1.28 0.02 1.25 0.02
9 Amygdala (r) 1.36 0.02 1.38 0.02 1.37 0.02
10 Caudate (t) 8.11 0.05 7.99 0.06 8.09 0.06
11 Caudate (l) 3.98 0.02 3.92 0.03 3.97 0.03
12 Caudate (r) 4.13 0.02 4.07 0.03 4.12 0.03
13 Globus Pallidus (t) 3.76 0.02 3.74 0.02 3.71 0.02
14 Globus Pallidus (l) 1.87 0.01 1.85 0.01 1.83 0.01
15 Globus Pallidus (r) 1.90 0.01 1.89 0.01 1.88 0.01
16 Hippocampus (t) 7.81 0.04 7.82 0.05 7.80 0.06
17 Hippocampus (l) 3.84 0.02 3.83 0.03 3.81 0.03
18 Hippocampus (r) 3.97 0.02 3.99 0.03 4.00 0.03
19 Putamen (t) 10.87 0.06 10.85 0.07 10.73 0.07
20 Putamen (l) 5.45 0.03 5.44 0.04 5.38 0.03
21 Putamen (r) 5.43 0.03 5.41 0.03 5.35 0.04
22 Thalamus (t) 16.88 0.06 16.79 0.07 16.80 0.08
23 Thalamus (l) 8.53 0.03 8.48 0.04 8.49 0.05
24 Thalamus (r) 8.34 0.03 8.31 0.04 8.30 0.04
25 Brainstem 22.10 0.11 22.18 0.14 22.03 0.12
Note  Siblings = unaffected siblings of participants with ADHD. (t): total, (l): left, (r): right. Means based on estimated 
marginal means corrected for age, age2, gender, scanner location; for subcortical volumes correction for total brain 
volume is also included. 
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Table 3  Regression analyses of brain volume differences between participants with ADHD and controls
p-values 
Outcome ADHD ADHD x age ADHD x age2 ADHD x gender
1 Total Brain 0.0027* - - -
2 Gray Matter 0.0005* - - -
3 White Matter 0.0625 - - -
4 Accumbens (t) 0.0082 - - -
5 Accumbens (l) 0.4478 0.0157 0.0345 -
6 Accumbens (r) 0.0079 - - -
7 Amygdala (t) 0.3313 - - 0.0122
8 Amygdala (l) 0.8702 - - 0.0365
9 Amygdala (r) 0.0790 - - 0.0327
10 Caudate (t) 0.3094 0.0004* 0.0346 -
11 Caudate (l) 0.3325 0.0003* 0.0407 -
12 Caudate (r) 0.4517 0.0035# 0.0475 -
13 Globus Pallidus (t) 0.0512 0.0073 - -
14 Globus Pallidus (l) 0.0146 0.0169 - -
15 Globus Pallidus (r) 0.1709 0.0081 - -
16 Hippocampus (t) 0.9625 - - -
17 Hippocampus (l) 0.6697 - - -
18 Hippocampus (r) 0.4842 - - -
19 Putamen (t) 0.0448 0.0011* - -
20 Putamen (l) 0.0465 0.0004* - -
21 Putamen (r) 0.0583 0.0018* - -
22 Thalamus (t) 0.4431 - - -
23 Thalamus (l) 0.5146 - - -
24 Thalamus (r) 0.4471 - - -
25 Brainstem 0.5369 - - -
Note  Results from the final regression model examining associations between binary ADHD diagnosis (ADHD versus 
control) and brain volumes. ADHD x age, ADHD x age2, and ADHD x gender denote interaction terms. Total Brain= 
sum of total gray and white matter volumes, t=total volume of left and right hemispheres summed, l= volume of 
left hemisphere; r= volume of right hemisphere. A dash indicates the interaction was dropped from the final model 
because it did not reach nominal significance (p<0.05). The main effect of ADHD was never dropped from the model. 
Included covariates: age, age2, gender, scanner location; for subcortical volumes covariates also included total brain 
volume. 
*  indicates p-value remains significant following multiple testing (Meff adjusted p-value threshold of 0.003). 
#   Although the ADHD x age interaction on right caudate volume just failed to meet the multiple-testing corrected 
threshold, plotting the data revealed that the pattern of results was very similar for left, right and total caudate 
volumes.
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Subcortical volumes. Main effects of binary ADHD diagnosis on subcortical regional 
volumes were nonsignificant (Table 3). However, the interaction between binary ADHD 
diagnosis and age on total, left and right caudate and putamen volumes was significant 
(caudate: total: p=0.0004; left: p=0.0003; right: p=0.0035) (putamen: total: p=0.0011; left: 
p<0.0004; right: p=0.0018) (Table 3). Post-hoc analyses revealed that increasing age was 
related to decreasing caudate and putamen volumes in controls (total caudate p<0.0001; 
total putamen p=0.0101), but not in participants with ADHD (total caudate p=0.8239; total 
putamen p=0.1588). Because results were similar for left, right and total volumes, sub-
sequent results are reported only for total caudate and putamen volumes. No significant 
interaction effects were present for the other subcortical volumes.
Comparisons of unaffected siblings to participants with ADHD and controls 
Whole brain volumes. Compared to participants with ADHD, unaffected siblings had a 
1.6% (20 ml; p=0.0439) larger total brain volume, and a 1.8% (13 ml; p=0.0346) larger total 
gray matter volume (Tables 2-3). Compared to controls, unaffected siblings had non-sig-
nificant smaller total brain volume (0.9%, 12 ml; p=0.3185) and smaller total gray matter 
volume (1.3%, 10 ml; p=0.1791). Nonetheless, a linear trend was present in these vol-
umes across the three groups (total brain volume: p=0.0018; total gray matter: p<0.0003; 
 Methods S2), indicating that unaffected siblings had total brain and total gray matter 
volumes intermediate to participants with ADHD and controls.
Figure 2  Group by age interaction on a) caudate nucleus volume and b) putamen volume. X-axis shows age 
in years, y-axis shows fitted values of total caudate and putamen volumes in ml. Siblings = unaffected siblings 
of participants with ADHD. The same pattern of results was found for total, left and right volumes.  
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Subcortical volumes. The interaction between group membership ‘unaffected siblings 
versus controls’ and age was a significant predictor of caudate and putamen volumes 
(total caudate p=0.0488; total putamen p=0.0086), but the interaction between group 
membership ‘unaffected sibling versus ADHD’ and age was not (total caudate p=0.1482; 
total putamen p=0.4776) (Figure 2). This suggests that the unaffected siblings differed 
from controls but not from participants with ADHD. Post-hoc analyses revealed that, as 
was the case for participants with ADHD, age was not related to caudate and putamen 
volumes in unaffected siblings (total caudate p=0.0897; total putamen p=0.4696).
Potential effects of IQ and medication use
When adding IQ as a covariate, ADHD-related reductions in total brain volume and gray 
matter volume were attenuated, but remained significant. The reduction in total brain 
volume was 1.6% (19 ml; p=0.0488) and in total gray matter volume 2.2% (16 ml; p=0.0077) 
(Tables S2 and S3). The interaction effect between binary ADHD diagnosis and age in the 
prediction of caudate and putamen volumes also remained significant after controlling 
for IQ (total caudate p=0.0002; total putamen p=0.0014; Table S3). Repeating regression 
analyses comparing controls to the small sample of medication-naïve participants with 
ADHD, the reduction in total brain volume no longer reached statistical significance, 
whereas reductions in total gray matter, caudate and putamen volumes (exception: right 
putamen) remained significant. However, overall results revealed the same direction of 
effects (Table S2 and S3).  
Discussion
We found that ADHD is linked to a 2.5% smaller total brain volume relative to controls, 
driven by a 3% smaller total gray matter volume, while total white matter was unaltered. 
Unaffected siblings had total brain and total gray matter volumes intermediate to par-
ticipants with ADHD and controls. Although no main effects of ADHD diagnosis on the 
studied subcortical volumes were found, age by diagnosis interactions revealed that age 
was linked to decreasing caudate and putamen volumes in controls, but not in partici-
pants with ADHD or their unaffected siblings.
Globalised gray matter volume reductions across the brain could indicate alterations to 
general mechanisms underlying normal brain development such as those concerning 
neuron number (e.g., neurogenesis, naturally-occurring neuron death) and neuronal mi-
gration (Kuan et al., 2000; Kwan et al., 2012). This is in line with results from genome-wide 
association and bioinformatics analyses that implicated abnormal neuronal migration 
and directed neurite outgrowth in ADHD (Franke et al., 2009; Poelmans et al., 2011). One way 
to probe for such mechanisms would be to use post-mortem brain tissue. Total brain 
and gray matter volume associations demonstrated no age-related changes, consistent 
with previous research showing reductions in total brain size in ADHD in children and 
adolescents (Castellanos et al., 2002; Durston et al., 2004), as well as in adults.
52 Chapter 2
The present study also found age-dependent associations of ADHD with caudate and 
putamen volumes. The caudate and putamen are part of the basal ganglia which play 
an important role in several basal ganglia-thalamocortical circuits (Alexander et al., 1986), 
involved in motor control, learning as well as selecting and enabling various cognitive, 
executive and emotional programmes (Ring and Serra-Mestres, 2002). Several of these pro-
cesses (e.g., motor functions, reward processing and cognitive and attentional control) are 
impaired in ADHD (Halperin and Schulz, 2006; Rommelse et al., 2008b). In the present study, 
caudate and putamen volumes decreased significantly with age in controls, in line with 
previous studies in typically-developing individuals reporting a decline in basal gan-
glia volumes across childhood development (Brain Development Cooperative, 2012; Goddings 
et al., 2014). In contrast, in participants with ADHD caudate and putamen volumes were 
developmentally stable. As a result, ADHD subjects appeared to have smaller caudate 
and putamen volumes in childhood and early adolescence relative to controls, but no 
longer around mid-to-late-adolescence. These results may be an underlying mechanism 
explaining previous studies reporting reductions in basal ganglia volumes in ADHD may 
normalise with age (Castellanos et al., 2002; Frodl and Skokauskas, 2012; Nakao et al., 2011). By 
early adulthood ADHD was related to larger caudate and putamen volumes relative to 
controls, inconsistent with previous studies in adults with ADHD, showing reductions 
(Almeida Montes et al., 2010; Onnink et al., in press; Seidman et al., 2011) or no differences (Ahrendts 
et al., 2011; Depue et al., 2010; Seidman et al., 2006). Most adult studies included older partici-
pants than the current study, potentially explanating this inconsistency. Developmental 
trajectories of caudate and putamen (Brain Development Cooperative, 2012; Goddings et al., 2014) 
may be delayed in ADHD, therefore larger volumes observed in the current study are no 
longer observed in studies on older samples. Alternatively larger volumes observed in 
early adulthood may represent overcompensatory mechanisms or are related to reduced 
neuronal pruning. The associations of ADHD with caudate and putamen volumes are 
consistent with hypotheses that subcortical alterations are key in the pathophysiology 
of ADHD (Halperin and Schulz, 2006).
Unaffected siblings showed total brain and total gray matter volumes intermediate to 
participants with ADHD and controls, although not significantly different from controls. 
Moreover, unaffected siblings differed significantly from controls but not participants 
with ADHD in their age by caudate or putamen interaction, and like for participants with 
ADHD, their caudate and putamen volumes were not subject to age effects. These findings 
provide suggestive evidence that total brain, total gray matter, caudate and putamen vol-
umes are linked to familial risk for ADHD. As familial underpinnings of ADHD are thought 
to be largely genetic (Faraone et al., 2005; Sprich et al., 2000), it is plausible that the identified 
brain-disorder associations are also genetically influenced. Familial, presumably genetic, 
mechanisms potentially underlie the reported ADHD-brain associations, creating possible 
new targets for molecular genetic research. 
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In this large sample, neurobiological alterations associated with ADHD were neither gen-
der- nor hemisphere-specific. When IQ was included as covariate, reductions in total brain 
and gray matter volumes were attenuated, but did not disappear. Medication use did not 
have an undue influence on the reported ADHD-brain associations. Most participants with 
ADHD had a lifetime history of medication use, suggesting that age effects in caudate 
and putamen were present in spite of the normalising effects of stimulant use reported 
in literature(Frodl and Skokauskas, 2012; Nakao et al., 2011). 
Strengths and limitations
A large well-defined sample of participants with ADHD, their unaffected siblings and con-
trols, is used which has added value over and extends existing meta-analyses. The current 
study was limited by a cross-sectional design. Nonetheless by including young adults 
and adolescents this study contributes towards linking the child and adult literature. 
Longitudinal follow-up of the current sample is under way. As the gender distribution 
between participants with ADHD and controls was unbalanced in the present sample, and 
gender-specific brain alterations have been reported in ADHD (Onnink et al., in press), further 
replication is needed. There is an active debate whether studies on ADHD should adjust 
for IQ group differences (Dennis et al., 2009), as IQ is likely to share meaningful variance 
with ADHD (Rommelse et al., 2008b), and therefore including IQ as a covariate may lead to 
overcorrection. Hence, we report findings with and without adjustment for IQ. Finally, 
the FIRST algorithm used to segment the subcortical volumes comes with limitations 
(Patenaude et al., 2011), nonetheless it is more objective than manual segmentation methods.
Conclusion
Our cross-sectional findings point to the relevance of different trajectories of brain de-
velopment in ADHD versus control subjects that are influenced by familial factors, and 
support the role of subcortical basal ganglia alterations as key to understanding the 
pathophysiology of ADHD.
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Supplementary material 
METHODS S1  Diagnostic assessment of ADHD in the NeuroIMAGE sample
NeuroIMAGE is a collaborative multi-site project involving ADHD and control families in 
the Netherlands. ADHD families were recruited through outpatient clinics in Arnhem, 
Groningen and Nijmegen as well as a VU University affiliated ADHD research institute 
in Amsterdam. Control families were recruited through primary and high schools in the 
same geographical regions as participating ADHD families.
To determine ADHD diagnosis during NeuroIMAGE, all participants in the study were 
similarly assessed using a combination of Conners ADHD questionnaires and a semi-struc-
tured diagnostic interview. For participants using medication, ratings were done regarding 
functioning off medication. Each participant was assessed with a Conners’ parent-rated 
questionnaire (CPRS-R:L)1 combined with either a teacher-rating (CTRS-R:L)2; applied for 
participants < 18 years, or a self-report (CAARS-S:L)3; applied for participants ≥ 18 years. 
All participants were administered the Dutch translation of the Schedule for Affective 
Disorders and Schizophrenia for School-Age Children – Present and Lifetime Version4 
(K-SADS), carried out by trained professionals. Both the parents and the participant, if ≥ 
12 years old, were interviewed separately and were initially only administered the ADHD 
screening interview. Participants with elevated scores on any of the screen items were 
administered the full ADHD section.
A diagnostic algorithm was applied to combine symptom counts on the K-SADS and Con-
ners questionnaires, both providing operational definitions of each of the 18 behavioural 
symptoms defined in DSM-IV5. Participants with a combined count of ≥ 6 hyperactive-im-
pulsive or inattentive symptoms were diagnosed with ADHD, provided they: a) met DSM-IV 
criteria for pervasiveness and impact of the disorder (measures derived from the K-SADS), 
b) showed an age of onset before 12 years (following the proposed changes for DSM-56), 
derived from the K-SADS, and c) the participant received a T score ≥ 63 on at least one 
of the DSM ADHD scales on either one of the Conners ADHD questionnaires. Unaffected 
siblings and controls were required to receive a T score < 63 on each of the scales of each 
of the Conners ADHD questionnaires, and have ≤ 3 symptoms derived from the combined 
symptom counts of the K-SADS and CTRS-R:L/CAARS-S:L. Criteria were slightly adapted 
for young adults (≥ 18 years), such that a combined symptom count of 5 symptoms was 
sufficient for a diagnosis7. Young adults were considered unaffected when they had ≤ 2 
symptoms on the combined symptom counts.
An additional category, labelled ‘subthreshold ADHD’, was created for participants who 
did not fulfil full criteria for either ADHD or unaffected status, and whom were not in-
cluded in the present study. A more detailed description of the NeuroIMAGE project and 
study procedures can be found elsewhere (see8; www.neuroimage.nl).
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METHODS S2  Comparisons of unaffected siblings to subjects with ADHD and controls on total 
brain and total gray matter volumes – post hoc linear trend analyses
 
Compared to subjects with ADHD, unaffected siblings had significantly larger total brain 
and total gray matter volumes (see main text). Moreover, compared to controls,  unaffected 
siblings had smaller total brain and total gray matter volumes, although these  differences 
were not statistically significant in the regression analyses (see main text). To enable 
 detection of more subtle linear trends in the data, orthogonal polynomial contrasts 
were conducted post-hoc. These contrasts revealed a significant linear trend across total 
brain and total gray matter volumes observed across the three groups (total brain: linear 
p=0.0018, quadratic p=0.6525) (total gray matter: linear p<0.0003, quadratic p=0.7725), 
consistent with the observation that unaffected siblings have mean total brain and total 
gray matter volumes intermediate to subjects with ADHD and controls.  
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Table S1  Correlation matrix of brain volumetric outcome measures (whole brain and subcortical); Eigenvalues 
of correlation matrix shown on diagonal
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Table S2  Mean brain volumes in ml (± SE) for participants with ADHD, unaffected siblings and controls cor-
rected for IQ; and for medicated and medication-naive participants with ADHD 
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Table S3  Regression of binary ADHD diagnosis on brain volumes a) controlling for IQ, and b) comparing con-
trols to the group of medication-naive participants with ADHD
p-values
Outcome ADHD ADHD x age ADHD x age2 ADHD x gender
a) IQ Total Brain 0.0488 - - -
Gray Matter 0.0077 - - -
Caudate (t) 0.5029 0.0002 0.0206 -
Caudate (l) 0.5273 0.0001 0.0249 -
Caudate (r) 0.6750 0.0015 0.0303 -
Putamen (t) 0.0371 0.0014 - -
Putamen (l) 0.0363 0.0006 - -
Putamen (r) 0.0527 0.0023 - -
b) Medication-naive ADHD Total Brain 0.1472 - - -
Gray Matter 0.0240 - - -
Caudate (t) 0.0674 0.0044 0.0442 -
Caudate (l) 0.0471 0.0012 0.0363 -
Caudate (r) 0.5992 0.0066 - -
Putamen (t) 0.8572 0.0071 - -
Putamen (l) 0.9746 0.0016 - -
Putamen (r) 0.8735 - - -
Note  Follow-up regression analyses examining associations between binary ADHD diagnosis (ADHD versus 
control) and brain volumes a) including IQ as an additional covariate, and b) comparing controls to the group of 
 mediction-naive subjects with ADHD (N=35). ADHD x age, ADHD x age2 and ADHD x gender denote interaction terms. 
Total Brain= sum of total gray and white matter volumes. t=total volume of left and right hemispheres summed,  
l= volume of left hemisphere; r= volume of right hemisphere. A dash indicates the interaction was dropped from the 
final model because it did not reach nominal significance (p<0.05). The main effect of ADHD was never dropped from 
the model. Included covariates for a)-b): age, age2, gender, scanner location; for subcortical volumes covariates also 
included total brain volume. 
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Voxel-based morphometry analysis reveals 
frontal brain differences in participants with 
ADHD and their unaffected siblings
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ABSTRACT
Objective: Data on structural brain alterations in attention-deficit/hyperactivity disorder 
(ADHD) have been inconsistent, due to methodological and sample heterogeneity and 
limited sample sizes. Both ADHD and brain volumes have a strong genetic loading, but 
whether brain alterations in ADHD are familial has been underexplored. We aimed to de-
tect structural brain alterations in adolescents and young adults with ADHD, compared to 
healthy controls, and examine whether these alterations were also found in their unaffected 
siblings, using a uniquely large sample.
Method: We performed voxel-based morphometry analyses on MRI scans of 307 partici-
pants with ADHD, 169 unaffected siblings, and 196 typically-developing controls (mean 
age=17.2 years; range 8-30 years), from the NeuroIMAGE project. First, we identified brain 
areas that differed between participants with ADHD and controls. Then we investigated 
whether these areas were different in unaffected siblings, considering influences of medi-
cation use, age, gender, and IQ. 
Results: Compared to controls, participants with ADHD had significantly smaller gray matter 
volume in five clusters located in the precentral gyrus, medial and orbital frontal cortex, 
and (para)cingulate cortices. Unaffected siblings showed intermediate volumes significantly 
different from controls in four of these five clusters (all except precentral gyrus). Medication 
use, age, gender or IQ did not have an undue influence on the results. 
Conclusions: Brain areas involved in decision making, motivation, cognitive control, and 
motor functioning were smaller in adolescents and young adults with ADHD compared to 
controls. Investigation of unaffected siblings indicated familiality of four of the structural 
brain differences, supporting their potential usefulness in molecular genetic analyses in 
ADHD. 
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common neuropsychiatric disorder 
characterized by developmentally inappropriate impulsive, hyperactive, and/or inatten-
tive symptoms (American Psychiatric Association, 2000). Previous magnetic resonance imaging 
(MRI) studies have reported smaller whole brain volumes in participants with ADHD 
compared to controls (Castellanos et al., 2002; Valera et al., 2007). Meta-analyses of regions 
of interest (ROI) studies showed significant smaller volume in total and right cerebral 
volume, frontal brain areas, the right caudate, and cerebellar regions in participants 
with ADHD compared to controls (Valera et al., 2007). Volumetric region of interest studies, 
however, are restricted to a small number of a priori selected regions, which could give 
rise to selection bias. 
A method that circumvents this, and allows a whole-brain hypothesis-free analysis, is 
voxel-based morphometry (VBM) (Ashburner and Friston, 2000). VBM is an MRI analysis tech-
nique which assesses differences between groups in voxelwise grey matter volume. Three 
meta-analyses of VBM studies, reporting on partly the same samples, have investigated 
the most prominent volumetric differences between participants with ADHD and controls 
(Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011). The first meta-analysis 
(N= 114 ADHD children and 143 controls) reported smaller grey matter volume in ADHD 
in the right putamen and globus pallidus (Ellison-Wright et al., 2008). A more recent one (N= 
202 children and adolescents and 176 adults with ADHD and 344 controls) confirmed the 
reduced localized subcortical grey matter findings in right globus pallidus and putamen, 
and also reported on a smaller right caudate nucleus, whereas larger local grey matter 
volume was found in the left posterior cingulate cortex (Nakao et al., 2011). The most recent 
study (N=175 children and adolescents and 145 adults with ADHD plus 288 controls) found 
reduced right globus pallidus and putamen volumes in children with ADHD, whereas the 
adult samples were characterized by anterior cingulate cortex volume reductions (Frodl 
and Skokauskas, 2012). However, studies used to generate the meta-analyses showed strong 
heterogeneity between samples and methods; reliability analysis revealed inconsistency 
in findings in 50% to 75% of the studies (Nakao et al., 2011). Given these limitations, in-
vestigating local volume differences within a single large sample has substantial added 
value over existing meta-analyses. 
Mechanisms underlying the relationship between ADHD and brain volumes are unclear. 
Both ADHD and brain volumes are known to be subject to genetic influences and familial 
(i.e. due to shared genetic and/or shared environmental factors) (Faraone et al., 2005; Peper et 
al., 2007). This suggests the potential usefulness of brain volumes in the search for ADHD 
risk genes (Gottesman and Gould, 2003). In this context, unaffected siblings of participants 
with ADHD are of interest, as they share on average 50% of their genetic material as well 
as the family environments with the ADHD proband. Consequently, if brain volumes of 
unaffected siblings are also significantly smaller than those in healthy controls, this would 
imply shared familiality between the brain phenotypes and the ADHD phenotype. Two 
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previous studies (N=90 and N=60) reported that unaffected siblings of participants with 
ADHD had alterations in prefrontal gray matter and occipital gray and white matter, as 
well as inferior frontal gyrus gray matter and inferior fronto occipital fasciculus white 
matter intermediate between those of participants with ADHD and controls (Durston et al., 
2004; Pironti et al., 2013), which indicates a shared underlying familial component. 
It is important to consider factors that might influence the analysis of case-control 
differences in ADHD. One of these is use of psychostimulant medication in participants 
with ADHD, with evidence showing that stimulant treatment might normalize specific 
structural brain abnormalities found in children with ADHD (Schweren et al., 2013). Two 
VBM meta-analyses reviewed above found that subcortical volume differences between 
ADHD and controls are smaller when participants with ADHD had used medication 
(Frodl and Skokauskas, 2012; Nakao et al., 2011). Further, increasing age was found to be 
associated with smaller brain volume differences (Frodl and Skokauskas, 2012; Nakao et 
al., 2011) between participants with ADHD and controls, which is in line with studies 
reporting delayed brain maturation in ADHD (Castellanos et al., 2002; Shaw et al., 2007). As 
previous MRI studies in ADHD included mostly children or adults (Ellison-Wright et al., 
2008; Frodl and Skokauskas, 2012; Nakao et al., 2011), the present study adds to the literature 
by focusing on adolescents and young adults. This allows to examine the important 
time window of the transition from adolescence into early adulthood in studying age 
effects. It is important to take gender into account, since gender distribution in child-
hood ADHD is skewed with boys outnumbering girls (Polanczyk et al., 2007), brain volume 
differs between males and females (Good et al., 2001), and brain differences in ADHD 
between males and females have been reported (Onnink et al., 2014). IQ may also influence 
brain volume-ADHD associations since on average children with ADHD tend to have 
a somewhat lower IQ than controls, and IQ has been associated with structural brain 
differences (Rushton and Ankney, 2009).
The aim of the current VBM study was two-fold. First, to investigate which brain areas 
would show case-control differences using a large sample of adolescents and young adults 
with ADHD and healthy controls. Second, to examine whether brain volumetric changes 
found in participants with ADHD relative to controls would also be found in their un-
affected siblings. The potentially confounding role of medication use, age, gender and IQ 
on ADHD-control brain volume differences in our sample are investigated.
Method
Participants: Participants were recruited from the NeuroIMAGE project, a follow-up (2009-
2012) of the Dutch part of the International Multicenter ADHD Genetics (IMAGE) study 
performed between 2003 and 2006 (Rommelse et al., 2008). In short, ADHD families with at 
least one child with ADHD and at least one biological sibling (regardless of ADHD diag-
nosis) were recruited, as were control families with at least one child and one biological 
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sibling with no formal or suspected ADHD diagnosis in any of the first-degree family 
members. For references and a detailed description of the NeuroIMAGE project and study 
procedures, see (von Rhein et al., 2014).
Inclusion criteria were the same for all participants: age between 8-30 years, European 
Caucasian descent, IQ ≥ 70 and no diagnosis of autism, epilepsy, general learning diffi-
culties, brain disorders and known genetic disorders. Participants were excluded from 
scanning if they had any contra-indication to scanning. Following these exclusions and 
quality control of MRI scans (described below), the sample comprised 307 participants 
with ADHD, 169 unaffected siblings of participants with ADHD and 196 controls. The 
study was approved by the Dutch local medical ethics committees, and after complete 
description of the study to the subjects, written informed consent was obtained.
Diagnostic Assessment of ADHD: To determine ADHD diagnosis at the time of partici-
pation in NeuroIMAGE, all participants in the study were similarly assessed using a com-
bination of a semi-structured diagnostic interview and Conners ADHD questionnaires. 
Symptom counts were taken from these measurements. Detailed description of diagnostic 
criteria can be found elsewhere (von Rhein et al., 2014) and Methods S1. 
Medication: Participants provided self-reported information about lifetime use of psy-
choactive medication. The current study classified individuals who never took medica-
tion as medication-naïve and compared them to individuals who reported to have taken 
medication during their lifetime.
IQ: Full-scale IQ was estimated by combining scores on two subtests of the WISC (if 
≤ 17 years ) or WAIS-III (if  > 17 years) that show the highest correlations with full-scale 
IQ score, namely Vocabulary and Block design (von Rhein et al., 2014).
Imaging data: MRI was conducted at two different locations (Donders Centre for Cogni-
tive Neuroimaging in Nijmegen and VU University Medical Centre in Amsterdam), using 
two comparable 1.5 Tesla MRI scanners (Sonata/Avanto Siemens, Munich, Germany), 
the same 8-channel head-coil and scan protocols. For each participant we obtained two 
high-resolution T1-weighted MPRAGE anatomical scans one before and one after a break 
in a longer scanning session. For participants who had two good scans, we averaged the 
VBM estimates across both scans, thereby improving signal-to-noise. If only one good 
scan was available, a single scan was used. Each participant’s T1-weigthed scan was nor-
malized to Montreal Neurological Institute (MNI) 152 standard space, bias-field corrected 
and segmented into grey matter, white matter, and cerebrospinal fluid using the unified 
procedure of the VBM 8.1 toolbox. Correction for total brain volume was incorporated in 
the toolbox. All data were smoothed with an 8 mm FWHM Gaussian smoothing kernel. 
Data analysis was restricted to voxels with grey matter with a probability exceeding 25% 
leading to inclusion of a total of 230,135 voxels. Details on MRI acquisition and preparation 
can be found in Methods S2 . 
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Statistical analysis: Inferential statistical analyses were conducted in Stata (StataCorp 
LP,College Station, TX, USA). To investigate case-control differences in brain volumes, multiple 
regression analyses were conducted including the voxel-wise grey matter relative volume 
values as outcome measures and binary ADHD diagnosis (ADHD versus control, N=502) 
as a main effect. Because of evidence for gender effects and linear and quadratic effects 
of age on brain volumes (Giedd et al., 2009; Shaw et al., 2008), the main effects of age, age2, 
and gender were included as covariates. Scanner location (Amsterdam, Nijmegen) was 
also included as a covariate to account for potential site effects. As observations were 
not independent within families (both the ADHD group as well as the control group 
contained siblings from the same families), the ‘robust cluster’ option in Stata was used 
which accounts for the correlation structure of the data in calculating robust standard 
errors (Williams, 2000). Differences were considered significant if they survived cluster-mass 
thresholding using the easythresh option in FSL (www.fmrib.ox.ac.uk/fsl), using an initial 
cluster forming threshold of z > 3.1. Subsequently, each cluster’s significance level was 
estimated on the basis of Gaussian Random Field theory, and those clusters surviving a 
FWE-corrected significance threshold of p < 0.05 showing volume differences >0.1 ml were 
reported. For comparison we repeated our main analysis in SPM while not taking into 
account the family relatedness in our sample (Methods S3 and Figure S1 and Table S1). 
For the second aim of the study, mean voxel values of each cluster showing case-control 
differences were calculated per individual using the fslmeants option (www.fmrib.ox.ac.
uk/fsl) and entered in a linear regression analysis in Stata, accounting for family related-
ness. Familiality was regarded as present if unaffected siblings significantly differed in 
mean voxel values from controls, but not from participants with ADHD, or had brain 
volumes significantly intermediate to participants with ADHD and controls.
Possible influence of medication use, age, gender and IQ, were carried out as post-hoc 
analyses. As controls and unaffected siblings did not use medication, the ADHD group was 
stratified by medication use and the mean voxel values were compared. To examine age 
and gender differences, the significant clusters were checked for age effects by including 
age x diagnosis, age2 x diagnosis, and gender x diagnosis interactions in the regression 
model. To investigate the influence of IQ, the main analysis was repeated adding IQ as a 
covariate. Because we had a skewed distribution of our groups in the two different scan-
sites used, we decided to investigate results separately by site. Lastly, as symptom counts 
were present in the complete sample, and correlate with diagnostic status, associations 
between symptom counts and brain-wide brain volume were investigated in the complete 
sample. Additionally, analyses on matched subsamples for gender, IQ and scan-site are 
described in the supplementary data Methods S4.
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Results
Sample: Descriptive information of the sample can be found in Table 1. Our sample 
included 672 adolescents and young adults and comprised 307 participants with ADHD, 
their 169 unaffected siblings and 196 controls. The ADHD group had a significantly 
lower IQ compared to the control group(p<0.001) and consisted of significantly more 
males(p<0.001); Table 1).
Table 1  Participant characteristics 
 
N  
individuals
Mean age 
(years; SD)
Age range 
(years)
Mean ADHD 
symptoms 
(SD)
Mean IQ  
(SD)
% male 
subjects
Site 
distribution 
(site1/site2)
Medication 
use (e/n/u)
ADHD 307 17.06 (3.42) 8-26 13.16 (2.99) 97.08 (15.18) 68% 130/177 246/35/26
Unaffected 
siblings
169 17.52 (4.11) 8-30 1.17 (2.20) 102.19 (14.54) 43% 78/91 -
Controls 196 16.66 (3.07) 9-24 0.76 (1.90) 106.61 (13.70) 49% 120/76 -
Note  SD: standard deviation. e/n/u: ever/never/unknown. IQ and %male were significantly different between subjects 
with ADHD and controls.
Differences in grey matter volume between participants with ADHD and controls: 
Whole brain VBM analysis, comparing participants with ADHD to controls, identified five 
clusters in which participants with ADHD had significantly smaller grey matter volumes 
than controls. As illustrated in Figure 1, these clusters were located in precentral gyrus, 
medial and orbital frontal cortex, frontal pole, and in paracingulate and cingulate cortices. 
Results can be found in Table 2 and Figure 2.
 
Table 2  Whole-brain VBM differences between participants with ADHD and controls
 
Size (nr voxels) MNI coordinates 
(x,y,z)
Best z-value Side of the brain Area
Cl 1 157 -40,-6,56 -3.96 L Precentral gyrus
Cl 2 244 -26,16,-24 -4.43 L Frontal orbital cortex
Cl 3 250 28,70,-2 -4.17 R Frontal pole
Cl 4 518 -14,52,14 -4.43 L Paracingulate, cingulate, frontal 
pole
Cl 5 667 2,22,-2 -3.79 L & R Frontal medial cortex, 
paracingulate, cingulate, 
subcallosal cortex
Note  Cl: cluster, L:left, R:right. Reported areas are identified with the Harvard Oxford cortical and subcortical struc-
tural atlases. Cluster 1 till 5 show smaller volume in participants with ADHD compared to controls. MNI coordinates 
are provided in mm for the peak voxel.
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Figure 1  Whole-brain significant clusters for case-control differences. Five clusters were identified numbered 
1 till 5.  
Figure 2  Mean voxel differences for the identified cluster between ADHD (n=307), unaffected siblings (n=169) 
and controls (n=196). 
Differences between unaffected siblings compared to participants with ADHD and 
controls: For all five clusters showing significant case-control differences, unaffected 
siblings showed a pattern of mean voxel volumes intermediate to that of the ADHD and 
control groups (Figure 2). In cluster 1 (precentral gyrus), cluster 2 (frontal orbital cortex) 
and cluster 3 (frontal pole) the unaffected siblings differed significantly from the controls, 
but not from the ADHD group. In cluster 4 (paracingulate, cingulate, frontal pole) all 
groups significantly differed from each other, whereas for cluster 5 (frontal medial cortex, 
paracingulate, cingulate, subcallosal cortex) the unaffected siblings differed significantly 
from the ADHD group but not from the controls (see Table 3). 
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Table 3  Mean voxel values comparisons for participants with ADHD – unaffected siblings – controls 
C-U p-value R2 U-A p-value R2 C-A p-value R2 Controls (SD) Unaffected 
siblings (SD)
ADHD (SD)
Cl 1 0.016 0.016 0.181 0.003 >0.0001 0.034 0.494 
(0.0652)
0.477 
(0.0686)
0.468 
(0.0626)
Cl 2 0.003 0.027 0.096 0.005 >0.0001 0.049 0.661 
(0.0723)
0.639 
(0.0686)
0.628 
(0.0723)
Cl 3 0.007 0.022 0.090 0.006 >0.0001 0.043 0.412 
(0.0573)
0.396 
(0.0568)
0.388 
(0.0590)
Cl 4 0.034 0.041 0.007 0.016 >0.0001 0.052 0.504 
(0.0544)
0.492 
(0.0576)
0.478 
(0.0562)
Cl 5 0.214 0.004 0.004 0.016 >0.0001 0.037 0.664 
(0.0823)
0.653 
(0.0833)
0.632 
(0.0762)
Note P-values and effect sizes for the mean volume differences for the identified clusters between subjects with ADHD, 
unaffected siblings and controls for the identified clusters and the marginal mean voxel values of the identified 
clusters and their standard deviations per group.Cl: cluster. C-U: mean volume differences between controls and 
unaffected siblings, U-A: mean volume differences between unaffected siblings and ADHD, C-A: mean volume differ-
ences between controls and ADHD. Values indicated in bold are nominally significant (p<0.05). Effect sizes (R2) are 
based on mean cluster comparisons using robust cluster regression in Stata after regressing out age, age2,gender and 
scannersite.
Possible confounding factors for brain associations: To investigate whether the current 
results were influenced by medication use, age, gender or IQ, we performed a series of 
sensitivity analyses. No significant differences were observed when the mean voxel vol-
umes of the clusters were compared between the 246 medicated ADHD patients and the 
35 never-medicated ADHD (Supplementary Table S2).
Age x diagnosis, age2 x diagnosis and gender x diagnosis interaction terms added to the 
regression models investigating the differences in mean voxel values between participants 
with ADHD and controls were non-significant for all five clusters (Supplementary Table 
S3, S4 and Supplementary Figure S2). 
When IQ was added as a covariate, an additional significant cluster was identified (171 
voxels) in the cuneus for which participants with ADHD showed smaller grey matter 
volume compared to controls. The other four significant clusters observed in this analysis 
overlapped with the clusters in the previous analysis (Figure S3 and Supplementary Table 
S5). The cluster in the precentral area was not significant in this analysis. 
To investigate whether our results were driven by one of the scan-sites our main results 
are plotted per site in the supplementary data (Supplementary Table S6). Additionally 
the results for subsamples carefully matched on gender, IQ or scan-site are described in 
our supplementary data (Methods S4 and Table S7). Analyses on subsamples matched on 
gender, IQ or scan-site revealed the same direction of the neural effects for all peak voxels.
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Differences in grey matter volume with increasing number of ADHD symptoms: An 
additional dimensional analysis of the number of ADHD symptoms in the complete sam-
ple (ADHD, unaffected siblings and controls) at the whole brain level identified seven 
clusters in which more ADHD symptoms were associated with significantly smaller grey 
matter volumes. These clusters overlapped with our main analyses and were located in 
medial and orbital frontal cortex, frontal pole, paracingulate and cingulate cortices. The 
precentral gyrus cluster reported in our main analyses did not show up in the symptom 
count analyses. Additional clusters were found in fusiform gyrus, precuneous and frontal 
operculum. Results can be found in Supplementary Table S8.
Discussion
The current study localized alterations of grey matter volume in ADHD and examined 
their underlying familial components in a uniquely large sample of adolescent and young 
adult participants with ADHD, their unaffected siblings and controls. Participants with 
ADHD, compared to controls, had smaller grey matter volume in five clusters including 
left precentral gyrus, medial and left orbito frontal cortex, frontal pole and paracingu-
late and cingulate areas. Unaffected siblings exhibited smaller grey matter volumes than 
controls in four clusters and showed overall an intermediate pattern compared to that 
of ADHD subjects and controls, indicating familial underpinnings. We could not detect 
any effect of medication use, or evidence that age, gender or IQ had a significant impact 
on our findings. 
Findings in precentral gyrus, linked to motor control and prefrontal cortex, the target of 
ADHD medication (Rubia et al., 2013), are in line and extend previous VBM studies (Carmona 
et al., 2005; McAlonan et al., 2007), cortical thickness studies (Almeida et al., 2010) and region 
of interest studies (Valera et al., 2007) on structural differences in the precentral gyrus and 
prefrontal cortex in ADHD. An important role of abnormalities of the prefrontal cortex and 
its connections in ADHD is indicated (Cubillo et al., 2012). However, findings in the prefrontal 
cortex have been inconsistent and are not supported by meta-analyses (Ellison-Wright et 
al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011). A possible contributing factor is the 
heterogeneity in age between studies, as development of the prefrontal cortex is late and 
protracted (Giedd et al., 2009). 
Subtyping of ADHD has been proposed, based on dorsal frontal-striatal, orbitofrontal-stri-
atal and fronto-cerebellar circuits, involved in cognitive control, reward and motivation, 
and timing and building temporal expectations respectively (Durston et al., 2011; Hart et al., 
2012). While meta-analyses of VBM studies did show corresponding subcortical regions 
to be altered in ADHD (Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011), 
and cerebellar volume differences have also been reported (Makris et al., 2013; Valera et al., 
2007), our study did not find structural differences in these regions. Possible explanations 
for this might be found in the adolescent age range of our sample and the previously 
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reported normalization of differences in caudate nucleus volume with age where other 
brain abnormalities between ADHD and controls persisted during development (Castella-
nos et al., 2002). Also, as discussed below, medication use might have contributed to the 
absence of findings for subcortical structures (Nakao et al., 2011). However, a meta-analysis 
on manual tracing studies of subcortical structures did find mean differences in caudate 
nucleus volume even without findings in VBM (Frodl and Skokauskas, 2012). A volumetric 
study segmenting the complete volume of the caudate nucleus and the putamen in the 
current sample also showed differences in both to be present (Greven et al., Accepted). Such 
findings could indicate that the differences in caudate nucleus and putamen volume in 
ADHD are dispersed as opposed to localized to the very same cluster of voxels, and hence 
not easily detected through VBM. 
To date, brain volumetric studies in ADHD have only rarely included unaffected siblings 
(Durston et al., 2004; Pironti et al., 2013). Our findings provide important insights into the 
familial underpinnings of structural brain differences in ADHD. Familial components 
can in theory be due to shared genetic and/or shared environmental factors. Since there 
is strong evidence for familial components of ADHD to be largely genetic (Faraone et al., 
2005; Greven et al., 2011), we hypothesize the familial effects in the reported brain areas to 
be mainly driven by genetic factors. Of relevance, a twin study investigating voxel-based 
brain volume in high and low ADHD risk concordant or discordant twin pairs, reported 
genetically mediated risk for ADHD in the medial orbitofrontal areas (van ‘t Ent et al., 2007), 
which overlaps with our results. If confirmed, the identified areas may prove useful in 
molecular genetic research in ADHD. 
We investigated whether medication use, age, gender or IQ influenced our results. Null 
findings for medication use might have been due to power limitations, as the major-
ity of our ADHD group had used medication. This fact might also have influenced our 
results, i.e. based on the meta-analytic results smaller case-control differences can be 
expected with medication use (Nakao et al., 2011). No interaction effects of age with ADHD 
status were found, suggesting that the observed cortical differences between ADHD and 
controls were stable across age throughout adolescence, in line with previous results in 
children (age range 5-18 years) (Castellanos et al., 2002). However, developmental delay has 
been suggested and reported in prefrontal areas of the brain in ADHD (Shaw et al., 2007), 
therefore longitudinal studies are warranted to investigate whether these changes remain 
throughout adulthood. Although we had a dysbalance in gender, post-hoc analyses did 
not find indications that our results are driven by gender specific differences.
When including IQ in the analysis, the precentral gyrus finding was no longer signifi-
cant, and an additional region in the cuneus reached significance. Volumetric  differences 
in the cuneus have not been reported previously in ADHD, however, an association be-
tween inattentive symptoms and resting state activitity in the cuneus have recently been 
shown (Wang et al., 2013). The cuneus finding was subthreshold in our main analysis and 
also became apparent in the analysis that was not corrected for family structure (Supple-
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mentary data). There is an active debate whether IQ needs to be included as a covariate 
in investigations of ADHD (Dennis et al., 2009). IQ is generally about 10 points lower in 
those with ADHD (Frazier et al., 2004), which could argue in favor of including IQ as a co-
variate. However, IQ might share meaningful variance with ADHD (Rommelse et al., 2008), 
at least partially, and therefore covarying for IQ might lead to an overcorrection. Here, 
both analyses are provided. The overlapping results of our main analyses and the dimen-
sional analysis on symptoms counts are in line with the view of ADHD as an extreme of 
a continuum of behavior in the population (Chen et al., 2008), and in line with previous 
studies reporting reduced brain volume with increasing ADHD severity (Hoogman et al., 
2012; Shaw et al., 2011).
Our findings should be viewed in light of strengths and limitations. We improved upon 
previous studies by including a large sample, including unaffected siblings, and both 
adolescents and young adults. Another strength is the use of a whole-brain hypotheses 
free approach. As the current study consisted of a large naturalistic group of participants 
with ADHD and controls, differences in IQ and gender were present in our sample, which 
is frequently the case in ADHD (Polanczyk et al., 2007; Rommelse et al., 2008). Similarly, the 
majority of the participants with ADHD had used medication. An alternative approach 
to the sensitivity analyses presented would have been to specify groups prior to analysis, 
e.g. by only investigating medication-naïve participants with ADHD matched to controls 
by age, gender, IQ, and psychiatric comorbidity (Makris et al., 2013), but the trade-off would 
have been a smaller sample size consisting of atypical ADHD cases. 
Several lines of future research follow from the current study. First, longitudinal studies 
are warranted to properly investigate developmental trajectories of brain differences in 
ADHD. Second, molecular genetic analyses on brain phenotypes with familial underpin-
nings can aid the search for and understanding of genetic risk factors for ADHD. 
To conclude, the current VBM analysis of MRI scans in a large sample of participants with 
ADHD, unaffected siblings and controls found that ADHD was associated with smaller 
gray matter volume in frontal and precentral areas of the cortex, involving decision mak-
ing, executive, and motor functioning areas. The identified clusters are potentially linked 
to familial risk for ADHD. 
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Methods S1
To determine ADHD diagnoses, a combination of Conners’ ADHD questionnaires and a 
semi-structured diagnostic interview was used1-4. Each participant was assessed with a 
parent-rated questionnaire (Conners’ Parent Rating Scales – Revised: Long version [CPRS-
R:L]) and either a teacher-rating (Conners’ Teacher Rating Scales – Revised: Long version 
[CTRS-R:L] applied for children <18 years) or a self report (Conners’ Adult ADHD Rating 
Scales–Self-Report: Long version [CAARS-S:L] applied for children ≥18 years). Partici-
pants were administered the Dutch translation of the Schedule for Affective Disorders 
and Schizophrenia for School-Age Children – Present and Lifetime Version (K-SADS-PL) 
containing developmentally appropriate questions to assess each of the 18 ADHD symp-
toms, compatible with the DSM-IV-TR (American Psychiatric Association [APA], Diagnostic 
and Statistical Manual of mental disorders, Text Revision [DSM-IV-TR] 2000). Parents, 
reporting on their children, as well as children themselves, if ≥12 years old, were inter-
viewed separately. Final scores on each item of the K-SADS were determined by weighing 
all available information. Initially, all participants were administered the K-SADS ADHD 
screening interview. Participants with elevated scores on any of the screen items were 
administered the full ADHD supplement. For participants using medication, ratings were 
gathered of participants’ functioning off medication. Using a diagnostic algorithm, a 
combined symptom count was calculated by adding symptom counts on the K-SADS 
and CTRS-R:L (for participants <18) or CAARS-S:L (for participants≥ 18), both providing 
operational definitions of each of the 18 behavioural symptoms defined by the DSM-IV. 
Symptoms of the CTRS-R:L or CAARS-S:L were only added to the combined symptom 
count if at least 2 symptoms were reported, in order to avoid the Conners’ score to put 
too much weight on the diagnosis. 
From the Conners’ ADHD questionnaires the following scales were used: DSM Inattentive 
behaviour (scale L of the CTRS-R:L/CPRS-R:L; scale E of the CAARS-S:L), DSM Hyper-
active/Impulsive behaviour (scale M of the CTRS-R:L/CPRS-R:L; scale F of the CAARS-S:L), 
and DSM Total (scale N of the CTRS-R:L/CPRS-R:L; scale G of the CAARS-S:L). Participants 
with a combined symptom count of ≥6 symptoms of hyperactive/impulsive behaviour and/
or inattentive behaviour were diagnosed with ADHD, provided they: a) met the DSM-IV 
criteria for pervasiveness and impact of the disorder (measures derived from the K-SADS), 
b) showed an age of onset before 12, c) received a T≥63 on at least one of three scales 
on at least one of the Conners’ ADHD questionnaires (i.e. CPRS-R:L and/or CTRS-R:L for 
children <18 years and CPRS-R:L and/or CAARS-S:L for children ≥18 years), pertaining to 
a period without medication.
Participants with a combined symptom count of ≥ 6 symptoms who did not meet one or 
more of these criteria were evaluated by a team of trained experts, in order to derive a 
consensus decision on their diagnosis. Unaffected participants were required to receive a 
T<63 on each of the above-mentioned scales of each of the Conners’ ADHD questionnaires, 
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and have a combined symptom count ≤3 symptoms. For young adults (≥ 18 years), criteria 
were slightly adapted, such that a combined symptom count of 5 instead of 6 symptoms 
was sufficient for a diagnosis5 and with ≤2 symptoms on the combined symptom count 
they were labelled ‘unaffected’. Diagnostic procedure for parents were similar to those 
applied for children ≥18 years. The ADHD questionnaire was completed by their partner 
(Conners’ Adult ADHD Questionnaire-Observer: Short version [CAARS-O:SV]). A retro-
spective childhood diagnosis was established in addition to a current diagnosis, using the 
same diagnostic algorithm used for young adults. Parents with a current and/or childhood 
diagnosis were labelled as affected.
Methods S2
MRI acquisition and preprocessing: MRI was conducted at two different locations 
(Donders Centre for Cognitive Neuroimaging in Nijmegen and VU University Medical 
Centre in Amsterdam), using two comparable 1.5 Tesla MRI scanners (Sonata/Avanto 
Siemens, Munich, Germany), the same 8-channel head-coil and scan protocols. For each 
participant we obtained two high-resolution T1-weighted MPRAGE anatomical scans (176 
sagittal slices, TR = 2730 msec, TE = 2.95 msec, TI=1000 ms, flip angle = 7 deg, GRAPPA 
2, voxel size = 1.0 x 1.0 x 1.0 mm, field of view = 256 mm), one before and one after a 
break in a longer scanning session. MRI scans which yielded clinically relevant incidental 
findings (n=16), and those for which manual ratings revealed poor quality or motion arte-
facts (n=4) were excluded from analysis6. For participants who had two good scans, we 
 averaged the VBM estimates across both scans, thereby improving signal-to-noise. If only 
one good scan was available, a single scan was used. Each participant’s T1-weigthed scan 
was normalized to Montreal Neurological Institute (MNI) 152 standard space, bias-field 
corrected and segmented into grey matter, white matter, and cerebrospinal fluid using 
the unified procedure of the VBM 8.1 toolbox (http://dbm.neuro.uni-jena.de/vbm/) in 
SPM (default settings)7. This method uses an optimized VBM protocol8,9 as well as a model 
based on Hidden Markov Random Fields (HMRF) developed to increase  signal-to-noise 
ratio10. Correction for total brain volume was incorporated in the toolbox. All data were 
smoothed with an 8 mm FWHM Gaussian smoothing kernel. Data analysis was restricted 
to voxels with grey matter with a probability exceeding 25% leading to inclusion of a 
total of 230,135 voxels. 
Methods S3
The main analysis was rerun using SPM defaults to compare our results to a standard VBM 
procedure not correcting for the family dependence in our data. As expected, inclusion 
of siblings within the group analysis increased both the within group similarity and be-
tween group differences, making the clusters more defined (smaller) when correcting for 
family dependence. The results without this correction (see Supplementary figure S1 and 
supplementary table S1) are within the same areas, but larger. While 5 distinct clusters are 
reported in the main analysis, they cluster into one large cluster in this analysis. Also a 
cluster in the precuneus reaches significance which is subthreshold in our main analysis. 
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Methods S4
A series of additional sensitivity analyses were conducted to examine possible effects 
of the factors of gender, IQ and scan-site within our sample. To ensure that none of the 
reported effects in the main body of the manuscript were dependant on differences be-
tween the groups in these factors, the main analyses were repeated with matched groups 
on each of these factors. Since this matching lead to the exclusion of a significant part 
of our sample, in particular the most severe patients with ADHD, we present these data 
additionally with the side note that we have reduced power and are looking at a more 
atypical ADHD group. 
The distribution of gender, IQ, and scan-site distribution differed between patients and 
healthy controls in this study. In addition to covarying gender, IQ and scan-site in the 
main analyses, we repeated the main analyses of the diagnostic group contrast of interest 
in subgroups of our sample matched on gender, IQ and scan-site distribution respectively. 
Gender matched groups were achieved by equalizing the ratio of females in the control 
group to the ADHD group. This lead to the exclusion of 55 females from the controls. IQ 
matched groups were achieved by subdividing the IQ scores into seven bins of 15 points 
each. Subsequently, the ratio of patients and controls was equalized to the mean of the 
entire sample for each bin. This led to the exclusion of 71 patients from the lower three 
bins, as well as 45 controls from the upper four. For matching the scan-site distribution 
we equalized the ratio of females and males in both the control group and the ADHD 
group at both sites. This lead to the exclusion of 29 male controls at site 1 and 47 female 
ADHD participants at site 2.  
Comparison of the results of the analyses on the matched subgroups can be found in 
supplementary table S8. These results showed that the direction of the neural effects is the 
same for all peak voxels in all sub-analyses. Due to a reduction of the sample size, not all 
clusters remained whole-brain significant. However, all sub-analyses showed whole-brain 
significant clusters, despite the reduction in power. In the gender-matched sub-analysis 
3 clusters remained whole-brain significant (overlap with cluster 2 (orbitofrontal), clus-
ter 3 (frontal pole) and cluster 4 (frontal pole) of the main analysis). In the IQ-matched 
sub-analysis 3 clusters remained whole-brain significant (overlap with cluster 1 (precen-
tral), cluster 2 (orbitofrontal) and cluster 5 ((para)cingulate) of the main analysis). In the 
scan-site matched subsample 2 clusters remained whole-brain significant (overlap with 
cluster 2 (orbitofrontal) and cluster 3 (frontal pole) of the main analysis).
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Table S1  Whole brain VBM differences between ADHD cases and controls using default SPM settings 
Size (nr voxels) MNI coordinates (x,y,z) Best z-value Side of the brain Area
Cluster 1 11745 -15,53,12 -5.23 Left Paracingulate, superior frontal 
gyrus, frontal pole
Cluster 2 2850 -2,72,38 -4.16 Left Precuneus cortex, cuneal cortex
Note Reported areas are identified with the Harvard Oxford cortical and subcortical structural atlases. Both clusters 
show smaller volume in subjects with ADHD compared to controls. MNI coordinates are provided in mm for the 
peak voxel. Cluster 1 corresponds with the 5 clusters reported in the main analysis. Cluster 2 was subthreshold of the 
accepted significance level in the main analysis.
Table S2  Medication use 
 
Mean voxel values of ADHD-medicated 
individuals (n=246)
Mean voxel values of ADHD-never 
medicated individuals (n=35)
p-value
Cluster 1 0.4670 (0.004210) 0.4545 (0.009126) 0.2359
Cluster 2 0.6268 (0.004232) 0.6157 (0.01102) 0.3593
Cluster 3 0.3836 (0.007563) 0.3855 (0.007563) 0.8286
Cluster 4 0.4756 (0.003050) 0.4663 (0.007628) 0.2538
Cluster 5 0.6311 (0.004583) 0.6257 (0.01023) 0.6167
Note Marginal mean voxel values and standard errors of the identified clusters for ADHD samples that ever used medi-
cation as well as never used medication are shown in the table. Corresponding uncorrected p-values for the difference 
between the two groups are provided. Medication use was unknown for 26 ADHD samples, which were excluded from 
this analysis. 
Table S3  Age x diagnosis and age2 x diagnosis interactions
 
Age x diagnosis Age2 x diagnosis
Cluster 1 0.89 0.15
Cluster 2 0.78 0.70
Cluster 3 0.81 0.79
Cluster 4 0.88 0.96
Cluster 5 0.09 0.10
Note  uncorrected p-values for the age x diagnosis and age2 x diagnosis interactions for the identified clusters.
Table S4  Gender x diagnosis interactions
Gender x diagnosis
Cluster 1 0.08
Cluster 2 0.14
Cluster 3 0.64
Cluster 4 0.99
Cluster 5 0.53
Note  uncorrected p-values for the gender x diagnosis interactions for the identified clusters.
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Table S5  Inclusion of IQ as a covariate
 
Size (nr voxels) MNI coordinates (x,y,z) Best z-value Side of the brain Area
Cluster 1 124 -12,50,20 -3.84 Left Paracingulate, cingulate, frontal pole
Cluster 2 164 28,70,-2 -3.99 Left Frontal pole
Cluster 3 171 -18,-72,38 -3.65 Right Cuneal cortex
Cluster 4 214 -26,16,-24 -4.32 Left Frontal orbital cortex
Cluster 5 616 2,20,-2 -3.82 Left and right Frontal medial cortex, paracingulate, 
cingulated, subcallosal cortex
Note  Identified whole-brain significant clusters when IQ was included as a covariate. MNI coordinates are provided 
in mm for the peak voxel.
Table S6  Comparison scannersites for main findings of the ADHD-control comparison
 
MNI coordinates (x,y,z) Best z-value main analysis Best z-value site 1 Best z-value site 2
Cluster 1 -40,-6,56 -3.96 -3.49 -2.56
Cluster 2 -26,16,-24 -4.43 -3.38 -3.16
Cluster 3 28,70,-2 -4.17 -2.84 -3.53
Cluster 4 -14,52,14 -4.43 -5.22 -1.82
Cluster 5 2,22,-2 -3.79 -3.05 -2.48
Note  Best z-values for the peak voxels from the main analysis, the subanalysis in site 1 and the subanalysis in site 2. 
MNI coordinates are provided in mm for the peak voxel.
Table S7  Peak voxel values main findings of the ADHD-control comparison in the subsample analyses 
matched on gender, IQ and scan-site
MNI coordinates  
(x,y,z)
Best z-value main 
analysis
Best z-value gender-
matched sample
Best z-value IQ-
matched sample
Best z-value scan-site-
matched sample
 Cl 1   -40,-6,56   -3.96   -3.39   -4.33   -3.21
 Cl 2   -26,16,-24   -4.43   -4.44   -3.84   -4.34
 Cl 3   28,70,-2   -4.17   -4.44   -3.53   -3.75
 Cl 4   -14,52,14   -4.43   -3.94   -3.11   -3.14
 Cl 5   2,22,-2   -3.79   -2.89   -3.80   -2.67
Note  Best z-values for the peak voxels from the main analysis, the analysis in a subsample matched on gender, the 
analysis in a subsample matched on IQ and the analysis in a subsample matched on scan-site. Z-values are indicated 
in bold if (part of) the cluster remained whole-brain significant in the subsample analyses. MNI coordinates are 
provided in mm for the peak voxel.
84 Chapter 3
Table S8  Symptom count analyses
Size (nr voxels) MNI coordinates
(x,y,z)
Best z-value Side of  
the brain
Area Overlap ADHD-
control analyses
  Cl 1 138 -28,-84,-18 -3.97 Right Occipital fusiform gyrus No
  Cl 2 141 -26,14,-28 -4.01 Left Frontal orbital cortex Yes
  Cl 3 143 -10,-44,54 -3.90 Right Precuneous No
  Cl 4 164 36,24,12 -3.95 Left Inferior frontal gyrus,  
frontal operculum
No
  Cl 5 222 20,70,10 -3.84 Left Frontal pole Yes
  Cl 6 250 -28,58,18 -3.74 Left Frontal pole Yes
  Cl 7 1484 0,32,-6 -4.06 Left Frontal medical cortex,  
paracingulate, cingulate 
Yes
Note  Identified whole-brain significant clusters for ADHD symptoms. MNI coordinates are provided in mm for the 
peak voxel. 
 
Figure S1  Whole-brain significant clusters for case-control differences when family dependence was not taken 
into account. The 5 clusters reported in our main analysis cluster into one blob in the analysis not taking 
family dependence into account. The second cluster in the precuneus was subthreshold of the accepted 
signifi cance level in the main analysis.
 
Figure S2  For exploratory purposes we plotted the mean voxel values for each cluster per group by age.  
No age x diagnose interaction was significant. 
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Figure S3  Whole-brain significant clusters for case-control differences when IQ was included as a covariate. 
Cluster 1 in the cuneal cortex was not identified in the analysis without IQ as a covariate. Cluster 2,3,4 and 5 
are identified in both analyses (with an without inclusion of IQ). 
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ABSTRACT
 
Background: Elucidating genetic mechanisms involved in Attention-Deficit/ Hyperactivity 
Disorder (ADHD) has been challenging. Relatively unexplored is the fact that genetic 
mech anisms can differ with age. The current study explored the association between 
 dopaminergic and serotonergic genes, ADHD symptoms and neurocognitive functioning 
in relation to age.
Methods: Associations of three ADHD risk factors witin DAT1, DRD4 and 5-HTT to ADHD 
symptoms and six neurocognitive measures were investigated in two samples of the Neuro-
IMAGE study: 756 children, adolescents and young adults with ADHD, their siblings, and 
controls (M age 17 years, SD 3.2), and 393 parents with and without ADHD (M age 48 
years, SD 4.8). Association analyses were performed in both samples, and effects were 
compared to address dichotomous age effects. Gene x age interactions were examined to 
address continuous age effects.
Results: Nominally significant moderating effects of age were found. First, DRD4-7R carrier-
ship was found to protect against ADHD in the adult group only. Second, in the adolescents 
the 5-HTT LL genotype was associated with better inhibition till the age of 17 years. Third, 
the 5-HTT LL genotype was associated with worse motor timing before age 19 and better 
after age 19. And lastly, DAT1 10-6 haplotype carriers showed worse working memory per-
formance till age 18 years. None of our effects survived correction for multiple comparisons. 
Conclusions: Our results are preliminary and may point to differential genotype-phenotype 
associations at different ages. Our findings are consistent with the idea that genetic and 
neurocognitive mechanisms in ADHD may change throughout life. 
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Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental 
disorder characterized by symptoms of inattention and/or hyperactivity and impulsivity 
(Diagnostic and Statistical Manual of Mental Disorders, DSM-5, 2013; Polanczyk et al., 2007). ADHD 
often persists into adulthood (Turgay et al., 2012) and is substantially influenced by genetic 
factors (Thapar et al., 2013). The heritability of ADHD is estimated to be ~76% (Faraone et 
al., 2005), but gene-finding in ADHD has been difficult. This is likely due to phenotypic 
 and genetic heterogeneity in combination with very small effect sizes of common gen-
etic variants contributing to ADHD risk (Gizer et al., 2009) and/or genetic risk factors 
of stronger effects being rare and non-specific (Poelmans et al., 2011; Thapar et al., 2013). 
Associations with ADHD have been studied most extensively for candidate genes in the 
dopaminergic, serotonergic, and noradrenergic systems, all hypothesized to play a role in 
ADHD (Banaschewski et al., 2010; Gizer et al., 2009). Dopaminergic genes are considered key 
candidates for ADHD because of the strong therapeutic effects of stimulant medication 
(Del Campo et al., 2011; Faraone and Buitelaar, 2010; Volkow et al., 2002). A central role of sero-
tonergic genes is suggested by their effects on (early) brain development (Azmitia, 2001), 
their influence on behavioral traits like impulsivity (Banaschewski et al., 2010; Landaas et al., 
2010), and their interaction with dopaminergic genes (Oades, 2008). Noradrenergic genes 
have also received considerable interest in ADHD research (Banaschewski et al., 2010), but 
a role of these genes could not be confirmed in meta-analysis (Gizer et al., 2009). To date, 
the dopamine transporter gene DAT1/SLC6A3, the dopamine receptor 4 gene DRD4, as 
well as the serotonin transporter gene 5-HTT/ SLC6A4 have been most extensively studied 
in ADHD. These three genes have repeatedly been associated with ADHD, although with 
substantial heterogeneity across – and between – childhood and adult studies (Franke et 
al., 2012; Gizer et al., 2009). This suggests the need to include possible moderating factors 
of these associations in future studies.
A potential explanation for the inconsistencies observed in association studies is the 
effect of age. A developmental approach has been used scarcely when the relationship 
between genes, the ADHD phenotype, and related neurocognitive dysfunctioning are 
studied. Longitudinal designs suggest that in particular hyperactive/impulsive ADHD 
symptoms decrease with age (Biederman et al., 2000; Larsson et al., 2006). Given that ex-
pression levels of genes can differ across different stages of development (Elia and Devoto, 
2007), the contribution of risk genes to ADHD may not be constant across the life course. 
Support for the latter theory has come from studies applying a longitudinal twin design 
(Greven et al., 2011; Larsson et al., 2004). A specific well-known example is the association 
of a different DAT1 haplotype with ADHD in adults (the 9-6 haplotype) compared to the 
haplotype reported with ADHD in children (the 10-6 haplotype) (Franke et al., 2008; 2010). 
In addition, previous (twin) studies have shown that genetic influences on neurocogni-
tive ability increase with age (Boomsma et al., 2002; Plomin and Spinath, 2004; Polderman et al., 
2007). These results imply that age is an important factor to take into account in molecular 
genetics analyses in ADHD. 
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A genetic design could further benefit from the inclusion of well-studied ADHD-related 
neurocognitive (dys)functions, since these ‘endophenotypes’ have been hypothesized to 
have a less complex genetic architecture than the disease phenotype, and they can pro-
vide further insight into the cognitive or neural mechanism that underlie ADHD (Crosbie et 
al., 2013; Crosbie et al., 2008; Gottesman and Gould, 2003). Results from several genetic studies 
support the utility of neurocognitive measures by showing an association of ADHD-re-
lated cognitive impairments with ADHD-related dopaminergic and serotonergic genes. 
Still, the exact influences of specific alleles of these candidate genes in ADHD-related 
neurocognitive functioning remain unclear as some conflicting results have been found 
for both DAT1 (10R allele of the 3’UTR VNTR polymorphism) (see for review (Rommelse et 
al., 2008b) and DRD4 (7R allele of the exon 3 VNTR polymorphism) (see for reviews, Kebir et 
al., 2009; Wu et al., 2012). For 5-HTT (S and L allele of the HTTLPR variant) cognitive studies 
including ADHD patients and/or healthy subjects are emerging and show conflicting 
results as well (Anderson et al., 2012; Lane et al., 2008; Oades, 2007; 2008; Paaver et al., 2007; 
Zilles et al., 2012). As neurocognitive impairments in ADHD have been found to vary with 
age (Seidman, 2006; Thissen et al., 2014) part of the conflicting results might be attributable 
to different age ranges investigated in different studies. 
The main aim of the current study was to explore the influence of age on the relationship 
of several well-known ADHD candidate genes with ADHD symptoms and ADHD-related 
neurocognitive deficits. Age was investigated by including an offspring sample with a 
broad age range (from late childhood, throughout adolescence, until young adulthood) 
and a sample of their middle-aged adult parents. Since previous ADHD genetic research 
mainly focused on children and young adults, the inclusion of adolescents and mid-
dle-aged adults might provide novel insights with regard to the influence of age. Further, 
by including two generations from the same gene-pool (i.e. parents and offspring), the 
effect of age differences between samples can be compared while minimizing the effects 
of population differences. Candidate genes – DAT1, DRD4, and 5-HTT – were selected 
based on the aforementioned evidence of association with ADHD (e.g., Gizer et al., 2009). 
The selection of neurocognitive measures – working memory, motor inhibition, timing 
abilities, and reaction time variability – was based on their robust association with deficits 
in children with ADHD ([working memory]: see for meta-analyses (Kasper et al., 2012; Marti-
nussen et al., 2005), [motor inhibition]: see for review (Willcutt et al., 2005) [timing abilities]: 
(Noreika et al., 2013; Toplak et al., 2006), [reaction time variability]: (Castellanos and Tannock, 
2002; Frazier-Wood et al., 2012; Klein et al., 2006)) and their unaffected siblings (Kuntsi et al., 
2013; Rommelse et al., 2008a; Rommelse, 2008; Rommelse et al., 2008d), and based on previously 
reported associations with our genes of interest ([DRD4]: Altink et al., 2012; [5-HTT]: Anderson 
et al., 2012; e.g. [DAT1]: Bellgrove et al., 2005; Durston et al., 2005; Froehlich et al., 2007; Paaver et 
al., 2007; Soderqvist et al., 2012; Zilles et al., 2012).
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Materials and methods
Participants 
All participants (parents and offspring) were selected from the Dutch follow-up (2009-
2012) of the International Multicenter ADHD Genetics (IMAGE) study performed between 
2003 and 2006 (as described previously in Nijmeijer et al., 2009). Inclusion criteria for offspring 
at IMAGE enrolment were age between 5 and 19 years, European Caucasian descent, 
IQ≥70, and no diagnosis of autism, epilepsy, general learning difficulties, brain disorders 
or known genetic disorders (such as Fragile X syndrome or Down syndrome). All families 
were re-invited to a follow-up assessment, with a mean follow-up period of 5.9 years 
(SD=.72) and no additional inclusion criteria, except a minimum age of 8 years for neuro-
cognitive testing and MR imaging. Diagnostic status and ADHD symptom severity were 
re-assessed at follow-up. The current study involved 255 ADHD families and 88 healthy 
control families with at least one family member with available genotype data and com-
plete neurocognitive assessment. The ADHD families consisted of 396 ADHD cases, 188 
unaffected siblings, and 393 parents (156 affected, 237 unaffected). The control families 
consisted of 172 offspring family members. In the offspring sample (hereafter referred to as 
adolescents) ~90% was ≥12 years of age, and only biological offspring (in both ADHD and 
control families) were included. The offspring sample consisted of children, adolescents 
and young adults (age range 8-25). The parent sample included biological parents from 
ADHD families only. Table 1 provides participants’ characteristics. 
ADHD diagnoses
All participants were assessed using a semi-structured diagnostic interview (Dutch 
translation of the Schedule for Affective Disorders and Schizophrenia for School-Age 
 Children – Present and Lifetime Version (K-SADS-PL) (Kaufman et al., 1997) and Conners’ 
ADHD questionnaires to determine current ADHD diagnosis. A diagnostic algorithm was 
applied to combine symptom counts on the K-SADS-PL and Conners’ questionnaire in 
both samples. A detailed description of the algorithm is provided in the Supplementary 
materials Methods S1.
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Table 1  Sample Characteristics of adults and children / adolescents / young adults
Adults* Children / Adolescents/ Young adults
N 393 756
Mean (SD) years of age 48.4 (4.8) 17.2 (3.2)
Range years of age 35 - 61 8 - 25
Estimated IQ M (SD) 102.7 101.0
Range estimated IQ 72 - 141 (15.3) 71 - 140 (14.5)
% Male 46 56
Conners’ Observer or Parent**, DSM-IV a
Inattention M (SD) 47.2 (9.5) 55.7 (12.5)
Range inattention 37 - 79 40 - 90
Hyperactive-Impulsive M (SD) 48.7 (9.5) 57.6 (15.0)
Range hyperactive-impulsive 37 - 84 41 - 90
ADHD diagnosis DSM-IVa
Inattentive n (%) 30 (8) 149 (20)
Hyperactive-Impulsive n (%) 23 (6) 36 (5)
Combined n (%) 41 (10) 145 (19)
Subthreshold n (%) 62 (16) 66 (8.5)
No ADHD diagnosis n (%) 237 (60) 360 (47.5)
* Adult sample includes only parents from children / adolescent / young adult sample.
** Observer rating in case of adults (partner or significant other); Parent rating in case of children/adolescents.
a T scores based on American norm group; Dutch T scores are found to be lower (Dutch [Adult] Twin Register). 
Measures
ADHD symptoms
Information concerning current ADHD symptoms was obtained using the Dutch version 
of the Conners Adult ADHD Rating Scales – Observer: Screen Version (CAARS-O:SV) for 
adults and the Conners Parent Rating Scales – Revised Long version CPRS-R:L for children 
and adolescents (Conners et al., 1999). For each adult, scores on the ADHD Inattentive and 
Hyperactive-Impulsive scales of CAARS were used as separate measures of current adult 
ADHD severity. This allowed examination of possible differential effects for inattention 
and hyperactivity-impulsivity. The same method was used for children and adolescents, 
using the CPRS subscales ADHD Inattentive and Hyperactive-Impulsive.
Neurocognitive tasks
Table 2 provides a brief description of the six neurocognitive variables used for associ-
ation analyses. Details on each paradigm are provided elsewhere (Leth-Steensen et al., 2000; 
Rommelse et al., 2008a; Thissen et al., 2014). All measures have shown an association with 
ADHD in this sample (Thissen et al., 2014; Thissen et al., 2014).
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Table 2  Description of the neurocognitive tasks and variables
Taska Measurement Potential(s) Dependent variable(s)
Motor Timing Task (1 s interval) Timing accuracy Median reaction times (in ms)
Reaction time variability Trial by trial variability (in ms) Infrequent slow response times 
Ex_Gaussian component τ
Stop Task* Speed of inhibition Stop Signal Reaction Time (SSRT)
Visuospatial Grid Task* Visuospatial working memory Number of correct trials
Digit Span (WISC/WAIS-IIIb) Verbal working memory Digit span backwards
Vocabulary and Block Design  
   (WISC/WAIS-IIIb)
Estimated Full-scale IQ Total IQ-score
a  Details on each of the paradigms are provided elsewhere (Leth-Steensen and others 2000; Rommelse and others 
2008, Thissen and others 2014)
b  Wechsler Intelligence scale for Children or Wechsler Adult Intelligence Scale
*  Adolescents performed these tasks during fMRI-measurement
Procedure
This study was part of a comprehensive assessment protocol (see for an overview: von Rhein 
et al., 2014) also containing functional and structural Magnetic Resonance Imaging (MRI). 
MRI scans were not recorded in parents. Participants were asked not to use psychostimu-
lant drugs from 48 hours before the assessment. For other psychotropic medication 
 participants were asked not to use it at least 3 days before the assessment. After the study 
procedures had been carefully explained, all participants gave their written informed 
consent, with parents providing consent for children <12 years of age. The study protocol 
was approved by the local medical ethics committees of Radboud university medical 
center in Nijmegen, and the VU Medical Center in Amsterdam.
Genotyping
An extensive description of DNA extraction and genotyping in IMAGE is provided else-
where (Brookes et al., 2006). Briefly, for the IMAGE sample DNA was extracted from blood 
samples or immortalized cell lines at Rutgers University Cell and DNA Repository, New 
Jersey, USA. Variable number of tandem repeat (VNTR) polymorphisms from exon 3 of 
the DRD4 gene, the 3’-untranslated region (UTR) and intron 8 of the DAT1/SLC6A3 gene, 
and the promoter region of the 5-HTT/SLC6A4 gene (HTTLPR) had been genotyped for 
previous studies by the IMAGE consortium (Brookes et al., 2006; Xu et al., 2008). Standard 
PCR protocols were used for all VNTR markers and amplified products were visualized on 
2% agarose under UV light. Extra samples from the NeuroIMAGE sample which had not 
undergone genotyping in IMAGE were genotyped at the Department of Human Genetics 
of the Radboud university medical center. DNA for those samples was isolated from saliva 
using Oragene containers (DNA Genotek, Ottawa, Ontario, Canada) according to the proto-
col supplied by the manufacturer. VNTRs were genotyped using standard PCR protocols. 
After the PCR, fragment length analysis was performed on the ABI Prism 3730 Genetic 
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Analyser (Applied Biosystems, Nieuwekerk a/d IJssel, The Netherlands) and results were 
analyzed with GeneMapper® Software, version 4.0 (Applied Biosystems). No deviations 
from Hardy Weinberg equilibrium were found for the VNTR polymorphisms (DRD4 exon 3: 
p=0.15 , DAT1 3’-UTR: p=0.78, DAT1 intron 8: p=0.55, HTTLPR: p=0.13). From the genotype 
of the DAT1 3’-UTR and intron 8 VNTRs, a haplotype was calculated using the HaPloStats 
package (R version 2.12.0) (Schaid et al., 2002) (see Table 3). 
Table 3  Genotypes for the genetic variants in the candidate genes
Adults Children / adolescents / young adults
DRD4 (7R-carriers / non-carriers) 77 / 148 243 / 422
5-HTT (HTTLPR SS/SL/LL) 37 / 114 / 66 95 / 330 / 236
DAT1 (adults:9-6 carriers / non-carriers; children /
adolescents / young adults: 10-6 carriers/non-carriers)
55 / 328 681 / 58
Data analyses
 ADHD measures and cognitive measures were normalized and standardized into z-scores 
(Van der Waerden transformation) for adults and adolescents separately. For stop signal 
reaction time (SSRT) of the Stop task, motor timing variability and tau, z-scores were 
mirrored, so that higher z-scores for all measures would have the same direction: better 
performance or more severe ADHD symptomatology. Reaction time median (RTM) was 
an exception, because a higher or lower median reflected a better or worse performance 
depending on how close this median was to the 1 s interval that needed to be reproduced. 
Performance ceiling effects did not occur on any of the tasks, as indicated by boxplot 
analyses with raw data in both samples (not shown).
Generalized estimating equations (GEE) were used with a linear regression model and 
robust estimators. To correct for familial dependence within the data set, family number 
was used as repeated measure and the structure for working correlation matrices was 
set at exchangeable. Only participants with available genotyping and neurocognitive 
data were included in the analysis (Table 3). Combining adolescents and parents in one 
sample produced a non-normal age distribution, therefore effects were analyzed in the 
adolescent and adult sample separately. We first tested whether the VNTR variants of 
DRD4 (presence or absence 7R risk allele), DAT1 (presence or absence of at least one 10-6 
risk haplotype in adolescents; presence or absence of at least one 9-6 risk haplotype in 
adults), or 5-HTT (presence of two [LL], one [SL], or no [SS] risk alleles) predicted ADHD 
diagnosis, inattentive and hyperactive/impulsive ADHD symptoms, and cognitive func-
tioning. For prediction of diagnosis, odds ratios were calculated, including two allele 
groups for 5-HTT (LL vs. other, and SS vs. other). Effects of age, gender, and the interaction 
of risk allele or haplotype with age were included and kept in the model if nominally 
significant. Two levels were applied for the main genetic effects on ADHD symptoms 
(two symptom domains), and six levels were applied for the main genetic effects on 
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neurocognitive functioning (six measures). Because the obtained symptom counts and 
neuropsychological measures are correlated, correction for multiple comparisons was 
undertaken by calculating the effective number of independent tests (Meff) based on 
the observed eigenvalue variance using the matSpD interface (http://genepi.qimr.edu.
au/general/daleN/matSpD; (Li and Ji, 2005; Nyholt, 2004)). This analysis showed that the 
original 8 tests corresponded to 7 independent tests. To correct for multiple testing and 
to determine the significance of the results Bonferroni correction was applied by dividing 
the significance level by the number of independent tests. As three genetic variants were 
tested, as well as two levels (adults and adolescents), a p-value of .05/7/3/2 = .00119 was 
considered significant. Effects were described as ‘nominal’ in case significant at the 0.05 
level, but not surviving multiple comparison correction. Post-hoc we investigated if results 
were altered if IQ was included as a covariate, as the inclusion of IQ in ADHD research is 
an active debate (Rommelse et al., 2008d).
If one of the genes was potentially related to a dependent measure (ADHD symptoms 
or cognitive functioning) in the adolescent or adult sample, we investigated whether 
the effects for adolescents or adults were significantly different by defining and testing 
contrasts for the regression weights associated with the relations.
Missing data were less than 1.5% (adolescents) and 2% (adults) for cognitive measures, 
except for adolescent inhibition (48% missing) and visuospatial working memory (46% 
missing). Visuospatial working memory and inhibition in adolescents were measured 
during fMRI. Measurement was performed in a random subgroup (75% of sample) because 
of time constraints in the assessment protocol, and MRI was contraindicated in about 
25% of the children (e.g. because of wearing braces). Missing data were not imputed. 
For analyses including DRD4, DAT1, and 5-HTT in adolescents, n=665, n=739, and n=661 
subjects were available, respectively. For analyses in adults including DRD4, DAT1, and 
5-HTT, n=225, n=386, and n=217 subjects were available, respectively.
Results
Genetic association with ADHD diagnosis and symptoms
The results of the associations between clinical diagnosis of ADHD and DRD4-7R, HTTLPR, 
and the haplotype in DAT1 are provided in Table 4. In adults, we found nominally signifi-
cant association between ADHD and DRD4-7R (Odds ratio: 0.50, p=.02): 25% of adults with 
ADHD were 7R carriers, whereas 40% of adults without ADHD were 7R carriers, suggesting 
a possible protective effect of the 7R allele against adult ADHD. In line with this, a nom-
inal effect of DRD4-7R was found on ADHD symptoms, both inattentive and hyperactive/
impulsive, in the adult group. Carriers of the 7R allele had less severe symptoms (Cohen’s 
d: -0.39 [p=.027] and -0.42 [p=.018], respectively). No association between 7R and ADHD 
diagnosis or symptoms was found in the adolescent sample. Only the effects between 
DRD4 and inattentive symptoms differed from the adults (contrast p=0.045).
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Table 4  Association between clinical diagnosis of ADHD and genetic variants
Childeren/ Adolescents/ Young adults Adults
DRD4-7R OR (p-value) 0.80 (0.24) 0.50 (0.02)
HTTLPR [LL vs other] OR (p-value) 0.74 (0.13) 0.76 (0.37)
HTTLPR [SS vs other] OR (p-value) 0.76 (0.27) 1.00 (0.99)
DAT1 10R-6R OR (p-value) 0.76 (0.60) -
DAT1 9R-6R OR (p-value) - 1.10 (0.76)
Note Odds Ratio (OR) and p-values of the χ2 association with ADHD diagnosis
Genetic associations with neurocognitive functioning 
DRD4
None of the associations between neurocognitive functioning and DRD4 survived multiple 
testing correction. 
 5-HTT 
No main effects were found for HTTLPR on neurocognitive functioning. However, two 
nominal interaction effects of HTTLPR x age were found. The first was found for inhibition 
in adolescents (p=.037). Until 17 years of age (age cut-offs based on fitted regression line), 
LL homozygotes performed better than SS homozygotes on inhibition (Cohen’s d=.47 
p=.029). This effect vanished at age 17. The HTTLPR x age effect on inhibition in adoles-
cents did not differ from the HTTLPR x age effect on inhibition in adults (p=.009) (before 
the age of 51, the LL genotype performed better than the SS genotype [p=0.02, Cohen’s 
d=.55]; after the age of 50, the SS genotype performed better than the LL genotype [p=.025, 
Cohen’s d=.71]) (contrast p=0.53). 
The HTTLPR x age interaction was also nominally significant for motor timing in the 
adolescents (p=0.008). Until age 19 the SS genotype was associated with better motor 
timing and the LL genotype with worse motor timing (p=0.024 Cohen’s d=.31), while after 
age 19 the LL genotype was associated with better motor timing (p=0.034 Cohen’s d=.42). 
The HTTLPR x age effect was non-significant in the adults. 
DAT1
None of the associations between neurocognitive functioning and DAT1 survived multiple 
testing correction. A nominally significant interaction effect of DAT1 x age was found on 
verbal WM in adolescents (p=.025) (between age 14-18 years, 10-6 non-carriers performed 
better than carriers of this haplotype [Cohen’s d=.48, p<.001]; after the age of 18 years, 
10-6 carriers were not performing differently from non-carriers [Cohen’s d=.50 p=.12]).
IQ
Post hoc analyses including IQ as a covariate did not significantly change our results 
(results not shown). 
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Discussion
The current study contributes to ADHD research by exploring the influence of age on the 
relationship of three well-known ADHD candidate genetic variants with ADHD symptoms 
and ADHD-related neurocognitive functions. Results suggest a different involvement of 
genetic factors in ADHD at different stages of life. The DRD4-7R allele was nominally 
associated with less ADHD inattentive symptoms in adults selectively, which differed 
significantly from the association in the adolescent sample. The HTTLPR SS genotype was 
nominally associated with worse inhibition in adolescents, until the age of 17 years. In 
the adult group, the LL genotype was nominally associated with better inhibition, which 
changed to an association with worse inhibition after the age of 50 years. For motor timing 
a nominal interaction effect between age and HTTLPR was found with the SS genotype 
performing better before the age of 19 years and worse after the age of 19 years compared 
to the LL genotype. A nominal interaction effects between DAT1 and age on verbal working 
memory in adolescents was also found, with the childhood risk haplotype (10-6) carriers 
performing worse before the age of 18 years. 
The nominal association between DRD4-7R and ADHD symptom severity in adults appears 
counterintuitive, as the 7R allele has generally been reported as the risk allele for ADHD (Li 
et al., 2006). However, previous results are inconsistent, with some reporting the opposite 
or no effect of the 7R allele, with most reports investigating childhood ADHD (Gizer et al., 
2009). As dopamine transporter density decreases with age (Spencer et al., 2005), and ADHD 
symptoms decrease during adolescence (Biederman et al., 2000), the protective effect of 
the 7R allele during adulthood might reflect changes in the dopaminergic system. Indeed, 
longitudinal analysis of associations between the DRD4-7R allele and (ADHD-related) 
cortical thickness showed association in early development, but this association was no 
longer found around 16-18 years of age (Shaw et al., 2006). Clinically, a better outcome for 
adolescent 7R carriers has been reported (Shaw et al., 2007). In contrast, in adult samples, 
the 7R allele has been associated with increased levels of ADHD and worse performance 
on neurocognitive measures (Congdon et al., 2008; Muglia et al., 2000), although associations 
to better cognitive performance have been reported as well (Boonstra et al., 2008). The 
studies by Congdon et al. and Muglia et al. included younger adult samples (mean age 
20 and 34 years, respectively) than our study and the study by Boonstra et al. (mean age 
39 years), which supports the idea that throughout adulthood the effects of dopamine 
genes on ADHD-related measures are not static. This is in line with results showing a 
trend towards protective effects of the 7R allele in older adults with ADHD in a sample 
with an age range up to ~65 years (Johansson et al., 2008). In general, it might be tentatively 
suggested that the 7R allele may have a protective effect in adult ADHD, only emerging 
during or after middle-to-late adulthood, but not yet (consistently found) during adoles-
cence and young adulthood.
98 Chapter 4
Our age-dependent findings of HTTLPR on both inhibition and motor-timing suggest a 
pleiotrophic effect of this genetic variant. The effects of HTTLPR may suggest that opti-
mal serotonin levels (high or low) differ with age, which at these specific developmental 
stages might be related to increased risk for expressing ADHD-related behaviours like 
motor timing, with opposite genetic results for inhibition. Inconsistent results have been 
reported for HTTLPR in ADHD, however, most of the studies in childhood ADHD report 
the L allele as the risk allele (Beitchman et al., 2003). A large meta-analysis (Landaas et al., 
2010), which examined the association of HTTLPR with adult ADHD, did not find the L 
allele to be a risk allele, but rather reported a slight overrepresentation of the S allele 
in adult ADHD, although this did not reach significance. This reported trend is in line 
with our results for difficulties in motor timing, although opposite to our inhibition find-
ing, and might indicate differential involvement of serotonin genes in young and middle 
adulthood compared to childhood in ADHD-related difficulties. The directional outcome 
of altering serotonin transporter levels may thus depend on developmental stage, as also 
suggested by others (Wiggins et al., 2014). As the S allele is related to lower transcription 
activity compared to the L allele (Lesch et al., 1996), our results might reveal a switch in the 
influence of serotonin with the optimal levels differing with age. That is, in our sample 
including subjects with and without ADHD, before young adulthood, a decrease in sero-
tonin transcription activity (S allele) seems beneficial for motor timing but detrimental for 
inhibition, whereas during (and possibly after) young adulthood an increase in serotonin 
(L allele) leads to better motor timing but worse inhibition. 
The nominal interaction between age and DAT1 10-6 carriership on verbal WM, which 
switched at the age of 18 years, is in line with previous results for clinical ADHD pheno-
types (Franke et al., 2008; Franke et al., 2010). However, more research is needed to unravel 
the (age-related) underlying mechanisms of DAT1 in ADHD-related cognitive functioning. 
Our findings should be viewed in light of certain strengths and limitations. An important 
strength is the investigation of a large, well-phenotyped sample of patients with ADHD 
and healthy controls. Through the availability of adolescents and middle-aged adults 
–  not yet structurally investigated in molecular genetic research on ADHD before – this 
study helps to fill a gap in the current literature. We improved upon previous studies 
by minimizing population differences because the adult and child/adolescent/young 
adults sample included parents and their offspring, which made both age groups well 
comparable. Moreover, because both groups were assessed as part of the same study, 
methodological differences used to assess both groups were minimized. As age effects 
were derived from a cross-sectional design, however, they should be considered pre-
liminary until replicated in longitudinal designs. Additionally reported age effects were 
only nominally significant, not reaching multiple comparison correction, and therefore 
should be considered as exploratory and in need of replication. Further, we were not 
able to replicate associations between a clinical diagnosis and the tested genetic vari-
ants of DAT1 and 5-HTT, although, as part of a large international study using childhood 
clinical diagnoses assessed earlier, the current sample did contribute to a significant 
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association between the DAT1 haplotype and diagnosis during childhood (Brookes et al., 
2006). Potential explanations for not finding an association between the DAT1 haplotype 
and ADHD diagnosis in the current study is the follow-up nature of our sample, where 
patients were re-diagnosed.
In sum, we found differential genotype-phenotype associations in different age groups: 
effects for DRD4-7R were selective for adults, while effects for HTTLPR were found in 
children/adolescents/young adults (inhibition and motor timing) and adults (inhibition). 
Our results are exploratory, did not survive multiple testing and are in need of replication. 
Nonetheless, they suggest age to be an important factor in genetic association analyses 
of ADHD and related neurocognitive functioning. Especially in adolescence, neurocog-
nitive measures might be more sensitive to the effects of genetic variation than clinical 
symptoms.
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Methods S1 Diagnostic algorithm for ADHD in the NeuroIMAGE sample
To determine ADHD diagnoses, a combination of Conners’ ADHD questionnaires and a 
semi-structured diagnostic interview was used. Each participant was assessed with a 
parent-rated questionnaire (Conners’ Parent Rating Scales – Revised: Long version [CPRS-
R:L])1 and either a teacher-rating (Conners’ Teacher Rating Scales – Revised: Long version 
[CTRS-R:L]2 applied for children <18 years) or a self report (Conners’ Adult ADHD Rating 
Scales–Self-Report: Long version [CAARS-S:L]3 applied for children ≥18 years). Partici-
pants were administered the Dutch translation of the Schedule for Affective Disorders 
and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL4) 
containing developmentally appropriate questions to assess each of the 18 ADHD symp-
toms, compatible with the DSM-IV-TR5.  Parents, reporting on their children, as well as 
children themselves, if ≥12 years old, were interviewed separately6. Final scores on each 
item of the K-SADS were determined by weighing all available information. Initially, all 
participants were administered the K-SADS ADHD screening interview. Participants with 
elevated scores on any of the screen items were administered the full ADHD supplement. 
For participants using medication, ratings were gathered of participants’ functioning off 
medication. Using a diagnostic algorithm, a combined symptom count was calculated by 
adding symptom counts on the K-SADS and CTRS-R:L (for participants <18) or CAARS-S:L 
(for participants≥ 18), both providing operational definitions of each of the 18 behavioural 
symptoms defined by the DSM-IV. Symptoms of the CTRS-R:L or CAARS-S:L were only 
added to the combined symptom count if at least 2 symptoms were reported, in order to 
avoid the Conners’ score to put too much weight on the diagnosis. 
From the Conners ADHD questionnaires the following scales were used: DSM Inattentive 
behaviour (scale L of the CTRS-R:L/CPRS-R:L; scale E of the CAARS-S:L), DSM Hyper-
active/Impulsive behaviour (scale M of the CTRS-R:L/CPRS-R:L; scale F of the CAARS-S:L), 
and DSM Total (scale N of the CTRS-R:L/CPRS-R:L; scale G of the CAARS-S:L). Participants 
with a combined symptom count of ≥6 symptoms of hyperactive/impulsive behaviour and/
or inattentive behaviour were diagnosed with ADHD, provided they: a) met the DSM-IV 
criteria for pervasiveness and impact of the disorder (measures derived from the K-SADS), 
b) showed an age of onset before 12, c) received a T ≥63 on at least one of three scales 
on at least one of the Conners’ ADHD questionnaires (i.e. CPRS-R:L and/or CTRS-R:L for 
children <18 years and CPRS-R:L and/or CAARS-S:L for children ≥18 years), pertaining to 
a period without medication.
Participants with a combined symptom count of ≥ 6 symptoms who did not meet one or 
more of these criteria were evaluated by a team of trained experts, in order to derive a 
consensus decision on their diagnosis. Unaffected participants were required to receive a 
T < 63 on each of the above-mentioned scales of each of the Conners’ ADHD question-
naires, and have a combined symptom count ≤ 3 symptoms. For young adults (≥ 18 years), 
criteria were slightly adapted, such that a combined symptom count of 5 instead of 6 
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symptoms was sufficient for a diagnosis7 and with ≤ 2 symptoms on the combined symp-
tom count they were labelled ‘unaffected’. Participants not meeting criteria for ADHD 
or unaffected status were labelled ‘subthreshold ADHD’. Diagnostic procedure for par-
ents were similar to those applied for children ≥ 18 years. The ADHD questionnaire was 
completed by their partner (Conners’ Adult ADHD Questionnaire-Observer: Short version 
[CAARS-O:SV]). A retrospective childhood diagnosis was established in addition to a cur-
rent diagnosis, using the same diagnostic algorithm used for young adults. Parents with 
a current and/or childhood diagnosis were labelled as affected.
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ABSTRACT
Objective: Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neuropsychi-
atric disorder that is usually accompanied by neuropsychological impairments. The use of 
heritable, psychometrically robust traits that show association with the disorder of interest 
can increase the power of gene-finding studies. Due to the robust association of intra-indi-
vidual variability with ADHD on a phenotypic and genetic level, intra-individual variability 
is a prime candidate for such an attempt. We aimed to combine intra-individual variability 
measures across tasks into one more heritable measure, to examine the relatedness to 
other cognitive factors and to explore the genetic underpinnings through quantitative trait 
linkage analysis. 
Methods: Intra-individual variability measures from seven tasks were available for 238 
ADHD families (350 ADHD-affected and 195 non-affected children) and 147 control families 
(271 children). 
Results: Intra-individual variability measures from seven different tasks shared common 
variance and could be used to construct an aggregated measure. This aggregated meas-
ure was largely independent from other cognitive factors related to ADHD and showed 
suggestive linkage to chromosomes 12q24.3 (LOD=2.93), 13q22.2 (LOD=2.36) and 17p13.3 
(LOD=2.00). 
Conclusions: A common intra-individual variability construct can be extracted from very 
diverse neuropsychological tasks, this construct taps into unique genetic aspects of ADHD 
and may relate to loci conferring risk for ADHD (12q24.3 and 17p13.3) and possibly autism 
(12q24.3). Given that joining of data across sites boosts the power for genetic analyses, 
our findings are promising in showing that intra-individual variability measures are viable 
candidates for across site analyses where different tasks have been used.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a strongly genetically determined (her-
itability ~70-75%) neuropsychiatric disorder (Nikolas and Burt, 2010). In most cases ADHD is 
accompanied by one or more neuropsychological impairments, such as executive dysfunc-
tion (Willcutt et al., 2005) and impairments in sensory, motor and timing processes (Halperin 
et al., 2008). Given that, in the vast majority of patients, multiple genes of small effect 
seem related to the disorder (Franke et al., 2009) in addition to environmental influences 
(Burt, 2009; Wood et al., 2010), interest has grown in using neuropsychological measures as 
measures of ADHD pathology that may have a simpler genetic architecture than ADHD 
itself (Asherson et al., 2005; Gottesman and Gould, 2003). Many recent studies have shown the 
utility of neuropsychological measures for ADHD genetic research (Doyle et al., 2008; Kuntsi 
and Stevenson, 2001; Polderman et al., 2006; Rommelse, 2008; Rommelse et al., 2008). However, 
error- and/or task-specific variance underlying neuropsychological data may still seriously 
hamper genetic studies. It may be expected that combining data across tasks increases 
the heritability estimate of the underlying construct (Fulker et al., 1999; Sham et al., 2000) 
through a reduction in the error variance underlying the individual measures (Kuntsi et 
al., 2006; Wood et al., 2008). This is only feasible when the tasks to be aggregated share a 
common variance both genetic and phenotypic (Epstein, 1983). Therefore, it is of interest 
to examine to what extent tasks tap onto the same underlying construct and if such a 
construct increases the power for detecting gene effects (Fulker et al., 1999; Sham et al., 2000).
A prime candidate for such analyses is intra-individual variability. Intra-individual vari-
ability refers to the moment-to-moment variability in (task-related) behaviour. Increased 
intra-individual variability has been reported in ADHD across a wide variety of behaviours 
(Klein et al., 2006), and the majority of the studies have focused on the subcomponent: 
variability of reaction time. Reaction time variability shows strong phenotypic (Halperin 
et al., 2008; Klein et al., 2006; Kuntsi et al., 2001) and genetic/familial association with ADHD 
(Andreou et al., 2007; Bidwell et al., 2007; Kuntsi and Stevenson, 2001; Nigg et al., 2004; Rommelse et 
al., 2008a; Uebel et al., 2010), across several measures. In a recent multivariate familial factor 
analysis, a large reaction time familial factor emerged (encompassing elements of both 
mean and variability in reaction time), which shared 85% of the familial variance with 
ADHD (Kuntsi et al., 2010). Animal studies also support a genetic contribution to intra-indi-
vidual variability (Perry et al., 2010), but firm explanations for the underlying mechanisms 
of intra-individual variability in ADHD are still lacking. Nevertheless, because of its strong 
phenotypic and genetic association with ADHD, intra-individual variability is of great 
interest as a potential target in ADHD genetic research.
Given this potential of intra-individual variability, it is essential to answer several issues. 
First, the extent to which intra-individual variability measured with different tasks rep-
resents the same underlying construct, when the tasks vary greatly in cognitive loading 
and stimulus pacing. Previous analyses have thus far only shown that intra-individual 
variability obtained from cognitive tasks can be aggregated to obtain a more heritable 
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measure (Wood et al., 2010a; Wood et al., 2011). In addition, intra-individual variability is 
differentially affected by rewards with and without a faster stimuli presentation rate in 
ADHD and controls (Kuntsi et al., 2009; Uebel et al., 2010), making it unknown if intra-indi-
vidual variability from tasks varying in stimulus pacing can be aggregated. Second, to 
what extent a common intra-individual variability construct shares familial variance with 
ADHD and cognitive constructs related to ADHD. Working memory, inhibition and intelli-
gence are interesting in this context given their established status as endophenotypes for 
ADHD and previous findings suggesting that intra-individual variability may be largely 
independent of these constructs (Kuntsi et al., 2010). Third, the genetic underpinnings of 
intra-individual variability using quantitative linkage analysis are unknown.
Materials and methods
Participants
Participants were recruited in the Dutch part of the IMAGE Project, which aims to identify 
genes increasing the risk for ADHD using quantitative trait loci linkage and association 
strategies (Brookes et al., 2006). ADHD phenotyping and in- and exclusion criteria in IMAGE 
have been described previously (Brookes et al., 2006). Families with at least one child with 
the combined subtype of ADHD (proband) and at least one additional sibling (regardless 
of ADHD status) participated. Control families were recruited from primary and high 
schools from the same geographical regions as the participating ADHD families. A total of 
238 ADHD families and 147 control families fulfilled inclusion criteria. Within the ADHD 
families, 238 probands (combined subtype ADHD), 112 affected siblings (64 with combined 
subtype, 28 with inattentive subtype and 20 with hyperactive-impulsive subtype) and 195 
non-affected siblings participated. Control families consisted of 271 children. For 51 control 
children, no additional control sibling could be recruited. Linkage data was available for 
209 probands, 98 affected siblings (53 combined subtype, 27 with inattentive subtype and 
18 with hyperactive-impulsive subtype) and 169 non-affected siblings. 
Cognitive measures
Psychostimulants were discontinued for at least 48 hours before testing.
Intra-individual variability measures
Intra-individual variability measures were derived from seven tasks that varied greatly 
with respect to cognitive load, pacing of stimuli, and measure of intra-individual variabil-
ity that was used (Table 1). The tasks are fully described elsewhere (Rommelse et al., 2008c).
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Table 1  Seven tasks used to derive measures of intra-individual variability
Task Short description Aim of 
measurement
N trials Self  
paced
Stimulus rate Intra-individual 
variability 
construct
Baseline 
speed
1-choice reaction time task Speed and 
accuracy of simple 
motor output 
32 trials No Variable, 
between 500-
2,500 ms
SDRT in ms 
averaged (32 
trials each hand)
Motor 
timing
Time production task estimating a 1-sec 
interval using a staircase algorithm, 
determining the time window in which 
a response was considered correct. The 
boundaries of the initial window were 
500 and 1500 ms and narrowed with 100 
ms, when a response was correct, while
it widened with 100 ms when a response 
was incorrect.
Accuracy and 
variability of  
timing a 1-sec 
interval
80 trials Yes Post-response 
interval of 1,500 
ms
SDRT in ms
Pursuit ‘Catching’ a randomly moving target 
(10 mm/sec) by moving the mouse cursor
Accuracy and 
variability of 
unpredictable 
motor movements
60 
samples 
(1/sec)
No - SD of mean 
distances in mm 
between cursor 
and target
Stop task 2-choice reaction time task, in which 
on 25% of the trials, a stop-signal was 
presented superimposed on the go-
signal, signaling to withhold the response
Speed and 
accuracy of 
inhibition of an 
ongoing response
240 trials No 3,000 ms SDRT in ms on 
go-trials
Shifting 
set
2-choice reaction time task, with three 
conditions: compatible responses only, 
incompatible responses only, and mixed 
compatible and incompatible
Speed and 
accuracy of 
inhibition and 
cognitive flexibility 
compared to 
baseline speed 
and accuracy
160 trials Yes Post-response 
interval of 250 
ms
SDRT in ms 
averaged across 
all trial types
Tracking Tracing a circle (radius 8 cm) Accuracy and 
variability of 
predictable 
motor 
movements
60 
samples 
(circle 
divided in 
60 equal 
parts)
Yes - SD of mean 
distances in mm 
between cursor 
and circle
Tapping Self-paced tapping task Speed and 
variability of 
self-generated 
motor output
Variable 
(duration 
task 18 
sec )
Yes - SD of intertap 
intervals in ms 
averaged (18 sec 
each hand)
Note  mm = millimeter; ms = millisecond; SD = Standard deviation; SDRT = Standard deviation of reaction time; Sec= 
second
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Working memory 
Verbal working memory was operationalized as the maximum span backwards of the 
WISC-III or WAIS-III subtest Digit Span (Wechsler, 2002).
Inhibition 
Inhibition was operationalized using the Stop Signal Reaction Time of the Stop task (fully 
described elsewhere (Rommelse et al., 2008c)), a 2-choice reaction time task consisting of 
75% go-trials and 25% stop-trials (identical to go trials, but with a visually presented 
superimposed stop signal). The Stop Signal Reaction Time is a measure of the speed of 
the inhibition process and can be calculated when the go- and stop-process are of equal 
duration. This is achieved by dynamically varying the delay between the go- and stop-sig-
nal, so that the participant successfully inhibits 50% of the stop-trials. 
Intelligence
Full-scale IQ was estimated by four subtests of the WISC-III (Wechsler, 2002): Vocabulary, 
Similarities, Block Design and Picture Completion. These subtests are known to correlate 
between .90-.95 with Full-scale IQ (Groth-Marnhat, 1997).
Statistical Analyses
All participants (probands, siblings and controls) were included in the structural equation 
modelling. Linkage analyses were conducted for 307 ADHD-affected and 169 non-affected 
siblings. 
Structural equation models
To account for potential differences in the correlation matrices for neuropsychological 
data, two separate groups were specified in the structural equation models (probands 
and their siblings, and controls and their siblings) to allow for the possibility of different 
variance / covariance structures within ADHD and control families. As the estimation of 
familial parameters requires sibling-pairs to be specified within the same group, it was, 
however, not possible to specify probands separately from their unaffected siblings in 
familial modeling. To meet the biometrical model assumptions, all data were age- and 
sex-regressed and the residuals transformed to normality using the optimized minimal 
skew command (lnskew0) in STATA version 9.2 (Statacorp, TX). To allow for differences in 
developmental trajectories across childhood and adolescence, age was divided into quar-
tiles and the regression was conducted separately within each quartile, and for males and 
females. To examine overlap of the intra-individual variability measures at the etiological 
level, familial structural equation models were run. Using the information that siblings 
reared together share, on average, 50% of their segregating alleles, univariate and multi-
variate models use within-trait and cross-trait cross-sibling correlations to decompose 
the variation of, and the co-variation between, traits into familial (F; between 50 and 
100% additive genetic + all common environmental) influences, and individual-specific 
environmental (E) influences, which include possible measurement error. In all models, 
to correct for ascertainment bias, the selection variable (ADHD status) was included with 
all its parameters fixed (Rijsdijk et al., 2005). This means that all analyses were necessarily 
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multivariate and ordinal in nature, if ADHD status was used. The threshold for ADHD 
status was fixed to a z-value of 1.64 to give a population prevalence of 5% and a familiality 
of 80% (Nikolas and Burt, 2010). 
AIM 1  To what extent does intra-individual variability1 measured with different tasks 
represent the same underlying construct?
Due to the computational demands of ordinal data analysis using more than six variables, 
this model had to be run using continuous data. This was the only model where it was not 
possible to correct for the selected nature of the sample, as the selection variable (ADHD 
status) was ordinal and previous analyses on an independent sample demonstrated that 
the correction makes only small differences to point estimates (Wood et al., 2011). Trait-level 
data were specified in a Cholesky (triangular) decomposition to ease optimization, but 
converted to a correlated factors solution of the Cholesky model. The correlated factors 
solution was mathematically equivalent to the Cholesky model, but made no assumptions 
regarding the ordering of the measured variables (Loehlin, 1996).
AIM 2  Quantification of the familial relationship of mean intra-individual variability 
with ADHD, inhibition, working memory and intelligence 
The correlated factors solution of the Cholesky model gives separate F and E correlation 
matrices between ADHD, intra-individual variability, mean of responses (average speed 
or accuracy, see Table 1), Digit span backwards, Stop Signal Reaction Time and IQ. Based 
on these, data were simulated for 1000 participants within an exploratory factor analyses 
in STATA v.10 (available upon request). This gave an indication of the underlying factor 
structure, but no specification of the underlying variance / covariance matrices could be 
deduced. Therefore, factors with an Eigenvalue greater than one and the factor loadings 
that were more than half alternative factor loadings were specified separately for F and 
E in a confirmatory familial factor model in Mx (see Figure 1). The exception was ADHD, 
which was specified to load onto both factors, as we aimed to investigate the etiology of 
ADHD with the cognitive variables.
AIM 3  Genetic analysis of mean intra-individual variability
DNA extraction has been described previously (Brookes et al., 2006). The Illumina Link-
age IVb SNP panel was used to successfully assay 5545 autosomal single nucleotide 
polymophenotypic correlationisms (SNPs) (as described in (Asherson et al., 2008)). After 
data cleaning 5407 SNPs with an average of 1.66 SNPs/centi-Morgan (cM) were entered 
into the linkage analysis. Linkage data in combination with the mean intra-individual 
variability variable was available for 307 ADHD-affected and 169 non-affected siblings. 
Linkage analysis of the age- and sex-regressed mean intra-individual variability trait was 
performed using MERLIN-regress software (Sham et al., 2002). The population-based mean 
and variance for the mean intra-individual variability trait were based on the sibling pairs 
of the control sample (n=271), for whom no genotyping was available. Heritability was 
set to 50% (Kuntsi et al., 2006), but given that heritability for these types of measures is 
measure-specific, analyses were repeated using heritability estimates between 60-90%. 
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MERLIN regress will robustly estimate linkage even if the heritability estimate is over-
estimated but it will give false positives if it is under estimated (Sham et al., 2002). To correct 
for inflated LOD-scores based on linkage disequilibrium (LD) between adjacent SNPs, we 
used r2 <.05 between SNPs to cluster SNPs into combined markers (Abecasis et al., 2002; Zhou 
et al., 2008). To ensure normality of the data, a transformation was conducted using the 
InverseNormal option in MERLIN-regress. Empirical p-values were derived with MERLIN 
by running 1000 simulations under the null hypothesis of no linkage while preserving the 
original phenotypes, family structures, allele frequencies, LD structures and missing-data 
patterns (Abecasis et al., 2002; Zhou et al., 2008). 
Results
Demographics
The groups did not differ in age, but the group of probands and affected siblings had a 
larger percentage of males than the groups of non-affected siblings and controls (pro-
bands: mean age = 12.0 (standard deviation [SD] = 2.5), % males = 84.5; affected siblings: 
mean age = 12.0 (SD = 3.4), % males = 56.3; non-affected siblings: mean age = 11.5 (SD = 
3.6), % males = 45.1; controls: mean age = 11.6 (SD = 3.2), % males = 40.6). Means (plus 
standard deviations) for raw intra-individual variability data are presented in Table 2.
Table 2  Means (+ standard deviation) for task-level intra-individual variability data
ADHD-affected
N=350
Unaffected siblings
N=195
Controls
N=270
Baseline speedbc 153.8 (115.2) 152.3 (120.4) 128.9 (92.9)
Motor timingbc 464.6 (488.4) 433.7 (461.6) 300.4 (223.1)
Pursuit 5.1 (4.3) 4.7 (3.5) 4.6 (3.2)
Stop taskabc 140.4 (40.5) 128.9 (42.7) 112.0 (35.9)
Shifting setc 1029.2 (517.3) 1098.1 (565.3) 993.3 (529.1)
Trackingbc 1.8 (1.0) 1.6 (0.9) 1.5 (1.0)
Tappingc 46.8 (21.1) 50.0 (45.9) 44.8 (20.3)
Group differences were examined using t-tests in STATA v9.2 and the results are indicated in subscript:
a indicates significant differences (P<.05) ADHD-affected versus unaffected siblings;
b indicates significant differences (P<.05) ADHD-affected versus controls; 
c indicates significant differences (P<.05) unaffected siblings versus controls
AIM 1  To determine the extent to that intra-individual variability measured with 
different tasks represents the same underlying construct
Table 3 gives phenotypic and familial correlations for each intra-individual variability 
variable. The phenotypic and familial correlation matrices show that all tasks shared 
common variance at both levels, justifying the use of an aggregated score (average familial 
correlation = .50). However, the low phenotypic correlation (average phenotypic correl-
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ation = .18) between task-level data, highlights the error variance in the raw data and the 
importance of reducing and creating more psychometrically sound phenotypes through 
aggregating task-level data which share a portion of the same familial influences (Sham 
et al., 2000). The data for each task were standardized and both a mean and a factor score 
were created out of the intra-individual variability tasks for the Cholesky model. Both 
scores showed a similar percentage of variance due to familial influences (~30%) and 
the high phenotypic correlation between them (.87) was driven both by the high familial 
correlation (.91) and environmental correlation (.86). Taken together, this suggests that 
both scores were equally suitable for subsequent genetic analysis; we chose to use the 
mean score as this is more easily replicable in independent samples. 
Table 3  Parameter estimates from the correlated factors solution of the Cholesky model within and across 7 
task-level measures of intra-individual variability
Baseline speed Motor timing Pursuit Stop task Shifting set Tracking Tapping
Baseline speed .10 .22 .25 .20 .22 .16 .10
Motor timing .61 .16 .21 .29 .20 .15 .10
Pursuit .70 .00 .21 .17 .15 .34 .21
Stop task .49 .55 .25 .18 .23 .17 .14
Shifting set .45 .61 .42 .58 .15 .02 .12
Tracking .68 .29 .55 .47 .10 .17 .12
Tapping .77 .39 .65 .68 .34 .95 .05
Note  Familial parameter estimates are shown on the diagonals; phenotypic correlations above the  diagonals and 
familial correlations are shown below 
AIM 2  Quantification of the familial relationship of mean intra-individual variability 
with ADHD, mean of responses, working memory, inhibition and intelligence 
Table 4 presents parameters from the Cholesky model that drove the specification of the 
familial factor model across ADHD, intra-individual variability, mean of responses (mean 
across the same tasks as used to define intra-individual variability), Digit span backwards, 
Stop Signal Reaction Time and IQ (Figure 1). The final model consisted of 2 familial factors. 
The first factor, reflecting 50% of the familial variance of ADHD, captured 100% of the 
familial influences on intra-individual variability, 60% on mean of responses and 12% on 
Stop Signal Reaction Time. The second factor, reflecting 15% of the familial variance of 
ADHD, captured 100% of the familial influences on Digit span backwards and 20% on Stop 
Signal Reaction Time. There was thus a clear separation of intra-individual variability 
and mean of responses from digit span backwards. Stop Signal Reaction Time, however, 
shared some familial influences with both factors. IQ was not related to the familial factor 
shared with reaction time data, but a portion (33%) of the familial influences on IQ were 
shared with the second factor. 
118 Chapter 5
Table 4  Parameter estimates from the correlated factors solution of the Cholesky model within and across 
ADHD, Intra-individual variability, Mean of responses, Digit span backwards, Stop Signal Reaction Time and IQ
 
ADHD Intra-individual 
variability
Mean of 
responses
Digit span 
backwards
Stop Signal 
Reaction Time
IQ
ADHD .40a .30 .15 -.21 .23 -.09
Intra-individual 
variability
.51 .30 .46 -.23 .28 -.26
Mean of responses .25 .85 .28 -.10 .12 -.08
Digit span backwards -.73 -.29 -.28 .12 -.18 .19
Stop Signal Reaction 
Time
.50 .50 .23 -.44 .28 -.13
IQ -.50 -.51 -.20 .12 -.17 .17
Note  Familial parameter estimates are shown on the diagonals; phenotypic correlations above the diagonals and 
familial correlations are shown below. ADHD = Attention-Deficit/Hyperactivity Disorder; IQ = Intelligence Quotient.
a Fixed parameter 
Note  The familiality of ADHD is fixed to .4, representing a heritability of 80%. Intra-individual variability and mean 
of responses represent a mean of standardized variables across all tasks.
Figure 1  Parameter estimates from a familial factor model within and across ADHD, intra-individual variability, 
mean of responses, digit span backwards, Stop Signal Reaction Time and IQ representing the percentage of 
the familial variance that is due to shared (F1 and F2) and non-shared (or specific; Sf1-6) familial effects.
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AIM 3  Genetic analysis of mean intra-individual variability 
Figure 2 provides the linkage analysis results. Permutation of the data showed the thresh-
old for genome-wide significance to be a LOD-score of 4.00 and the threshold for suggest-
ive linkage to be a LOD-score of 1.94. Strongest linkage to intra-individual variability was 
observed on chromosomes 12q24.3 (LOD-score: 2.93, empirical p-value = 0.006), 13q22.2 
(LOD-score: 2.36, empirical p-value = 0.019), and 17p13.3 (LOD-score: 2.00, empirical 
p- value 0.039), all reaching the threshold for suggestive linkage. Supplementary Figures 
1, 2 and 3 show the gene content of these regions.
Figure 2  Genome-wide logarithm of the odds (LOD) score graph of intra-individual variability
Discussion
We set out to examine the usefulness of intra-individual variability as a phenotype for 
gene-finding studies in ADHD. Intra-individual variability measures from seven different 
tasks shared common variance at both the phenotypic and genetic level, which replicates 
previous studies (Andreou et al., 2007; Bidwell et al., 2007; Buzy et al., 2009; Klein et al., 2006; Kuntsi 
et al., 2001; Kuntsi et al., 2006; Kuntsi et al., 2010; Nigg et al., 2004; Perry et al., 2010; Rommelse et al., 
2008; Uebel et al., 2010; Wood et al., 2010; Wood et al., 2011; Wood et al., 2008) yet remains quite 
remarkable, given variation in cognitive loading and stimulus pacing. The increase in 
familiality for the aggregated data (from an average familial estimate of .15 for task-level 
data to an familial estimate of .30 for aggregated data) supports previous data suggesting 
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an increase in power, through a reduction in error variance for aggregated data. Increased 
intra-individual variability in ADHD thus appears fundamental, task-independent, and 
– as our further analyses indicated – (largely) independent of other cognitive functions 
impaired in ADHD such as working memory, inhibition and IQ. Although as in previous 
studies (Kuntsi et al., 2010; Wood et al., 2010; Wood et al., 2011) the familiality estimate of 
 intra-individual variability falls shy of the 80% estimates for ADHD1, the significant 
 familial parameter suggests that intra-subject variability may still provide a useful endo-
phenotype measure as was also demonstrated by the linkage analysis. Furthermore, 
 intra-individual variability represented a more informative endophenotype for ADHD than 
simple reaction time data, because it proved to be a better representation of the familial 
ADHD factor than simple reaction time data (100% versus 60%, respectively). Together, 
these results suggest that defining a sample based on intra-individual variability, rather 
than the ADHD clinical phenotype, may produce a genetically more homogeneous sample 
and be useful in genetic studies. 
Indeed, using intra-individual variability in linkage analysis identified three candidate 
areas (12q24.3, 13q22.2 and 17p13.3). The chromosome 17 peak has been reported previously 
in a meta-analysis on genome-wide linkage studies in ADHD (Zhou et al., 2008), suggesting 
that this locus may contain genes conferring risk for increased intra-individual variabil-
ity and ADHD. The other two candidate areas (12q24.3 and 13q22.2) were not reported 
in this meta-analysis nor in our linkage scan of ADHD in a much larger sample which 
included the current sample (Zhou et al., 2008), but nominal evidence for linkage to ADHD 
diagnosis has been found for the 12q24.3 locus (Fisher et al., 2002; Hebebrand et al., 2006). 
The lack of overlap between the chromosome 13 locus with previous ADHD phenotype 
linkage analyses may either suggest that the identified linkage peak for intra-individual 
variability does not confer risk to ADHD, or that intra-individual variability may indeed 
have a simpler genetic architecture than ADHD itself and was more powerful in linkage 
analyses than phenotypic ADHD symptoms (Asherson et al., 2005). 
The linkage signals were compared to previously reported linkage signals in other psychi-
atric disorders and it appeared that the chromosome 12q24.3 locus has also been reported 
in autism (Yang and Gill, 2007). A linkage peak in 12q24.3 indeed showed suggestive linkage 
in a quantitative linkage analysis investigating Social Communication Scale measures, a 
measure of autism related behaviours, in this sample (Nijmeijer et al., 2010). Given the high 
comorbidity of ADHD and autism (Rommelse et al., 2011), the increased intra-individual 
variability in both disorders (Rommelse et al., 2011) and the shared genetic underpinnings 
(Rommelse et al., 2011), this locus may potentially be of interest in the search for pleiotropic 
genes for these disorders. 
The exact cognitive and neurobiological mechanisms leading to increased intra-indi-
vidual variability in ADHD are not yet understood. Recent cognitive models, such as 
the original cognitive-energetic (Sergeant, 2005) and state regulation (Borger and van der 
Meere, 2000) models, suggest that increased intra-individual variability in ADHD may be 
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related to suboptimal energetic mechanisms, such as diminished activation and effort. 
These mechanisms are distinct, but not independent, from executive functions such as 
inhibition (Borger and van der Meere, 2000; Sergeant, 2005). The current findings support this 
idea, with intra-individual variability being largely, but not completely, independent from 
response inhibition (Stop Signal Reaction Time). Neurobiological explanations for the 
increased intra-individual variability in ADHD suggest that it may be related to a lack of 
default mode network suppression as defined by a failure to deactivate the ventromedial 
prefrontal cortex and caudate with increasing task difficulty (Sonuga-Barke and Castellanos, 
2007). Other hypotheses include abnormalities in the fronto-parietal-thalamic brainstem 
network (Paus et al., 1997), catecholaminergic deficiencies in the regulation of normal peri-
odicity in neuronal activity (Castellanos et al., 2005), insufficient astrocyte function impair-
ing neuronal firing and myelination of axons (Russell et al., 2006), and altered dopamine 
function failing to modulate signal transmission appropriately (Sagvolden et al., 2005). An 
intriguing alternative explanation is that intra-individual variability in ADHD may be 
related to abnormalities in the structural organization of the brain (Kanai and Rees, 2011). 
That is, in ADHD a less efficient organization yet normal myelinisation of fiber tracts 
in the brain has been reported (de Zeeuw et al., 2012). This may cause a proportion of the 
neural signals to take the normal route, another proportion to take a ‘detour’ and arriving 
later than average at the destination, hence resulting in an average greater variability in 
responding. Given that a decreased homogeneous ordering of fiber tracts has also been 
frequently reported in autism (Groen et al., 2011), this hypothesis may form an explanation 
for the overlap of our linkage results using intra-individual variability with a locus re-
ported previously for autism.  
The current study provides a starting point in investigating the underlying genetic com-
ponents of intra-individual variability. Being underpowered for genome-wide linkage 
due to sample size, replication is a key issue. Nevertheless, our findings support growing 
evidence that a common intra-individual variability construct can be extracted from very 
diverse neuropsychological tasks, that this construct taps into unique genetic aspects of 
ADHD and that this construct may relate to loci conferring risk for ADHD and possibly 
autism. Given that the joining of neuropsychological data across sites boosts the power 
for genetic analyses, our findings are hopeful in showing that intra-individual variability 
measures are viable candidates for across site analyses where different tasks have been 
used.
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Candidate genetic pathways for atten-
tion-deficit/hyperactivity disorder (ADHD) 
show association to hyperactive/impulsive 
symptoms in children with ADHD.
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ABSTRACT
Objective: As multiple genes with small effect size are assumed to play a role in atten-
tion-deficit/hyperactivity disorder (ADHD) disease etiology, considering multiple variants 
within the same analysis likely increases the total explained phenotypic variance, thereby 
boosting the power of genetic studies. We investigated whether pathway-based analysis 
could bring us closer to unraveling the biology of ADHD. 
Method: We describe pathway as a pre-defined gene selection based on a well-established 
database or literature data. Common genetic variants in pathways involved in dopamine/
noradrenaline and serotonin neurotransmission and genes involved in neurite outgrowth 
were investigated in cases from the International Multicentre ADHD Genetics (IMAGE) study. 
We performed multivariable analysis to combine the effects of single genetic  variants within 
the pathway genes. Phenotypes were DSM-IV symptom counts for inattention and hyper-
activity/impulsivity (n=871) and symptom severity measured with the Conners Parent 
(n=930) and Teacher Rating Scales (n=916). 
Results: Summing genetic effects of common genetic variants within the pathways showed 
significant association with hyperactive/impulsive (p
empirical
=0.007), but not inattentive 
symptoms (p
empirical
=0.73). Analysis of parent-rated Conners hyperactive/impulsive symp-
tom scores validated this result (p
empirical
=0.0018). Teacher-rated Conners scores were not 
associated. Post-hoc analyses showed significant contribution of all pathways to the hyper-
active/impulsive symptom domain (dopamine/noradrenaline p
empirical
=0.0004, serotonin 
p
empirical
=0.0149, neurite outgrowth p
empirical
=0.0452). 
Conclusion: The current analysis shows association between common variants in three 
genetic pathways with the hyperactive/impulsive component of ADHD. This study demon-
strates that pathway-based association analyses, using quantitative measures of ADHD 
symptom domains may increase the power of genetic analyses to identify biological risk 
factors involved in this disease. 
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a common neuropsychiatric disorder 
characterized by developmentally inappropriate inattentiveness and/or increased impul-
sivity and hyperactivity(DSM-IV, 1994). Although ADHD is highly heritable, with heritabil-
ity estimates around 76% (Faraone et al., 2005), discovering genetic risk variants has been 
challenging. A number of candidate genes have been associated, but altogether explain 
only a small part of the heritability (Gizer et al., 2009), and so far, genome-wide association 
studies (GWASs) have not yielded genome-wide significant findings (Neale et al., 2010). 
Difficulty in discovering genetic risk variants has been attributed to the fact that ADHD 
is clinically heterogeneous (Faraone, 2000). Factor analyses of ADHD symptoms demon-
strate that ADHD is indeed multidimensional, with studies of teacher and parent ratings 
supporting a two-factor structure in children (Toplak et al., 2012) separating inattention 
and hyperactivity/impulsivity. The Diagnostic and Statistical Manual of Mental Dis-
orders (DSM-IV) diagnostic criteria make sub-classifications, distinguishing an inatten-
tive  clinical subtype (predominantly inattentive symptoms), a hyperactive/impulsive 
subtype (predominantly hyperactive/impulsive symptoms) and a combined type ADHD 
(both inattentive symptoms as well as hyperactive/impulsive symptoms) (DSM-IV, 1994). The 
two symptom domains of ADHD can be attributed, in part, to different brain networks 
(Makris et al., 2009) and twin studies show partial genetic overlap between inattentive and 
hyperactive/impulsive symptoms, but also clear genetic specificity (Greven et al., 2011). 
For these reasons, studying the genetics of symptom domains separately might reduce 
phenotypic heterogeneity, increase the power of genetic studies, and enable us to identify 
dimension-specific genetic risk variants. 
Apart from the multidimensionality, additional challenges in discovering genetic risk 
variants in ADHD are the small effect sizes of single common genetic variants and different 
genetic variants leading to similar phenotypes (Franke et al., 2009). As genome-wide genetic 
analyses aimed at identifying common risk variants, mainly focused on investigating 
Single Nucleotide Polymorphisims (SNPs) (Lasky-Su et al., 2008; Mick et al., 2010; Neale et al., 
2010) association, extremely large samples are needed to achieve genome-wide signifi-
cance (Neale et al., 2010; Psychiatric, 2011) and sample sizes in ADHD research are still small 
compared to other disorders (Psychiatric, 2011). A recent study performing cross-disorder 
GWAS using data from the Psychiatric Genomics Consortium of cases and controls for 
schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorders and 
ADHD, showed a significant polygenic component for ADHD, suggesting that searching 
for a combination of genetic variants might be fruitful (Cross-Disorder Group of the Psychiatric 
Genomics et al., 2013). Considering the combined effect of multiple variants in the same 
analysis might increase the explained phenotypic variance (Bralten et al., 2011), thereby 
boosting the power of genetic studies. Therefore, we investigated whether pathway-based 
analyses considering multiple SNPs within the same biological process, could bring us 
closer to unraveling the underlying genetic component of ADHD. 
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Alterations in dopaminergic, noradrenergic and serotonergic neurotransmission have been 
hypothesized to play a role in ADHD (Biederman and Spencer, 1999; Staller and Faraone, 2007). 
Medications used to treat ADHD affect these systems (Del Campo et al., 2011; Volkow et al., 2002) 
and reduce behavioral symptoms (Faraone and Buitelaar, 2010; Faraone and Glatt, 2010). Although 
serotonergic medications are not efficacious for ADHD (Verbeeck et al., 2009), serotonin inter-
acts with dopamine (Oades, 2008), therefore medication working on the dopamine system 
might also alter serotonin signaling. Secondly, projection sites of these neurotransmitter 
systems regulate cognitive processes, attention and motor behavior in ADHD, supported 
by structural and functional imaging data (Bush et al., 2005; Frodl and Skokauskas, 2012; Nakao 
et al., 2011). Thirdly, although not achieving genome-wide significance, genetic associations 
have been found for several candidate genes within these systems (Gizer et al., 2009). Final-
ly, animal studies show gene knock-out of catecholaminergic genes to cause ADHD-like 
behavior, altered catecholamine release and symptom reduction in response to ADHD 
medication (Davids et al., 2003). In addition, another biological process implicated in ADHD, 
mainly through genetic studies, is neurite outgrowth (Franke et al., 2009). Genes involved 
in this process were found to be enriched in the top results of the five available GWASs of 
ADHD (Poelmans et al., 2011). 
Prior studies investigated whether SNPs in the top results of individual analysis were over-
represented in pre-determined gene/pathways lists , or if those genes formed a network 
of functionally interacting proteins (Stergiakouli et al., 2012). Others selected variants based 
on candidate genes/pathways from literature (Oades et al., 2008). However, so far no studies 
have conducted a combined analysis of candidate genetic pathways allowing to investigate 
if certain genetic pathways together are associated with disorder-specific phenotypes. 
In the current study we used a case-only design to investigate whether pathway-based ana-
lyses of dopamine, noradrenaline and serotonin neurotransmission and genes involved in 
neurite outgrowth moderate the underlying behavioral components and severity of ADHD. 
Common genetic variants within these pathways were included into the same analysis.  
Method
Sample
The present study is part of the International Multicentre ADHD Genetics (IMAGE) study 
(Brookes et al., 2006; Muller et al., 2011a,b), an international collaborative study in seven 
European countries (Belgium, Germany, Ireland, Spain, Switzerland, the Netherlands 
and the United Kingdom) and Israel aiming at identifying genes that increase ADHD 
susceptibility. Participants were aged 5–17 years and of European Caucasian descent, 
based on information on ethnicity and genetic data (Asherson et al., 2008)(see Figure S1). 
Exclusion criteria included IQ < 70, presence of autism, epilepsy, known neurological 
disorders and any genetic or medical disorder associated with externalizing behaviors 
that might mimic ADHD. Details of the sample have been described elsewhere (Brookes et 
al., 2006; Kuntsi et al., 2006). 
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ADHD phenotyping
In short, a semistructured, standardized, investigator-based interview (Parental Account 
of Children’s symptoms [PACS] (Taylor, 1986)) and questionnaires (parent and teacher Con-
ners long version rating scales (Conners, 1998), parent and teacher Strengths and Diffi-
culties Questionnaires (SDQ) (Goodman, 1997)) were used to establish an ADHD diagnosis 
in children previously clinically diagnosed with ADHD, see (Rommelse et al., 2007) for the 
standardized algorithm that was applied to derive each of the 18 DSM-IV (DSM-IV, 1994) 
symptoms. Symptom count was defined by the number of symptoms per behavioral do-
main. Both symptom domains ranged from 0-9 symptoms. To investigate symptom severity 
a 4-point scale was used from the inattention and hyperactivity/impulsivity subscales of 
the Conners Parent Rating Scale (CPRS-R) (Conners et al., 1998a) and the Conners Teacher 
Rating Scale (CTRS-R) (Conners et al., 1998b). 
Genotyping
Genome-wide genotyping of the IMAGE probands was performed as part of the GAIN 
study using the Perlegen genotyping platform, described before (Neale et al., 2008). To 
increase coverage, an imputation approach was used with the Hapmap II release 22 data 
set (Li et al., 2010). The imputed data underwent quality control in which SNPs with an 
imputation score < 0.3 and minor allele frequency < 0.05 were excluded. After this step 
we had 2,182,904 SNPs across the genome. To avoid overestimation of our statistics, link-
age disequilibrium-pruned genotypes were used, using the “indep” command with an r2 
threshold of 0.8 (PLINK software (Purcell et al., 2007)). After this step we had 299,296 SNPs.
In this work we describe pathway as a pre-defined gene selection based on a well-estab-
lished genetic database or literature data. Selection of dopamine (74 genes) and serotonin 
(32 genes) genetic pathways was based on Ingenuity Pathway Analysis software (www.in-
genuity.com). This is a well established, frequently updated genetic database for pathway 
analysis. The information used in Ingenuity to produce these pathways is extracted from the 
scientific literature, and includes genes, drugs, biomarkers, chemicals, cellular and disease 
processes, and signaling and metabolic pathways. For noradrenaline, only the receptors are 
defined in Ingenuity, no pathway has been defined yet. Noradrenaline and dopamine share 
most of their synthesis-pathway as noradrenaline arises from the hydroxylation of dopa-
mine (Goldstein, 1966). Promiscuity has been found for transporters (Carboni et al., 1990) and 
receptors (Cornil and Ball, 2008; Wedemeyer et al., 2007) of both noradrenaline and dopamine, 
probably due to the similarities in their chemical structure. By including the noradrenaline 
receptors (8 genes) and transporter with the dopamine pathway, we aimed at capturing the 
noradrenaline pathway as well. The dopamine/noradrenaline pathway contained 82 genes. 
Dopamine/noradrenaline and serotonin pathways overlap in 13 genes. The selection of the 
neurite outgrowth genes was based on literature (Poelmans et al., 2011), including 45 genes 
from the top results of the five GWAS studies available on ADHD.
SNPs within all genes as well as 25 kilo basepairs (kb) flanking regions (capturing regu-
latory sequences) were selected.
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Data Analysis
Association analysis to symptom counts was performed separately for hyperactive/impul-
sive symptoms and inattentive symptoms. Symptom count distribution were normalized 
and standardized using the Blom transformation (SPSS version 18). 
SNP-by-SNP linear regression was performed using the “linear” command in PLINK with 
sex and age as covariates. To decrease genetic heterogeneity, a combined analysis ap-
proach was applied using a multivariable approach described earlier (Bralten et al., 2011). 
By summing single SNP association statistics, the observed summed statistic was created. 
To get a distribution on permuted summed statistics we ran 10,000 max(T) permutation 
tests using the “mperm” command, implemented in PLINK, for each SNP. The association 
statistics of the observed and permuted data were saved using the “mperm-save-all” 
PLINK command and added to create a summed statistic per run for all SNPs at the same 
time. The empirical p-value was determined as the number of times the observed summed 
statistic was smaller than the permuted summed statistic divided by the total number of 
permutations. Significance threshold for the empirical p-values was set as 0.05 divided 
by the number of tests.
We carried out our analysis in two steps. In step 1, we analyzed the combined effect of 
the SNPs in the three pathways on both inattentive and hyperactive/impulsive symptom 
counts . We then tested the association of the combined pathways with symptom severity 
using parental and teacher Conners scores. Post-hoc, we investigated potential effects of 
single pathways, genes and SNPs that might drive the association(Figure 1). Overlapping 
genes were only considered once in the combined analysis, but present in both separate 
analysis. For gene-wide association we used the analysis program VEGAS (Liu et al., 2010). 
VEGAS uses single SNP p-values to perform gene-based association tests. Significance 
threshold was set to 0.05 divided by the number of genes tested.
 
Figure 1  Different analysis steps
Step 1
DSM-IV Symptom count
n=871
Step 2
Symptom severity
n=930
Post-doc analyses
Dopamine/norepinephrine
Serotonin
Neurite outgrowth
Hyperactive/impulsive symptomsInattentive symptoms
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Figure 1 shows the different steps in our analysis. Analysis started by separating the in-
attentive and hyperactive/impulsive symptom counts. As hyperactive/impulsive symptoms 
showed association, we extended the analysis by investigating hyperactive/impulsive 
symptom severity using Conners’ scores. At step 2 post-hoc analyses were performed to 
investigate the pathways separately. 
Results
Table 1 shows the general characteristics of the studied sample. 
Table 1  Demographic characteristics of the studied individuals.
Value N
Mean years of age (SD) 10.83 (2.78) 930
% male 87 930
Median symptom count hyperactivity (SD) 8 (1.27) 871
Median symptom count inattentiveness (SD) 8 (1.04) 871
Median Conners’ parent hyperactive/impulsive (SD) 80 (10.15) 930
Median Conners’ teacher hyperactive/impulsive (SD) 69.5 (12.16) 916
Selection of dopamine/noradrenaline, serotonin and neurite outgrowth genes yielded 
a total of 146 unique genes (Table 2). The dopamine/noradrenaline and the serotonin 
pathways overlapped in 13 genes (251 SNPs). Four genes positioned on the X-chromosome 
(HTR2C, MAOA, MAOB and PPP2R3B) were not included in the analysis, one gene was 
not captured by the array used (PRKAR1B). The final data set contained 141 genes and 
5,179 SNPs. 
Table 2  Selection of genes
Genes dopamine/noradrenaline pathway
ADCY1 ADRA1D DRD5 PPP1R10 PPP2CA PPP2R5C PTSa
ADCY10 ADRA2A GCH1a PPP1R11 PPP2CB PPP2R5D QDPRa
ADCY2 ADRA2B IL4I1 PPP1R12A PPP2R1A PPP2R5E SLC18A1a
ADCY3 ADRA2C MAOAab PPP1R14A PPP2R1B PRKACA SLC18A2a
ADCY4 ADRB1 MAOBab PPP1R14B PPP2R2A PRKACB SLC18A3a
ADCY5 CALY NCS1 PPP1R14C PPP2R2B PRKACG SLC6A2
ADCY6 COMT PCBD1ab PPP1R14D PPP2R2C PRKAG1 SLC6A3
ADCY7 DDCa PPM1J PPP1R1B PPP2R3A PRKAG2 SMOXa
ADCY8 DRD1 PPM1L PPP1R3A PPP2R3Bb PRKAR1A SPRa
ADCY9 DRD2 PPP1CA PPP1R3C PPP2R4 PRKAR1Bb TH
ADRA1A DRD3 PPP1CB PPP1R3D PPP2R5A PRKAR2A 
ADRA1B DRD4 PPP1CC PPP1R7 PPP2R5B PRKAR2B 
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Genes serotonin pathway
DDCa HTR3D SLC18A1a
GCH1a HTR3E SLC18A2a
HTR1A HTR4 SLC18A3a
HTR1B HTR5A SLC6A4
HTR1D HTR6 SMOXa
HTR1E HTR7 SPRa
HTR2A IL4I1a TPH1
HTR2B MAOAab TPH2
HTR2Cb MAOBab 
HTR3A PCBD1a 
HTR3B PTSa 
HTR3C QDPRa 
Genes neurite outgrowth
ADAMTS17 EMP2 MAP1B PPM1H
ASTN2 FAM190A MBOAT1 RORA
ATP2C2 FHIT MEIS2 SLCO3A1
BMPR1B FLNC MMP24 SPOCK3
CDH13 GPC6 MOBP SUPT3H
CDH23 HK1 MYT1L TLL2
CREB5 HKDC1 NCKAP5 UGT1A9
CSMD2 ITGA11 NEDD4L UNC5B
CTNNA2 KCNIP4 NOS1 ZNF423
DNM1 KCP NRXN1 
DUSP1 LRP1B NUCB1 
DYNC2H1 MAN2A2 NXPH1 
a  present in dopamine/noradrenaline and in serotonin pathways
b  no SNPs for analysis
Step 1: The combined pathway analysis for DSM-IV symptom counts showed a signifi-
cant association with hyperactive/impulsive symptoms (pempirical=0.007), but not with 
 inattentive symptoms (pempirical=0.73) (Table 3). Single gene and single SNP analyses did 
not reveal significant associations
Step 2: Given the results of step 1, we tested symptom severity of hyperactivity/impulsiv-
ity derived from the parental Conners scores with the three genetic pathways combined 
and observed a significant association (pempirical=0.0018). Post-hoc analyses showed that 
all pathways were independently associated with the hyperactivity/impulsivity score 
(dopamine/noradrenaline pempirical=0.0004, serotonin pempirical=0.0149, neurite outgrowth 
pempirical=0.0452) (Table 3). Single gene and single SNP analysis did not reveal significant as-
sociations. For further information on single SNP results please contact the corresponding 
author directly. The combined pathways were not associated with hyperactive/impulsive 
scores on the teacher-rated Conners scale (pempirical=0.75). 
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Table 3  Association results from the combined analysis of symptom counts and combined and separate 
analysis of three genetic pathways with hyperactive/impulsive (HI) symptom severity measured with the 
parent-rated Conners Scale (n=930)
 
N SNPs IA symptom counts HI symptom counts HI symptom severity p-value
Combined analysis 5,179 0.73 0.007 0.0018
Dopamine/noradrenaline 
pathway
1,163a - - 0.0004
Serotonin pathway 407a - - 0.0149
Neurite outgrowth genes 3,860 - - 0.0452
a  251 SNPs were present in the serotonin pathway as well as in the dopamine/noradrenaline pathway. 
Table 4 shows a small to moderate correlation between hyperactive/impulsive and in-
attentive symptom counts. Hyperactive/impulsive symptom counts and Conners scores 
correlate moderately.
 
Table 4  Correlation analyses between the studied phenotypes. Correlation coefficients are shown with 
 corresponding p-values in brackets
 
Symptom count  
hyperactivity/ impulsivity
Symptom counts 
inattentiveness
Conners parent 
hyperactivity/ impulsivity
Symptom counts inattentiveness .182 (<.001)
Conners parent hyperactivity/
impulsivity
.254 (<.001) .087 (.008)
Conners teacher hyperactivity/
impulsivity
.386 (<.001) .111 (.001) .238 (<.001)
Discussion
The current study is the first to show an association between dopamine/noradrenaline, 
serotonin pathways and neurite outgrowth genes to the hyperactive/impulsive component 
of ADHD using hypothesis-based pathway association analysis using a case-only design. 
No association to the inattentive component was observed. Post-hoc analyses showed in-
dividual contribution of all three pathways. Single genes or SNPs did not show significant 
association, suggesting that the observed associations are the result of combined small 
effects of multiple genetic variants. 
The concept of biological pathways has been investigated before in ADHD. Top results 
from GWAS studies and rare variants were investigated for overrepresentation in certain 
genetic biological pathways (Poelmans et al., 2011; Stergiakouli et al., 2012). Findings show 
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overlap suggesting convergence of both rare and common variants in the risk of ADHD. 
When Elia et al. (Elia et al., 2012) investigated rare variants only, they showed multiple genes 
carrying these variants belonging to the metabotropic glutamate receptor gene family. An-
other approach has been to use predefined genetic pathways as a starting point for gene/
variant selection and testing (Brookes et al., 2006; Chaste et al., 2011; Ribases et al., 2009; Ribases 
et al., 2012). Oades et al. (Oades et al., 2008) selected genes that were related to serotonin 
function and applied a family-based multivariate approach clustering the phenotypes, 
to increase their statistical power. The current study extends previous approaches by 
including all variants in the studied pathways, by investigating both ADHD symptom 
domains separately, and by increasing our power by joining single SNP effects. Although 
IMAGE was part of these prior analysis (13 of the 45 neurite outgrowth genes were based 
on the single SNP effects in the IMAGE study), these 13 genes do not drive our results. 
Our results suggest a link between candidate genetic pathways and hyperactivity/impul-
sivity but not with inattentiveness. Symptom domain-specific genetic associations have 
previously been reported. Markunas et al. (Markunas et al., 2010) identified association be-
tween the SLC9A9 gene and hyperactive/impulsive Conners scores. Lasky-Su et al. (Lasky-Su 
et al., 2008a) found association between two variants within the dopamine receptor 4 gene 
(DRD4) and ADHD symptoms which was driven by the inattentive symptoms only. In a 
previous paper, using the IMAGE sample, Lasky-Su et al. (Lasky-Su et al., 2008b) investi gated 
domain-specific genetic associations using GWAS and reported nominal associations 
for variants within candidate genes included here. Also, in healthy twins, hyperactive/
impulsive symptoms have been associated to variants within the dopamine pathway (Mill 
et al., 2005). Further, although the neurite outgrowth network has not yet been linked to 
hyperactivity or impulsivity symptoms, it showed overrepresentation in the top results of 
a GWAS study studying motor coordination problems in ADHD (Fliers et al., 2012) and some 
neurite outgrowth genes studied here, in particular NOS1 (Hoogman et al., 2011; Reif et al., 
2009) and CTNNA2 (Terracciano et al., 2011), have been associated to impulsivity. 
One possible explanation of lack of association with inattention may be related to a higher 
degree of phenotypic heterogeneity compared to hyperactivity/impulsivity. Therefore, the 
current sample might not have enough power to detect genetic effects. However, as both 
symptom domains are highly heritable (hyperactive/impulsive 88%, inattentive 79%) 
(McLoughlin et al., 2007) and standard deviations are similar (Table 1), different phenotypic 
heterogeneity is not expected. Alternatively genetic mechanisms other than those studied 
here might be involved in the inattention domain. 
The current study analyzed symptom count and symptom severity. Both are part of the 
hyperactive/impulsive domain, however, there is only moderate to small correlation be-
tween them. Symptom counts have been created through a semi-structured diagnostic 
interview in combination with few items from ADHD rating scales, whereas the symptom 
severity measures were rated by parents or teachers. Therefore we expect them to capture 
different aspects of the disorder.
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It should be noted that the selected pathways were associated with parental but not with 
teacher-rated hyperactivity/impulsivity. Discrepancies between raters have been observed 
previously (De Los Reyes and Kazdin, 2005; Hartman et al., 2007; Martin et al., 2002), with correl-
ations between mother and teacher ratings ranging from .23 to .49 (Sollie et al., 2012; Willcutt 
et al., 1999) and significant differences in mean scores (Martin et al., 2002). Low correlation 
values suggest them to capture different aspects of the disorder. Linkage analysis for 
parent-rated and teacher-rated Conners scores also showed rater-specific quantitative 
trait loci (Zhou et al., 2008). Informant differences can be attributed to several factors, like 
different standards and biases in reporting and scoring the symptoms (Hartman et al., 2007), 
or setting-specific behavior observed only by one rater (Merwood et al., 2013). Teacher ratings 
might be more prone to measurement error, as teachers need to divide their attention 
over multiple children and observe each individual for a limited amount of time while 
performing specific school-related activities. Parents might have more opportunities to 
observe their child in multiple daily life settings, but can be biased depending on having 
another child with similar behavior or not. 
Our findings should be viewed in light of certain strengths and limitations. An important 
strength is the combination of multiple genetic variants in a well-characterized ADHD 
sample accounting for small effect sizes and genetic heterogeneity in ADHD. A limitation 
is that our sample shows reduced power to find associations explaining 1% or less of the 
variance (http://pngu.mgh.harvard.edu/~purcell/gpc/qtlassoc.html) therefore replication 
in an independent sample is necessary. We were unable to define the direction of the 
effects, or whether directions were different for the different genes/pathways studied, 
which we acknowledge to be a limitation. 
For pathway and gene selection we took a conservative approach, only including genes 
selected using a well-established database or literature. Pathway selection remains dif-
ficult as the currently available databases are far from complete, therefore we feel they 
should be used as not more than a starting point for pathway analyses. Therefore inter-
esting genes might have been missed. As we only included the most promising candidate 
pathways for ADHD, we might have missed others as new candidates are still emerging 
(Elia et al., 2012). 
Given our case-only design, our results should be seen as moderating individual symp-
toms within the disorder, but not necessarily contributing to ADHD susceptibility. To 
investigate if these pathways increase the susceptibility to ADHD a case-control study 
should be performed. Also, it would be interesting to validate the current analysis in 
samples with an equal gender distribution, adult ADHD samples and population-based 
samples. 
In conclusion, our results support the hypothesis that genes of the dopamine/noradren-
aline and serotonin neurotransmitter pathways as well as neurite outgrowth genes are 
involved in ADHD through the hyperactive/impulsive component but not the inattentive 
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one. The current study shows that pathway-based association analyses in combination 
with more homogeneous phenotyping may overcome power problems in association test-
ing by taking into account allelic heterogeneity. 
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Figure S1  Multidimensional scaling (MDS) based on genetic distance. The distribution of populations in the 
MDS plot provides information on the genetic similarities between the populations. Our sample (IMAGE) can 
be found in the left bottom of the figure.
 
Based on the MDS plot, seven individuals seem to deviate from the main population 
cluster (in the dotted square). To investigate possible confounding of the inclusion of 
these individuals, analyses were rerun excluding them. Exclusion of these individuals did 
not change our results. The common SNPs in the dopamine/noradrenaline and serotonin 
neurotransmission pathways and those in the neurite outgrowth genes still show an as-
sociation with hyperactive/impulsive symptom counts (pempirical without outliers =0.0115, 
pempirical all=0.007). For the hyperactive/impulsive symptom severity measured with par-
ental Conners, we obtained the same result (pempirical without outliers =0.005, pempirical 
all=0.0018).
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CHAPTER 7
Source-based morphometry reveals 
a structural brain component that 
differentiates participants with ADHD but  
is not associated to ADHD candidate genes
Bralten J, Chen J, van Hulzen K J E, Greven C U, Zwiers M P, Rommelse N N J, Hartman 
C A, O’Dwyer L, Oosterlaan J, Hoekstra P J, Heslenfeld D, Franke B, Arias Vásquez A, 
Turner J, Calhoun V, Buitelaar J K, Liu J. Source-based morphometry reveals a structural 
brain component that differentiates participants with ADHD but is not associated to 
ADHD candidate genes.
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ABSTRACT
Background: Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental 
disorder with strong genetic loading. Univariate analyses documented differences in brain 
structure between participants with ADHD and controls. However, univariate analyses do 
not take into account the relationship between brain areas and are based on a large number 
of statistical tests. Multivariate analysis techniques, like independent component analysis 
(ICA), can address these issues. 
Methods: In the current study we performed a Source-Based Morphometry (SBM) analysis 
on structural brain data of a large sample of participants with ADHD, their siblings, and 
controls (n=539). SBM uses ICA to identify independent sources within the imaging data, 
which are decomposed as components. We tested whether these structural components 
were different between subjects with and without ADHD (adjusting for family structure). 
Then, we analyzed gene-brain associations for six candidate genes for ADHD (DAT1, DRD4, 
DRD5, 5HTT, HTR1B and SNAP25) by performing gene-wide association analyses to the 
ADHD component.  
Results: After decomposing our data in 23 independent components, one component 
showed a significant difference for ADHD status (p=0.001395), which was reliable (em-
pirical p=0.0029). This component consisted of occipital areas, frontal areas, pre- and 
post-central gyrus, and precuneus. The component was not associated to one of the six 
candidate genes for ADHD.
Conclusion: Using a multivariate approach, we found a pattern of structural brain data 
which differentiated individuals with ADHD from those without ADHD. Our sample could 
not detect associations to candidate genes for ADHD, indicating genetic effects to be small 
or other genetic variants to be involved.
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Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental 
disorder characterized by symptoms of inattention, and/or hyperactivity and impulsiv ity 
(DSM-5, 2013b). ADHD has been recognized as a neurobiological disorder, as evidenced by 
abnormal brain structure and function documented by brain imaging studies. Structural 
magnetic resonance imaging (MRI) studies report that ADHD is associated with reductions 
in total brain volume (Castellanos et al., 2002), and reductions in frontal, striatal, and cere-
bellar volume (Valera et al., 2007). Next to segmentations of regions of interest, which are 
limited by setting a priori hypotheses, studies have also used whole-brain approaches to 
investigate differences between individuals with ADHD and healthy individuals. One of 
these approaches is voxel-based morphometry (VBM) (Ashburner and Friston, 2000; Good et 
al., 2001). This hypothesis-free method compares brain volume differences between cases 
and controls using a voxel-by-voxel approach. VBM studies comparing participants with 
ADHD to controls indicate reduced grey matter in putamen, globus pallidus, caudate 
nucleus, anterior cingulate cortex, and increased grey matter in posterior cingulate cortex 
(Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011). Univariate approaches 
will only detect voxels for which a main effect is present (in this case a mean difference 
in volume between the groups). Univariate approaches, however, are not well-suited to 
identify weak effects across multiple variables and to take into account relationships 
between voxels. Multivariate approaches have specific advantages for simultaneously 
assessing many variables for an aggregate effect.
Different multivariate approaches exist (for a review see Liu and Calhoun, 2014), one of 
which is independent component analysis (ICA). ICA assumes that the observations seen 
in our data are a linear mixture of signals from different underlying sources. The ICA al-
gorithm decomposes the mixed signal into components that are maximally independent. 
ICA approaches on brain imaging data have been used before for structural brain data 
(also known as Source-Based Morphometry (SBM)) (Xu et al., 2009), but also for other types 
of imaging data like functional MRI data (Calhoun et al., 2009; Liu et al., 2009) and resting 
state MRI data (de Celis Alonso et al., 2014). SBM identifies maximally independent sources 
of linearly covarying grey matter concentrations. Previous studies showed that using SBM 
compared to VBM can identify additional brain areas to be different between groups (Xu et 
al., 2009). The main outcome of SBM is two-fold: first, a reduction of the dimensionality of 
the data, as voxels with correlated information will be clustered into the same component, 
and second, the identification of (independent) patterns within the voxel data, that can 
be used to investigate if there are structural differences between groups. 
ADHD is a highly heritable disorder (Faraone et al., 2005), and brain volumes are also her-
itable (Peper et al., 2007). Further, brain volumetric anomalies in ADHD are familial, sug-
gesting that shared genetic risk factors may underlie the liability to ADHD and smaller 
brain volumes (Bralten et al., Submitted; Durston et al., 2004; Greven et al., Accepted). Therefore, 
combining brain imaging with genetics (imaging genetics) in ADHD research can aid our 
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understanding of the pathophysiology of the disorder. So far, findings for genetic risk 
factors associated with ADHD are sparse and inconsistent (Faraone et al., 2005; Thapar et al., 
2013). The largest meta-analysis of candidate genes exploring their genetic associations 
with ADHD risk suggested variants within six genes to be associated to the ADHD pheno-
type. Three dopaminergic genes, DAT1/SLC6A3, DRD4, DRD5, two serotonergic genes, 
5-HTT/SLC6A4, HTR1B, and one gene involved in vesicle transport and membrane fusion, 
SNAP25, were found (Gizer et al., 2009). 
The current study had two aims. First, we wanted to identify patterns of structural volu-
metric data that differ between participants with ADHD, and participants without ADHD 
by using multivariate analysis in a family-based sample of participants with ADHD, their 
siblings and controls. Second, we aimed at investigating if these differences were associ-
ated with candidate genes for ADHD. 
Methods
Subjects
Participants were recruited from the NeuroIMAGE project, a follow-up (2009-2012) of the 
Dutch part of the International Multicenter ADHD Genetics (IMAGE) study performed 
between 2003 and 2006 (Rommelse et al., 2008). In short, ADHD families with at least one 
child with ADHD combined subtype and at least one biological sibling (regardless of 
ADHD diagnosis) were recruited, as were control families with at least one child and one 
biological sibling with no formal or suspected ADHD diagnosis in any of the first-degree 
family members. For references and a detailed description of the NeuroIMAGE project 
and study procedures, see (von Rhein et al., 2014).
Inclusion criteria were the same for all participants: age between 8-30 years, European 
Caucasian descent, IQ ≥ 70 and no diagnosis of autism, epilepsy, general learning diffi-
culties, brain disorders and known genetic disorders. Participants were excluded from 
scanning if they had any contra-indication to scanning. The study was approved by the 
Dutch local medical ethics committees, and written informed consent was obtained from 
all participants.
To determine ADHD diagnosis according to the DSM-IV criteria at the time of participation 
in NeuroIMAGE, all participants in the study were similarly assessed using a combination 
of a semi-structured diagnostic interview (K-SADS) (Kaufman et al., 1997) and Conners ADHD 
questionnaires (Conners et al., 1999; Conners et al., 1998a,b; Conners et al., 1997). Symptom counts 
were taken from these measurements. Detailed description of diagnostic criteria can be 
found elsewhere (von Rhein et al., 2014) and in Methods S1 of the Supplementary materials. 
Two groups were made, one group of participants with an ADHD diagnosis and one group 
with participants without an ADHD diagnosis (unaffected siblings + controls). Participants 
provided self-reports about lifetime use of psychoactive medication.
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MRI acquisition 
MRI data were acquired at two different locations (Donders Centre for Cognitive Neuro-
imaging in Nijmegen and VU University Medical Centre in Amsterdam), using two com-
parable 1.5 Tesla MRI scanners (Sonata/Avanto Siemens, Munich, Germany), the same 
8-channel head-coil and scan protocols. For each participant we obtained high-resolution 
T1-weighted MPRAGE anatomical scans (176 sagittal slices, TR = 2730 msec, TE = 2.95 
msec, TI=1000 ms, flip angle = 7 deg, GRAPPA 2, voxel size = 1.0 x 1.0 x 1.0 mm, field of 
view = 256 mm). MRI scans which yielded clinically relevant incidental findings, and 
those for which manual ratings revealed poor quality or motion artifacts were excluded 
from analysis (Blumenthal et al., 2002). 
Imaging data preparation
Each participant’s T1-weigthed scan was normalized to Montreal Neurological Institute 
(MNI) 152 standard space, bias-field corrected and segmented into grey matter, white 
matter, and cerebrospinal fluid using the unified procedure of the VBM 8.1 toolbox (http://
dbm.neuro.uni-jena.de/vbm/) in SPM (default settings) (Ashburner, 2007). This method uses 
an optimized VBM protocol as well as a model based on Hidden Markov Random Fields 
(HMRF) developed to increase signal-to-noise ratio (Ashburner and Friston, 2000; Cuadra et al., 
2005; Good et al., 2001). Correction for total brain volume was incorporated in the toolbox. 
All data were smoothed with an 8 mm FWHM Gaussian smoothing kernel. We excluded 
one participant that showed an average grey matter concentration that was more than 4 
standard deviations away from the mean.
Covariates and family structure
Since both the ADHD group as well as the control group contained siblings from the same 
families, observations were not independent within families. Therefore, we accounted for 
this by including family identifier as a random factor in a mixed effects regression model. 
This was done prior to the ICA analyses on the structural brain data. Because of evidence 
for gender effects and linear and quadratic effects of age on brain volumes (Giedd et al., 
2009; Shaw et al., 2008), the main effects of age, age2, and gender were included as fixed 
effects in the mixed model. Scanner location (Amsterdam, Nijmegen) was also included 
as a fixed effect to account for potential site effects. A linear mixed effects model was used 
in Matlab (Mathworks, Inc.) including the intercept and applying the restricted maximum 
likelihood (REML) approach. This model was fitted for every voxel and the residuals were 
saved, projected back onto the brain and subsequently used in our ICA approach.
Component estimation
Prior to the independent component analyses an estimation on the number of expected 
components was performed. The method we used to do this is the minimum description 
length (MDL) approach (Rissanen, 1978). This approach estimates the number of compo-
nents that most efficiently describes the original data. This approach allowed us to use 
a data driven method for selecting the number of components rather than an arbitrarily 
selected number of components.
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Independent component analyses
ICA assumed the data to be a linear mixture of unknown underlying components that are 
mutually independent. The algorithm attempts to separate the independent “sources” 
that have been mixed together. The equation can be found in Formula 1 where X is the 
observed data matrix, S is the source matrix and A is the mixing processing matrix, with 
elements of A referred to as mixing or loading coefficients. S’ is the component matrix and 
W is the unmixing process matrix, or demixing matrix. This is the pseudo-inverse of A. 
Formula 1:
ICA: X = A * S  S’ = W * X
The essence of ICA is to find W so we can estimate S’ to be as close as possible to the 
true independent components S. To do this the Infomax algorithm is used (Bell and Sej-
nowski, 1995), which maximizes the entropy function as described in Formula 2. In this 
figure fy(Y) is the probability density function of Y, E is the expected value and H is the 
entropy function. This method separates the unknown source signals from a number of 
signal mixtures by looking for the most independent combinations and is performed by 
gradient ascent in Matlab.
Formula 2:
max{H(Y)}=-E[lnf
y
(Y)];
Y=          , U=W • X+W
0
The ICA analysis was performed on the matrix of the residuals derived from our mixed 
model analyses. This matrix was then decomposed into mixing matrix and source matrix. 
The mixing matrix gives the relationship between the participants and the components. 
The source matrix gives the relationship between components and the voxels in the brain.
Genetic data
Genome-wide genotyping of the IMAGE probands was performed as part of the GAIN study 
using the Perlegen genotyping platform of 600,000 tagging single nucleotide polymorph-
isms (SNPs) (for details on genotyping, data cleaning, and quality control procedures see 
(Neale et al., 2008)). For NeuroIMAGE, genotyping was performed for affected, unaffected 
and control individuals who had not been genotyped before; this was done using the 
HumanCytoSNP-12 genotyping chip with 200,000 tagging SNPs. Quality control steps were 
performed for the genotype data. SNPs were excluded if the call rate per SNP was less than 
95%, the minor allele frequency was less than 1%, or the SNPs failed the  Hardy-Weinberg 
equilibrium test at a threshold of p≤10–6 (genome-wide). Participants were excluded if 
the call rate per individual was lower than 95%. To increase genomic coverage and to 
l
l+e-U
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harmonize genotyping, imputation was performed in the different datasets using the 1000 
Genomes Reference data. Imputation quality needed to exceed 0.8 for SNPs to be used 
for analysis. Six genes were extracted from the genome-wide data for genetic analyses, 
including a 100 kb flanking region. Genetic data was pruned prior to analysis, excluding 
SNPs in high linkage disequilibrium (r2>0.80) using the “indep” command in PLINK. 
Selection was done separately for the two separate genotyping chips for DAT1/SLC6A3, 
DRD4, DRD5, 5-HTT/SLC6A4, HTR1B and SNAP25. 
Statistical analysis
ICA
The mixing matrix was used to investigate differences between participants with ADHD 
and participants without ADHD. A two-sample t-test was used on every column of the 
mixing matrix to test whether components differed significantly between our two groups. 
To correct for the number of t-tests performed, a threshold was used of p=0.05/the num-
ber of components. To validate the component that differed between participants with 
ADHD and controls, 10,000 permutations on group designations were performed and 
results were compared to the observed result. The empirical p-value was conducted by 
calculating the number of times our permuted result was more extreme than our observed 
result and dividing this by the number of permutations. 
Gene-wide Analysis
Genetic association analyses to the component that showed to be different for partici-
pants with ADHD were performed in PLINK. Statistical analysis was performed using 
the “linear” command in PLINK. To decrease heterogeneity effects, we used a gene-wide 
analysis method (Bralten et al., 2011; Hoh et al., 2001). The analysis consisted of a SNP-by-SNP 
linear regression and the estimation of the effect of the complete gene. Multiple testing 
correction was performed by running 10,000 max permutation tests using the “mperm” 
command and obtaining an empirical p value for each SNP. The association statistics of 
the observed and permuted data were saved using the “mperm-save-all” command and 
then added to create a ∑statistic per run for all SNPs at the same time (10,001 in total, one 
for the observed data and 10,000 for the permuted data). The empirical p value was then 
estimated by the number of times the observed ∑statistic was smaller than the permuted 
∑statistic divided by the total number of permutations (10,000). Results were considered 
significant at a p value 0.05/6 (as six genes were tested).
Visualization
The source matrix was used for visualization purposes of our component of interest. A 3D 
image with z-values of the source matrix was made and thresholded at |Z|>3 and superim-
posed on a template brain using orthoview. The coordinates of our component of interest 
were transformed to the coordinates of the standard space of Talairach and Tournoux 
[1988] and entered into the Talairach Deamon (Lancaster et al., 2000) and  summarized using 
the “write Talairach Table” option of the FIT toolbox (http://mialab.mrn.org/software/
fit/index.html). 
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Results
Subjects
Descriptive information of the studied sample can be found in Table 1. The analyses 
included 263 participants with ADHD (including 51 sibling pairs) and 276 participants 
without ADHD (including 51 siblings pairs) of which both imaging and genetic data was 
available.
 
Table 1  Participant characteristics 
ADHD Non ADHD
N individuals 263 276
Mean age (years; SD) 17.2 (3.0) 17.6 (3.5)
Age range (years) 9-24 8-26
Mean ADHD symptoms (SD) (range 0-18) 13 (3.0) 1 (2.2)
Mean IQ (SD) 95.8 (17.8) 104.4 (16.1)
% male subjects 76 42
Chip distribution (chip1/chip2) 142/121 0/276
% on medication 87 0
Scan-site (site 1/site 2) 137/125 152/125
Note  SD: standard deviation
ICA
Twenty-three components were estimated based on the component estimation step and 
used as a starting point for the SBM analysis. When we analyzed the mixing matrix with 
a two-sample t-test comparing participants with ADHD to participants without ADHD, one 
component, number 22, showed a significant difference (t(537)=3.00, p=0.001395, Cohen’s 
d: 0.26) that survived our multiple comparison correction. The difference showed lower 
values for the component loadings for participants with ADHD compared to participants 
without ADHD (Table 2 and Figure 1). Component 22 is comprised of positive z-values in 
large areas in the occipital lobes, areas in the temporal lobe, pre- and post-central gyrus, 
frontal areas, and cingulated cortex, and smaller areas with negative z-values in frontal 
areas and the precuneus (see Figure 2). The Talairaich coordinates corresponding to the 
brain areas exceeding |z|>3 can be found in Table 3. Permutations (10,000) of ADHD 
grouping labels showed that this component was reliable (empirical p=0.0029). 
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Figure 1  Component loadings of component 22 by diagnose
Table 2  Mean differences
Diagnose Mean N Std. Deviation
non ADHD 0.000162 277 0.001295
ADHD -0.000171 262 0.001275
Note  Mean values for component 22 by diagnose
 
Figure 2  Spatial map (|Z|>3) of component 22 which significantly differentiated participants with ADHD from 
participants without ADHD
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Table 3  Talairach regions of component 22 (|Z|>3)
Area’s with negative z-values  Brodmann Area L/R volume (cm3) random effects: Max Value (x, y, z)
Sub-Gyral 6, 8, 20, 37, 40 9.5/7.0 18.6 (-33, -43, 38)/27.6 (34, -40, 38)
Superior Frontal Gyrus 6, 8, 10, 11 5.9/4.3 12.1 (-22, 14, 45)/9.5 (15, 17, 53)
Inferior Parietal Lobule 2, 7, 39, 40 5.8/6.6 21.7 (-36, -40, 38)/23.8 (39, -40, 39)
Middle Frontal Gyrus 6, 8, 9, 10 5.1/5.9 10.7 (-22, 21, 40)/14.6 (37, 18, 39)
Middle Temporal Gyrus 21, 22, 39 4.6/1.8 12.9 (-40, -60, 29)/8.2 (50, -51, 5)
Declive * 3.3/4.1 11.7 (-18, -88, -18)/15.5 (15, -88, -18)
Precuneus 7, 19, 31, 39 2.4/3.8 11.5 (-39, -65, 36)/8.8 (19, -60, 47)
Areas with positive z-values  Brodmann Area L/R volume (cm3) random effects: Max Value (x, y, z)
Cuneus 7, 17, 18, 19, 23, 30 18.9/18.6 49.5 (-6, -77, 11)/45.3 (13, -68, 12)
Middle Occipital Gyrus 18, 19, 37 14.7/14.4 31.0 (-28, -92, 0)/37.7 (37, -78, 9)
Precuneus 7, 19, 23, 31 14.2/11.6 36.5 (-13, -66, 28)/35.7 (3, -73, 24)
Lingual Gyrus 17, 18, 19 13.2/13.2 39.7 (-3, -89, -8)/45.7 (3, -88, -8)
Sub-Gyral 6, 10, 37, 40 11.5/16.0 31.3 (-16, -66, 25)/41.7 (39, -75, 12)
Middle Temporal Gyrus 19, 20, 21, 22, 37, 38, 39 9.2/13.2 23.1 (-43, -72, 16)/35.9 (42, -72, 12)
Culmen * 9.2/10.6 20.2 (-10, -54, 1)/13.6 (9, -47, 2)
Precentral Gyrus 4, 6, 9 7.6/1.7 7.2 (-55, 1, 29)/8.4 (36, 8, 37)
Middle Frontal Gyrus 6, 8, 9, 10, 11, 46, 47 7.1/5.3 12.3 (-34, 14, 44)/15.0 (28, 48, 6)
Inferior Parietal Lobule 40 6.9/2.9 11.3 (-31, -37, 53)/8.9 (31, -41, 55)
Inferior Frontal Gyrus 9, 10, 11, 44, 45, 46, 47 6.3/6.1 9.0 (-13, 18, -20)/8.6 (40, 44, 1)
Cingulate Gyrus 24, 31, 32 5.1/3.6 11.5 (-4, -58, 26)/21.1 (16, -54, 28)
Posterior Cingulate 23, 29, 30, 31 5.0/5.8 40.8 (-21, -61, 9)/50.3 (16, -65, 12)
Postcentral Gyrus 1, 2, 3, 5, 7, 40, 43 4.5/4.2 10.6 (-31, -34, 50)/12.2 (31, -32, 50)
Medial Frontal Gyrus 6, 8, 9, 10, 11, 25, 32 4.4/6.1 11.4 (-12, 15, -17)/11.6 (13, 15, -17)
Inferior Occipital Gyrus 17, 18, 19 4.2/4.5 29.9 (-33, -90, -1)/37.0 (21, -91, -7)
Superior Temporal Gyrus 13, 22, 38, 39, 41, 42 3.8/9.3 7.6 (-50, -31, 13)/10.2 (61, -36, 17)
Inferior Temporal Gyrus 19, 20, 21, 37 3.5/4.5 21.3 (-40, -71, 0)/22.1 (43, -70, 2)
Fusiform Gyrus 18, 19, 20, 37 3.2/4.7 22.1 (-18, -91, -11)/16.3 (46, -73, -11)
Note  Voxels above the threshold were converted from MNI to Talairach coordinates and entered into a database to 
provide anatomic and functional labels for the left (L) and right (R) hemispheres. Both negative (top) and positive 
(bottom) z-values. The volume in each area is provided in cubic centimeters (cm3), areas >0.33 cm3 are reported. 
Within each area, the maximum z value and its coordinate are provided.
Gene-wide analysis
Gene-wide associations of component 22 to six candidate genes for ADHD revealed 
non-significant associations for all six genes (Table 4). Single SNP associations were 
also non-significant after multiple comparison correction (data not shown). 
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Table 4  P-values of gene-wide association analyses with component 22
Gene CytoSNP Chip (n=397) Number of variants Perlegen Chip  (n=142) Number of variants
DAT1 0.2030 112 0.6495 140
DRD4 0.9122 85 0.0428 74
DRD5 0.3020 28 0.7311 33
5-HTT 0.9544 49 0.6971 43
HTR1B 0.7489 95 0.4667 118
SNAP25 0.6415 77 0.3076 99
Note  No gene-wide association reached our multiple comparison corrected threshold for significance 
(p<0.0083).
Discussion
Using a multivariate approach to detect patterns of structural brain data, we identified a 
component which was significantly different between participants with ADHD and par-
ticipants without ADHD. This component comprised smaller volumes in participants with 
ADHD in large areas of occipital lobe, areas in the temporal lobe, pre- and post-central 
gyrus, frontal areas and the cingulate, and small areas with larger volume in patients in 
frontal areas and the precuneus. The component was not associated with any of the selec-
ted ADHD-candidate genes DAT1/SLC6A3, DRD4, DRD5, 5-HTT/SLC6A4, HTR1B, or SNAP25. 
Investigation of the brain regions included in the component that was different in ADHD 
showed the findings for some of the areas with smaller volume in ADHD to be in line with 
previous studies. Smaller brain volume in frontal areas has been linked to ADHD before 
with univariate analyses, as have findings of smaller grey matter volume in precentral 
gyrus and cingulate (Bralten et al., 2014; Frodl and Skokauskas, 2012). The findings in occipital 
areas did not pop up in univariate analyses of this sample using the imaging data com-
paring participants with ADHD to controls (Bralten et al., 2014), and was also not reported 
in meta-analyses of structural brain data in ADHD (Frodl and Skokauskas, 2012; Nakao et al., 
2011). A VBM study of adult ADHD did report structural differences in visual areas of the 
brain based on univariate analysis methods (Ahrendts et al., 2011). 
Applying machine learning approaches to imaging data in ADHD, which are also based 
on multivariate analysis, previously lead to the identification of the occipital lobe as 
having a high predictive value in ADHD classification (Peng et al., 2013). This speaks to 
the added value of performing a multivariate approach taking into account the relation 
between brain areas. Visual areas of the brain have also been implicated in ADHD in 
analyses of resting state fMRI data (Castellanos and Proal, 2012; Wang et al., 2013), and discon-
nection of frontal cortex and occipital cortex has been reported in EEG studies in children 
with ADHD (Mazaheri et al., 2010). The occipital lobe is involved in visual perception and 
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hypothe sized to play a main role in attention (Fox et al., 2006), which could explain the 
link to ADHD. Another potential overlap of our findings with those of previous studies is 
that grey matter volume in the cuneus, which was also part of our component and has a 
 basic role in visual processing, has been suggested to be associated with better inhibitory 
control in bipolar depression patients (Haldane et al., 2008). Deficits in inhibitory control 
are also often reported in ADHD (Alderson et al., 2007; Crosbie et al., 2008). 
The SBM approach conducted in the current research can be considered as the multivari-
ate version of the commonly used VBM approach to structural brain data. SBM has the 
advantage that it incorporates the additional information about the grouping of regions 
and is therefore able to identify naturally grouped regions. This contrasts with the VBM 
approach which does not recognize the relationship between voxels (for a more compre-
hensive comparison of SBM to VBM see (Xu et al., 2009)). In light of the assumption that we 
find underlying, potentially biologically relevant sources with this approach, we could 
speculate that the correlation of brain areas in the reported component might indicate 
these areas to be involved in similar processes and/or be controlled by a similar set of 
etiologic factors.
We investigated the relationship between the differential brain component and candidate 
genes for ADHD to gain more insight in the mechanism of these risk genes (Bigos and Wein-
berger, 2010; Durston, 2010; Meyer-Lindenberg and Weinberger, 2006). However, we were unable to 
find an association between the brain component and the genes for ADHD selected based 
on a candidate gene meta-analysis. This negative result might be explained by several 
factors: 1) These genes have no direct effect on brain volume variation and other genetic 
variants are involved, or 2) our sample size, although substantial for neuroimaging studies 
in ADHD research, is too small for imaging genetics studies, given the likely very small 
effect sizes of genes involved in multifactorial disorders. 
Our findings should be viewed in light of some strengths and limitations of the study. 
The multivariate approach used had the advantage to identify potential structural brain 
networks that can be relevant for ADHD. Limitations faced in our study, as well as multiple 
other ADHD studies, are the potential confounding effects of medication use (Schweren 
et al., 2013) (almost the complete ADHD sample used medication) and the presence of 
several comorbidities that are often found with ADHD (Biederman and Faraone, 2005; Gillberg 
et al., 2004; Lycett et al., 2014; Rappley, 2005; Reinhardt and Reinhardt, 2013). Limitations in the 
genetic part of our approach can be found in the candidate gene approach we used, as 
other genes might be involved, which we did not test. Another limitation is the need to 
investigate both genotyping platforms used in the NeuroIMAGE sample separately, as 
this reduced our power. Additionally, our sample size was limited for imaging genetics 
purposes. Finally, the approach used is data-driven, and the patterns identified are based 
on the correlation between volumes, which is a statistical measure. Although we assume 
this correlation to be potentially biological in its nature, we should keep in mind that the 
analytical approach does not test for that.
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To conclude, the current study benefitted from a multivariate approach to find a pattern 
of grey matter volume in occipital, frontal, temporal, pre- and post-central and cingu-
late areas of the brain that was significantly different between participants with ADHD 
compared to participants without ADHD. The structural pattern was not associated to 
six promising candidate genes for ADHD. Our results are in line with previous univariate 
approaches used in ADHD research, but extends them by finding additional brain areas 
that are different in ADHD.
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Supplementary materials chapter 7
Methods S1
To determine ADHD diagnoses, a combination of Conners’ ADHD questionnaires and a 
semi-structured diagnostic interview was used1,2,3,4. Each participant was assessed with a 
parent-rated questionnaire (Conners’ Parent Rating Scales – Revised: Long version [CPRS-
R:L])1 and either a teacher-rating (Conners’ Teacher Rating Scales – Revised: Long version 
[CTRS-R:L]2 applied for children <18 years) or a self report (Conners’ Adult ADHD Rating 
Scales–Self-Report: Long version [CAARS-S:L]3 applied for children ≥18 years). Partici-
pants were administered the Dutch translation of the Schedule for Affective Disorders 
and Schizophrenia for School-Age Children – Present and Lifetime Version4 (K-SADS-PL) 
containing developmentally appropriate questions to assess each of the 18 ADHD symp-
toms, compatible with the DSM-IV-TR5. Parents, reporting on their children, as well as 
children themselves, if ≥12 years old, were interviewed separately. Final scores on each 
item of the K-SADS were determined by weighing all available information. Initially, all 
participants were administered the K-SADS ADHD screening interview. Participants with 
elevated scores on any of the screen items were administered the full ADHD supplement. 
For participants using medication, ratings were gathered of participants’ functioning off 
medication. Using a diagnostic algorithm, a combined symptom count was calculated by 
adding symptom counts on the K-SADS and CTRS-R:L (for participants <18) or CAARS-S:L 
(for participants≥ 18), both providing operational definitions of each of the 18 behavioural 
symptoms defined by the DSM-IV. Symptoms of the CTRS-R:L or CAARS-S:L were only 
added to the combined symptom count if at least 2 symptoms were reported, in order to 
avoid the Conners’ score to put too much weight on the diagnosis. 
From the Conners ADHD questionnaires the following scales were used: DSM Inattentive 
behaviour (scale L of the CTRS-R:L/CPRS-R:L; scale E of the CAARS-S:L), DSM Hyper-
active/Impulsive behaviour (scale M of the CTRS-R:L/CPRS-R:L; scale F of the CAARS-S:L), 
and DSM Total (scale N of the CTRS-R:L/CPRS-R:L; scale G of the CAARS-S:L). Participants 
with a combined symptom count of ≥6 symptoms of hyperactive/impulsive behaviour and/
or inattentive behaviour were diagnosed with ADHD, provided they: a) met the DSM-IV 
criteria for pervasiveness and impact of the disorder (measures derived from the K-SADS), 
b) showed an age of onset before 12, c) received a T ≥63 on at least one of three scales 
on at least one of the Conners ADHD questionnaires (i.e. CPRS-R:L and/or CTRS-R:L for 
children <18 years and CPRS-R:L and/or CAARS-S:L for children ≥18 years), pertaining to 
a period without medication.
Participants with a combined symptom count of ≥ 6 symptoms who did not meet one or 
more of these criteria were evaluated by a team of trained experts, in order to derive a 
consensus decision on their diagnosis. Unaffected participants were required to receive 
a T<63 on each of the above-mentioned scales of each of Conners’ ADHD questionnaires, 
and have a combined symptom count ≤3 symptoms. For young adults (≥ 18 years), criteria 
were slightly adapted, such that a combined symptom count of 5 instead of 6 symptoms 
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was sufficient for a diagnosis6,7 and with ≤2 symptoms on the combined symptom count 
they were labelled ‘unaffected’. Diagnostic procedure for parents were similar to those 
applied for children ≥18 years. The ADHD questionnaire was completed by their partner 
(Conners’ Adult ADHD Questionnaire-Observer: Short version [CAARS-O:SV]). A retrospec-
tive childhood diagnosis was established in addition to a current diagnosis, using the 
same diagnostic algorithm used for young adults. Parents with a current and/or childhood 
diagnosis were labelled as affected.
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CHAPTER 8
General discussion
The work presented in this thesis focused on identifying brain correlates of the highly 
heritable disorder ADHD and gaining insight into its genetic underpinnings by using alter-
native complex and multivariate approaches based on phenotypic or genetic data. In this 
final chapter I discuss, how results from this thesis have improved our understanding of 
the biological underpinnings of ADHD, the challenges faced in imaging genetics of ADHD, 
and how the results will influence future research. I do so in line with the subdivision of my 
thesis into the three parts: the ADHD brain, ADHD genetics, and imaging genetics in ADHD. 
Summary of our approach and results 
The ADHD brain 
The first part of this thesis (chapters 2 and 3) describes volumetric brain differences 
between participants with ADHD and controls, and the familial underpinnings of these 
differences. Smaller brain volumes in ADHD were observed in total brain volume, caudate, 
and putamen volumes. The caudate and putamen volume reductions were found to be de-
velopmentally sensitive, and observed when using a segmentation approach, FSL-FIRST, 
that segmented the whole volume of these regions (chapter 2). Smaller brain volumes in 
ADHD were also found using a voxel-by-voxel approach in the precentral gyrus, medial 
and orbital frontal cortex, and (para)cingulate cortices (chapter 3). Differences between 
the studies described in chapter 2 and chapter 3 of this thesis, performed on the same 
sample, are the findings for caudate and putamen. In chapter 2 a significant interaction 
of caudate and putamen volume with age reveals an association of these volumes with 
ADHD that is predominantly seen in younger participants. In chapter 3 no associations 
of structural brain measures are found in striatal areas. This suggests that the volumet-
ric differences in ADHD in caudate and putamen are potentially dispersed rather than 
localized to specific parts of the volume. 
Importantly, our studies showed that the differences in brain volumes between par-
ticipants with ADHD and controls could also be observed in unaffected siblings. This, 
together with existing literature showing familial components of ADHD to be largely 
genetic (Faraone et al., 2005; Greven et al., 2011; Sprich et al., 2000), indicates that these brain 
areas contribute to the biological risk for ADHD. To be able to investigate this, MRI data 
of ADHD and control families were used. Because siblings share on average 50% of their 
DNA as well as 100% of their family environments, sibling data cannot be considered in-
dependent of each other. Using family data in this way (with siblings being present in the 
same contrast group) is still rather uncommon in neuroimaging research. Subsequently, 
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the available neuroimaging software was unable to deal with this type of data, and I de-
veloped a customized script that extracted the data from the imaging software and dealt 
with the dependence of the data by clustering based on family identifier. 
ADHD genetics 
Part two of my thesis focused on the genetics of ADHD. As single variant association ana-
lyses to ADHD diagnostic status have shown considerable pitfalls (Neale et al., 2010a; Thapar 
et al., 2013), this thesis describes more complex analysis methods to investigate genetic 
associations in ADHD. In chapter 4, the associations of three functional genetic variants 
from the ADHD risk genes DAT1, DRD4, and 5-HTT with ADHD symptoms and six neuro-
cognitive measures were investigated. Neuropsychological data of adolescent and adult 
samples with a broad age-range (8-25 and 35-61 respectively) were used. Since previous 
ADHD genetic research mainly focused on children and young adults, the inclusion of 
adolescents and middle-aged adults fills a gap in the literature. Although effect sizes of 
the reported associations were modest, and results need to be replicated, age might be 
an important factor in genetic association analyses in ADHD. 
In chapter 5 and chapter 6 I used methods that did benefit from the aggregating effects 
of either multiple phenotypes (chapter 5) or multiple genetic variants (chapter 6). These 
chapters showed that using aggregated measures can provide additional power to de-
tect association. Additional power comes from the combination of multiple sources of 
information collected for the same individual (either multiple phenotypic measures, e.g. 
intra-individual neuropsychological variables (chapter 5), or multiple genetic variants, 
e.g. genetic variants from the pathways of the dopamine/noradrenaline, serotonin neuro-
transmitter systems and genes from the neurite outgrowth network (chapter 6)). Given the 
complex heterogeneous phenotype of ADHD, part two of this thesis shows that breaking 
ADHD up in parts, e.g. in terms of specific neuropsychological deficits or clinical dimen-
sions of behavior, can facilitate studies to identify genes involved in ADHD. An example 
is the finding that the intra-individual variability (IIV) construct found to share familial 
influences with ADHD was (largely) independent of other cognitive functions impaired in 
ADHD such as IQ, working memory, and inhibition (chapter 5). Another example from the 
‘ADHD genetics’ part of this thesis is that the association of candidate genetic pathways 
for ADHD was only significant for hyperactivity/impulsivity symptoms and entirely absent 
for inattention symptoms (chapter 6). 
Imaging genetics
In part three of this thesis I present an imaging genetic study, i.e. a study describing the 
combination of genetics and brain imaging. Based on the assumption that the obser-
vations in structural imaging data are an independent and a linear mix of underlying 
sources, a multivariate brain imaging approach was used in order to identify these inde-
pendent sources. The independent sources were decomposed as components. This work 
identified a component that differed between individuals with and without ADHD, for 
which potential association to candidate genes for ADHD was investigated (chapter 7). 
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The multivariate method used to find this component focussed on independent grey 
matter concentration patterns in the large amount of data derived from VBM analyses 
(in our case more than 230,000 data points) (Hyvarinen and Oja, 2000; Turner et al., 2012). 
The extracted component included brain regions previously linked to ADHD (i.e. frontal 
areas) (Frodl and Skokauskas, 2012; Nakao et al., 2011; Shaw et al., 2006) as well as areas that fell 
into the same pattern, but might be more unexpected for ADHD (like the occipital lobes).
Investigating the relationship between brain components and candidate genes for ADHD 
has been suggested to be helpful in the quest for genetic component(s) associated to the 
risk of psychiatric illness and/or to unravel the mechanisms of risk (Bigos and Weinber-
ger, 2010; Durston, 2010; Meyer-Lindenberg and Weinberger, 2006). In chapter 7, the association 
between the DAT1, DRD4, DRD5, 5-HTT, HTR1B, and SNAP25 genes, selected based on 
meta-analytic evidence of association with ADHD status from a large meta-analysis of 
candidate gene studies (Gizer et al., 2009), and the ADHD component was tested. However, 
no significant associations were found.
 Interpretation in the context of existing literature 
 The ADHD brain
Our results on volumetric differences in the ADHD brain (chapter 2 and chapter 3) fit with 
the literature supporting structural and functional differences in fronto-striatal brain 
 areas in ADHD (Castellanos, 1997; Cortese et al., 2012; Durston et al., 2011). The robust findings 
in frontal areas of the brain (chapter 3) are in line with the important role of the prefron-
tal cortex in the pathophysiology of ADHD proposed by others (Cubillo et al., 2012; Halperin 
and Schulz, 2006), together with theories of dorso-frontal-striatal, orbitofrontal-striatal, 
and fronto-cerebellar circuits being main players in ADHD (Durston et al., 2011). Although 
previous meta-analyses of VBM studies report local volume differences in striatal areas 
(Ellison-Wright et al., 2008; Frodl and Skokauskas, 2012; Nakao et al., 2011), our VBM analysis did 
not support these differences (chapter 3). Caudate and putamen, however, were found to 
be smaller in the younger participants with ADHD compared to controls when a different 
segmentation method was used investigating total volumes of these structures (chapter 
2). A study investigating structural variation in the caudate in ADHD reported smaller 
volumes as well as different shapes in participants with ADHD (Qiu et al., 2009). This finding 
gives rise to the possibility that shape and volume differences are not localized in the 
same voxels in different individuals (large heterogeneity between individuals). This may 
explain why these differences are not found with a voxel-by-voxel comparison approach, 
but are found when investigating average caudate and putamen volume.
Our cross-sectional brain analyses showed both developmentally stable as well as devel-
opmentally sensitive brain volumetric alterations in ADHD (chapter 2). Different measures 
and study-designs (cross-sectional versus longitudinal) have been used to investigate the 
impact of age on volumetric changes in ADHD (Almeida Montes et al., 2013; Nakao et al., 2011). 
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Based on especially the longitudinal work, a developmental delay in brain maturation 
was hypothesized in ADHD (a delay of approximately 3 years is suggested throughout 
most of the cerebrum and most prominent in prefrontal regions) (Castellanos et al., 2002; 
Shaw et al., 2007). However, the findings from this thesis on age-independent smaller total 
brain volume and frontal brain areas rather suggest a deviant development of these brain 
areas in participants with ADHD. Brain imaging studies on adult ADHD are still limited 
by small sample sizes. Results so far have been inconsistent with some adult studies 
reporting volume reductions in frontal areas of the brain in ADHD compared to controls 
(Biederman et al., 2008; Hesslinger et al., 2002; Pironti et al., 2013; Seidman et al., 2011; Seidman et al., 
2006), whereas others did not find this (Amico et al., 2011; Onnink et al., 2014). Findings from 
our analyses in a rather large sample, aged between 8-30 years, indicate that cases with 
ADHD do not “catch-up” their delay in brain volume differences in total brain volume or 
prefrontal cortex, but rather remain different from healthy controls. 
The striatum findings, which were indeed developmentally sensitive in our data, could 
suggest that individuals with ADHD do experience a developmental delay. Differences 
between cases with ADHD and controls in striatal brain volume were present in younger 
individuals, but this difference disappeared around mid-to-late adolescence. However, in 
the older participants brain volumes became smaller with increasing age only in controls 
(in line with reports of normal development of these brain areas (Brain Development Coopera-
tive, 2012; Goddings et al., 2014)), whereas this was not observed in participants with ADHD. 
The findings that, by early adulthood, caudate and putamen volumes were larger in par-
ticipants with ADHD than controls add to the current literature on adult ADHD. Previous 
work described samples with smaller volumes (Almeida Montes et al., 2010; Seidman et al., 
2011) or no differences at all between participants with ADHD and controls (Ahrendts et al., 
2011; Depue et al., 2010; Onnink et al., 2014; Seidman et al., 2006). However in all cases the adult 
samples in literature are older than the sample used in this thesis, potentially contributing 
to these apparent inconsistencies. A possible model that could fit these observations is 
animated in Figure 1. In this model both controls and participants with ADHD show a par-
allel increase in caudate and putamen volume throughout childhood to mid-adolescence, 
with the control group starting from a larger volume than the ADHD group, consistent 
with the findings of smaller volume for participants with ADHD in childhood (Castellanos et 
al., 2002; Frodl and Skokauskas, 2012; Nakao et al., 2011; chapter 2). Subsequently, after reaching 
the peak volume, both controls and individuals with ADHD show a decrease in volume 
with age. As the peak volume in those with ADHD is reached later than in controls, in 
young adulthood we are able to observe a larger caudate and putamen volume in this 
group. Potentially, the subsequent decrease in volume is more steep in participants with 
ADHD compared to controls, explaining reports of smaller striatal volumes in participants 
with ADHD in adulthood (Onnink et al., 2014).
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Figure 1  Hypothesized model for the striatal volumes where children with ADHD start from a smaller volume 
and reach their peak volume at a later age than healthy controls, potentially explaining the larger volumes 
 observed in our young adult group
ADHD genetics
The findings reported in this thesis contribute to our understanding of the genetics of 
ADHD in several ways. While there is still a quest for increasing sample sizes for GWAS 
in ADHD to generate genome-wide significant findings similar to the recent study by the 
PGC schizophrenia working group (Schizophrenia Working Group of the Psychiatric Genomics, 
2014), the research field can also benefit from methods to maximize the information to be 
gathered from data that is already available. This can e.g. be achieved by using pheno-
types that theoretically represent more homogeneous subgroups for the complex ADHD 
phenotype. In this thesis I contributed to these attempts and showed that investigating 
an underrepresented age group in ADHD research (chapter 4), aggregation of phenotypic 
data (chapter 5), or aggregation of genetic effects (chapter 6) can be fruitful in investiga-
tions of the genetic underpinnings of ADHD. 
Aggregation of phenotypic and/or genetic effects has been performed in ADHD research 
before. On the phenotypic side (i.e. neuropsychological measures), data has been clus-
tered through factor analyses, attempting to find underlying latent variables (Kuntsi et al., 
2010; Rommelse et al., 2008b; Smith et al., 2013). On the genetic side, aggregation of genetic 
effects has been used in the form of polygenic scores (International Schizophrenia et al., 2009). 
Using a gene-set approach described in chapter 6, we aggregated genotype data across 
catecholaminergic pathways, and could finally prove an association of the dopamine/
noradrenaline and serotonin pathways to ADHD symptoms. Although risk-conferring 
roles for dopamine/noradrenaline and serotonin neurotransmission genes had been sug-
gested in ADHD already many years ago (Biederman and Spencer, 1999; Staller and Faraone, 
2007), available GWAS of ADHD thus far could not show variants of these genes in the 
top findings (Neale et al., 2010b). 
One thing one has to keep in mind is that once we step away from a clinical diagnosis or 
the single-variant analyses, the results are becoming less specific. The catecholaminergic 
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processes studied in the current thesis have also been suggested to play a role in other 
psychiatric disorders (just a grasp of the overwhelming literature reporting on catechol-
aminergic processes and psychiatric disorders or traits: Cervenka et al., 2012; Fontenelle et 
al., 2011; Hamon and Blier, 2013; Licinio and Wong, 2004). The IIV construct investigated for 
ADHD has also been linked to other psychiatric disorders (Cole et al., 2011; Depp et al., 
2012; van Iterson and Kaufman, 2009). However, less specificity does not need to be a prob-
lem, as was shown in the cross-disorder analyses that reported four genomic regions to 
be genome-wide significant when multiple psychiatric genetic data sets were combined 
(Cross-Disorder Group of the Psychiatric Genomics et al., 2013b). Considering genetic overlap, and 
involvement of similar neurobiological processes, it can be intriguing to examine these 
type of pathways and phenotypes across diagnostic boundaries. Indeed, analyses on the 
genetics of ADHD have shifted from studying diagnostic status to studying quantitative 
traits (Asherson and Gurling, 2012; Kebir and Joober, 2011; Shaw et al., 2014; Wood and Neale, 2010), 
which can be extended over multiple diagnostic groups (will be more extensively dis-
cussed later in this chapter).
Imaging genetics
In part three of this thesis the imaging genetics approach we applied is described. To 
our knowledge the multivariate ICA method used on the brain side has not been used 
for structural MRI in ADHD research before. The approach has been successfully applied 
in other disorders, like schizophrenia (Xu et al., 2009) and Alzheimer’s disease (Meda et al., 
2012) however. It has been shown to provide advantages over univariate VBM analyses 
and to detect distinct brain source networks between groups (Xu et al., 2009). In this thesis, 
I did not only want to identify brain networks linked to ADHD, but also attempted to use 
these networks as endophenotypes. I aimed to find significant imaging genetic associ-
ations between candidate ADHD genes and the brain component found to differ between 
participants with ADHD and controls. Those could point to the underlying biological 
mechanisms of genetic risk factors for ADHD. It has been hypothesized that genetic effects 
of single genes on brain phenotypes might be larger than those of clinical phenotypes, 
or that these endophenotypes might be less genetically complex (Durston, 2010; Gottesman 
and Gould, 2003). A comparative study in schizophrenia research indeed reported that risk 
variants had larger effect sizes at the level of brain structure and brain function compared 
to effect sizes for behavioral traits (Rose and Donohoe, 2013). However, considering the incon-
sistent findings of reported studies and the still relatively small effect sizes in literature, 
imaging genetics in ADHD has not (yet?) lived up to its expectations. 
To circumvent the limitations of sample size, the ENIGMA consortium meta-analyzed a 
large sample (of 20,000-26,000 individuals) for associations between brain volume and 
genetic risk variants (Hibar et al., submitted; Stein et al., 2012). Their sample size made it pos-
sible to find genome-wide significant associations. However, the ENIGMA studies made 
it clear that effect sizes for association of genetic variants to brain volumetric data are 
similar to effect sizes reported for GWAS of complex behavioral traits (Stein et al., 2012). 
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Additionally, the assumption that the investigation of brain volumes could locate genetic 
variants associated with disease could not yet be confirmed. An example is the reported 
association of SNP rs7294919 with hippocampus volume; this SNP is not present in the 
top results of GWAS studies with diseases/disorders for which the hippocampus is a po-
tential endophenotype. As the sample sizes of GWAS in Alzheimer’s disease are large, and 
Alzheimer’s disease is linked to the neurodegeneration of the hippocampus, not finding 
the SNP in the top results (Lambert et al., 2013) indicates that the endophenotype approach 
might be less promising than initially expected. It is not clear, though, whether brain 
volumes form an ideal endophenotype; the situation might be different for other brain 
measures like functional MRI-based BOLD response or magnetic encephalogram-based 
brain oscillations. 
Strengths and limitations 
The ADHD brain
The analyses performed in part one of this thesis have the great strength that a large 
and well-phenotyped sample could be used to investigate structural brain differences in 
ADHD. Such brain differences in ADHD have also been the topic of previous meta-analyses 
(Castellanos et al., 2002; Frodl and Skokauskas, 2012; Nakao et al., 2011; Valera et al., 2007), however, 
all sample sizes of single studies in these meta-analyses were smaller than in the current 
study (single studies ranged from 17 to 291 participants with ADHD and controls; current 
study included 307 participants with ADHD and 196 controls). Meta-analyses are ham-
pered by the inherent design limitations of the single studies, and single studies in ADHD 
show considerable heterogeneity in their findings, like opposite findings. Therefore, the 
current investigation of volumetric differences within a single large sample adds value 
over existing meta-analyses. The family-based design of our study is another strength of 
this work. Inclusion of families made it possible to study familial underpinnings of the 
reported volumetric differences between participants with ADHD and controls. Further-
more, this thesis focused on an ADHD sample including adolescents and young adults, 
which is an underrepresented group in ADHD literature (most studies focus on child or 
adult samples). Thereby, the current thesis contributes to filling a gap in the neuro imaging 
literature in ADHD. Additionally, both segmented brain areas as well as voxel-based 
 measures could be investigated in the same sample. 
However, some difficulties were also experienced. As an increased sample size to inves-
tigate brain differences between patients with ADHD and controls was preferred, data 
collection was aimed at getting the biggest sample possible. To be able to do this, efforts 
were combined between researchers from Groningen, Amsterdam, and Nijmegen. MRI 
scans were performed in Amsterdam or Nijmegen. Although matching of the samples be-
tween the sites was tried as much as possible, our final data set did have some differences 
between scan sites. More participants with ADHD were scanned in Amsterdam, and more 
controls were scanned in Nijmegen. Next to the imbalance in ADHD-control distribution 
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between scan-sites, the ADHD cases and controls also differed on some additional vari-
ables. The first difference was that participants with ADHD showed a significantly lower 
IQ. IQ is generally about 10 points lower in those with ADHD than in normal controls 
(Frazier et al., 2004), therefore this was not unexpected. As IQ might share meaningful vari-
ance with ADHD (Rommelse et al., 2008a), it has been an active debate how to handle this 
difference in studies comparing participants with ADHD to controls (Dennis et al., 2009). 
In the current thesis findings have been reported with and without the inclusion of IQ 
as a covariate in the analyses. The second difference is the sex distribution. More male 
participants with ADHD than female participants with ADHD (68% males) were collected, 
while the control sample was more balanced in sex distribution (49% males). Having 
more male participants with ADHD was also not unexpected, as the sex distribution in 
childhood ADHD is skewed with boys outnumbering girls (Polanczyk et al., 2007). However, 
brain volume differences are present between males and females (Good et al., 2001; Rijpkema 
et al., 2012), and brain differences in ADHD between males and females have also been 
reported (Onnink et al., 2014). Sex was included as a covariate in our analyses to take this 
into account, and additional post-hoc analyses on diagnose x sex interactions as well as 
matched subsample analyses on sex indicated that the main results were not driven by 
differences in the distribution of men and women. 
There are some potential confounding factors in our sample that require further investi-
gation. The first is medication use in ADHD cases. A previously published meta-analysis 
showed that the brain volumetric differences reported between individuals with ADHD 
and controls were attenuated when a higher percentage of participants reported to have 
used medication (Nakao et al., 2011). Normalization of brain structure and function of white 
matter, basal ganglia, anterior cingulated cortex, thalamus, and cerebellum with long-
term stimulant treatment have also been described (Schweren et al., 2013; Sobel et al., 2010). 
Most ADHD cases in our sample had used medication during extended periods of time, 
which limited our options to perform a powerful analysis between people having used 
medications and medication-naïve individuals. The second potential confounder is the 
almost inevitable presence of psychiatric comorbidities (Biederman and Faraone, 2005; Gillberg 
et al., 2004; Lycett et al., 2014; Rappley, 2005; Reinhardt and Reinhardt, 2013). Although studies have 
been conducted in samples with “pure” ADHD (meaning without any other psychiatric 
comorbidity), their sample sizes are considerably smaller (Makris et al., 2013), which is not 
unsurprising considering that ADHD with a comorbidity is the rule rather than the excep-
tion (Biederman and Faraone, 2005; Gillberg et al., 2004; Lycett et al., 2014; Rappley, 2005; Reinhardt 
and Reinhardt, 2013). However, this makes it difficult to decide, whether volumetric brain 
differences are specific to ADHD or not, as some studies have suggested structural brain 
differences between “pure” ADHD and ADHD+comorbidity (Onnink et al., 2014; Sasayama 
et al., 2010; Stevens and Haney-Caron, 2012). Nevertheless, we feel that using a naturalistic 
ADHD sample (in terms of IQ distribution, sex distribution and comorbidity), like the 
sample used in my thesis, is also a strength, as the findings are more likely to apply to 
the wider ADHD population. 
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ADHD genetics
The genetic analyses described in part two of this thesis took advantage of advanced 
methodological approaches to maximize the information to be gathered from existing 
data. The extensive neuropsychological battery as well as the large number of genetic 
variants measured in our sample made it possible to combine multiple sources of in-
formation for increased statistical power. Genetic analyses, for example, are faced with 
large multiple comparison problems (by the number of genotypes analyzed), so testing an 
aggregated measure (of these variants) reduces the number of tests considerably. Another 
strength of this approach is that the aggregation can occur between samples and data 
sets, highlighting its potential in collaborations involving studies with slightly different 
measures. However, there is also a downside to the use of an aggregated measure: results 
will be less specific and less straightforward to interpret. Our phenotypic IIV construct 
(chapter 5) was derived from the combination of seven different tasks, and, even though 
a common underlying construct was found, it is unclear which specific cognitive and 
neurobiological mechanisms were driving the observed effect (i.e. increased intra-indi-
vidual variability in ADHD).
In the aggregation of genetic effects through our pathway analyses (chapter 6), compared 
to single variant analyses, specificity regarding the direction and size of the genetic ef-
fect is missed, because the result is based on permutations (empirical p-value). Another 
limitation, that is still common in genetic research in complex psychiatric diseases such 
as ADHD, is the selection of candidate genes and candidate pathways, which requires 
prior hypotheses. On the one hand, depending on prior hypotheses limits the number of 
tests performed (an advantage), but on the other hand it comes with the disadvantage 
of the need to define a clear hypothesis for a complex disorder like ADHD, for which the 
underlying processes are still largely unknown. Additionally, relying on prior hypotheses 
eliminates the possibility to find new, unexpected mechanisms.
One of the practical challenges we had to face in our sample was that genotyping was 
performed on two different genotyping platforms due to different time points of sample 
collection. Genome-wide genotyping of data from trios (probands and parents) collected 
in IMAGE was performed on the Perlegen platform that genotyped more than 600,000 
SNPs, designed to cover the genome, funded by the Genetic Association Information Net-
work (GAIN) (Brookes et al., 2006; Manolio et al., 2007). Additional genome-wide genotyping 
of the samples collected in NeuroIMAGE (control families and additional ADHD families) 
and samples not yet genotyped in IMAGE (siblings) was performed with the CytoSNP12 
array that contained around 300,000 SNPs, and was not designed for genome-wide SNP 
coverage (but to cover structural variations across the genome) (von Rhein et al., 2014). 
Although imputation of genetic data makes it possible to compare genotyping data from 
different platforms, the genetic coverage and local imputation quality of the CytoSNP 
array was lower compared to the Perlegen platform. Therefore, the conclusion was drawn 
that the data of these two genotyping arrays should not be directly combined, but rather 
used in meta-analytic approaches. 
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Imaging genetics
In part three of this thesis a multivariate imaging approach called Independent Com-
ponent Analysis (ICA) was used. This method makes it possible to investigate potential 
structural brain networks that can be relevant for ADHD. The main advantages of the 
ICA approach are the ability to find patterns of volume difference that cannot be detected 
by VBM analyses (Kasparek et al., 2010; Xu et al., 2009), and a reduction of the number of 
multiple comparisons compared to univariate analyses of voxel-by-voxel data. Another 
advantage was that our sample was considerably large for having both imaging data as 
well as genetics data available for the same individuals making it possible to study genetic 
associations to our imaging results.
A limitation of the ICA approach used is that it is data-driven, and the extracted patterns 
are based on the correlation between volumes, which is a statistical measure. Although 
the assumption is that this correlation is potentially biological in its nature, one should 
keep in mind that correlation does not test for that. Other limitations of our approach can 
be found in the candidate gene approach used, the need to investigate both genotyping 
platforms separately (discussed previously), and the sample size which was still rather 
limited for imaging genetics purposes. 
Implications 
The ADHD brain
Results in this thesis on the familial brain differences between participants with ADHD 
and controls can be a starting point for additional research. By showing the familiality 
of these differences our results pave the way for molecular genetics analyses to better 
understand the mechanisms leading to ADHD. Next to that, the intermediate pattern of 
unaffected siblings, who are genetically more similar to their siblings with ADHD than to 
the control group, but do not have the ADHD diagnosis, indicates the dimensionality of 
ADHD traits once more. The developmentally specific findings for caudate and putamen 
volume (chapter 2) will shape future volumetric studies in ADHD by highlighting the 
need to take developmental stages into account when studying ADHD. Considering that 
changes in ADHD symptoms also occur with increasing age (Biederman et al., 2000; Spencer 
et al., 2007), our data points to ADHD as a neurodevelopmental disorder, that has a dis-
tinct (neuro)biological profile at different stages throughout life. Longitudinal studies are 
needed to elaborate on our findings.
ADHD genetics
The aggregation approaches used in this thesis are examples on how to maximize the 
information that can be extracted from data points that are collected within the same 
study. The phenotypic measure used for aggregation was comprised of different neuropsy-
chological measures, but showed common variance. This notion of common variance of 
different measures from the same study can be taken a step further, which is to aggregate 
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measures taken from different studies. Given that sharing of data across sites boosts the 
power for genetic analyses, our findings are promising in showing that IIV measures are 
viable candidates for across-site analyses. 
The same principle can be discussed for the aggregated genetics measure used. Specifi-
cally, because the candidate pathways chosen in the current analyses have been hypothe-
sized to play a role in other psychiatric disorders as well, and large consortia are at the 
forefront of psychiatric genetics research, a potential use of the current approach can 
be a mega-pathway-based analyses across different psychiatric disorders (Cross-Disorder 
Group of the Psychiatric Genomics et al., 2013a). However, even despite the existence of large 
consortia, the field of multifactorial (psychiatric) disorders is going to suffer from power 
restrictions for a long time; for example, the recently published GWAS meta-analysis of 
36,989 cases with schizophrenia and 113,075 controls was only able to explain 7% of the 
genetic liability to schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
Given the increased power and potential to take allelic heterogeneity into account, the 
pathway approach conducted can therefore also be extended to other candidate pathways 
for ADHD (or other psychiatric disorders) in future studies, as more promising candidate 
pathways exist, like for example the glutamatergic pathway (Elia et al., 2012). In this thesis 
we restricted analyses to the most established candidate pathways for ADHD. 
Imaging genetics
The imaging genetics analysis that was conducted in the current thesis has several impli-
cations. The first is that the multivariate approach used revealed that next to the frontal 
and caudate areas, which were also found in the univariate analyses, other brain areas 
may also contribute to ADHD, as they were present in the same component. This indicates 
that the multivariate approach to imaging data extends the univariate approaches. In light 
of the null findings for the gene-wide analyses that were performed, this thesis implies 
that starting from candidate genes for imaging genetics purposes is still suboptimal. 
Add itionally, although our data set is one of the largest including both neuroimaging and 
genetic data in an ADHD sample, it still lacks the power to find significant gene-brain 
associations, and larger data sets are needed for this.
Clinical implications
The results of this thesis, together with findings from the ADHD literature, may also have 
clinical implications on the long term. But prior to that, it should be made clear that the 
extracted neuroimaging and genetic findings are not suitable to diagnose ADHD, due 
to the lack of sensitivity and specificity. Having said that, the results do provide useful 
information on the underlying biology/aetiology of ADHD. As the underlying mechanisms 
in ADHD are very complex and still poorly understood, by increasing our knowledge of 
ADHD, the present thesis contributes to the potential to use the underlying mechanisms 
for diagnostic, preventive, and treatment purposes in the future. 
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Currently, the DSM-5 (DSM-5, 2013), which is an update of the DSM-IV (DSM-IV, 1994), is the 
standard manual used as a guide for diagnostic purposes in ADHD. Although improve-
ments have been made in DSM-5, the original aim to include neurobiological measures 
for diagnostic purposes was not reached. Our results on neurobiological differences be-
tween participants with ADHD and controls are on a group level, and do contribute little 
to a diagnostic level for an individual patient. However, the indication that multivariate 
approaches (this thesis) can increase the statistical power to detect differences, can be 
interesting for upcoming machine learning algorithms. Machine learning algorithms use 
multivariate approaches on an individual level, for example to classify individuals ac-
cording to diagnostic status (Orru et al., 2012). For neuroimaging data this approach already 
showed its potential in a range of neurological and psychiatric disorders, with promising 
results (e.g. Kloppel et al., 2008). The use of multiple data sources can improve classification, 
for example, combining imaging data with genetic data might be more predictive than 
using either modality separately. An example is provided by the group of Yang and co-
workers, who showed that the integration of both imaging and genetic data in the same 
algorithm showed a slight improvement in diagnostic accuracy (87%) compared to using 
either genetic (74%) or imaging data (82%) alone (Yang et al., 2010). Clinical implications 
can also be found in the use of quantitative traits compared to binary diagnostic status. 
Dimensionality of ADHD traits has been described in this thesis as well as by others 
(Hoogman et al., 2012; Larsson et al., 2012; Levy et al., 1997; Shaw et al., 2011) and clarifying the 
genetic risk/ neurobiological underpinnings of ADHD traits will help to clarify underlying 
mechanisms in ADHD as well. 
Future research
Based on the findings described and discussed in this thesis, suggestions for future re-
search can be given. As both neuroimaging and genetic data from a broad age-range of in-
dividuals indicate the potential role of age, longitudinal studies are warranted to explore 
the effects of age in ADHD. The NeuroIMAGE data set already collected follow-up data 
on questionnaires and neuropsychological data that was also collected six years before 
as part of the IMAGE project. These follow-up data provided insight in the persistence of 
ADHD (van Lieshout et al., 2014) and the course of neuropsychological impairments (Thissen 
et al., 2014). An additional follow-up of the NeuroIMAGE sample is currently under way 
and will also provide follow-up data of neuroimaging measures, making it possible to 
investigate structural and functional brain abnormalities in a longitudinal design. 
Considering the imaging data on ADHD, the current thesis used the largest sample avail-
able to investigate structural brain alterations, but this came with some challenges (as 
discussed above). The alternative, working with a more matched sample, can result in 
small and atypical ADHD samples (Makris et al., 2013). However, future research might 
benefit from studies that go for an in-between approach: try to select large samples that 
are matched on a number of key-variables. Considering the notion that comorbidities 
General discussion  177
occur frequently with ADHD, it is not preferable to match a sample based on comorbidity, 
and future research can benefit from investigating (neurobiological and/or neuropsychi-
atric) overlap between disorders (Cross-Disorder Group of the Psychiatric Genomics et al., 2013a; 
van Hulzen et al., 2015). IIV and catecholaminergic genetic pathways are just examples of 
aggregated measures which can be useful in future studies across diagnostic categorical 
boundaries.
Both imaging and genetic studies in ADHD will benefit from increasing sample sizes, as 
small samples have reduced power to find a true effect (Button et al., 2013). Increasing 
sample sizes will confirm the reliability of neuroimaging findings in ADHD as well as 
provide genome-wide significant associations with common genetic variants. Collabor-
ations in genetic research in schizophrenia already demonstrated that increased sample 
sizes can help to discover genetic variants, and even report significant associations to 
prior hypothesized candidate genes (e.g. DRD2) (Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). 
Next to increased sample sizes, working out smart ways to maximize the information that 
can be extracted from already collected data will still be important. Two parallel research 
approaches are needed: (i) large consortia that localize the main differences between in-
dividuals with ADHD and controls, and (ii) deeply phenotyped data-collections at single 
sites (which should still need to be composed of a large sample size), that will be useful 
to work out the underlying mechanisms involved in different aspects of ADHD (i.e. quan-
titative behavior, brain, neuropsychology), as single site data will be more homogeneous 
than a combined set of data sets. 
Although hypothesis-driven approaches have some limitations, investigation of candidate 
genes and candidate brain areas will remain useful in future research by providing in-
sights into the underlying mechanisms in ADHD. Hypothesis-free approaches used in the 
current thesis can provide new leads to follow, like the linkage peak observed in chapter 
6 and the occipital lobe findings in chapter 7. Future research should investigate whether 
genome-wide whole-brain analyses in ADHD, being hypothesis-free on both genetic and 
neuroimaging data points, can provide new hypotheses. These approaches have already 
been used in other disorders, like schizophrenia (Liu et al., 2009) and Alzheimer’s disease 
(Hibar et al., 2011; Meda et al., 2012).
Investigating families, as was done in the current thesis, is one way to move forward in 
imaging genetics research of ADHD. The study of healthy relatives can help to distinguish 
between genetic association with clinical risk and genetic association with biological risk 
(Rasetti and Weinberger, 2011). Both the unaffected sibling group as well as the inclusion of 
multiple family members with ADHD add to the knowledge of underlying mechanisms 
important for ADHD. Additionally, families offer the opportunity to include environmental 
factors that are the same between probands and unaffected siblings.
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As ADHD is such a heterogeneous disorder, future research should consider ways to take 
that into account. The lack of specificity of findings with categorical diagnostic groups is 
also highlighted by the new strategic plans of the U.S. National Institute of Mental Health 
(NIMH). In these plans strong emphasis is put on a project known as the Research Domain 
Criteria Project (RDoC) (http://www.nimh.nih.gov/research-funding/rdoc/index.shtml). 
RDoC wants to implement classification of mental disorders based on dimensions of be-
havioral and neurobiological measures, for research purposes. The NIMH noted that little 
dimensional data is available as studies mostly exclude individuals with a subthreshold 
diagnosis (meaning they do not meet DSM criteria to fall into the affected groups, but are 
too deviant to be included in the control group). By promoting the use of dimensional 
data, spanning the range from normal to abnormal, the idea is to increase the knowledge 
on how constructs are related and involved in disorders. This will increase knowledge of 
current diagnosis, it might help to better define disorders, and it can improve treatment 
choices. Different classes of variables have been suggested to be able to contribute to this 
dimensional approach (i.e. genes, molecules, cells, neural circuits, physiology, behaviors, 
and self-reports). At the current time RDoC is not intended for clinical diagnosis, but as 
a framework to guide classifications of patients for research studies by deconstructing 
the clinical diagnosis. Three recent studies in ADHD already highlight the usefulness of 
this approach by showing dimensional brain-behavior relationship for internalizing and 
externalizing symptoms across diagnostic classifications (Chabernaud et al., 2012), different 
neural signatures for different ADHD subtypes (Fair et al., 2012), and the potential of subtyp-
ing childhood ADHD by using biologically based behavioral dimensions (temperament) 
(Karalunas et al., 2014).
Key findings of this thesis
–  Participants with ADHD showed a reduction in total brain volume of 2.5% compared 
to controls, which was driven by a 3% reduction of grey matter volume, whereas white 
matter volume was unaltered (chapter 2).
–  Age-dependent differences in caudate and putamen volumes were found between 
participants with ADHD and controls. Increasing age was associated with decreasing 
caudate and putamen volumes in controls, while age was unrelated to caudate and 
putamen volumes in people with ADHD (chapter 2).
–  Voxel-based whole-brain analyses showed reduced gray matter volume in five clusters 
located in the precentral gyrus, medial and orbital frontal cortex, and (para)cingulate 
cortices of individuals with ADHD compared to controls (chapter 3).
–  Unaffected siblings of participants with ADHD showed brain volumetric measures that 
were significantly different from controls, indicating familial influences. This result 
highlights the potential usefulness of these brain volumetric measures in molecular 
genetics studies in ADHD (chapter 2 and chapter 3).
General discussion  179
–  Investigation of adolescents and young adults, underrepresented age groups in ADHD 
research, is valuable, as age can be an important factor accounting for (part of the) 
inconsistent findings in ADHD research (chapter 2 and chapter 4).
–  A common intra-individual variability measure, extracted from very diverse neuro-
psychological tasks, showed familial association to ADHD and may relate to loci con-
ferring risk for ADHD (12q24.3 and 17p13.3) and possibly autism (12q24.3) (chapter 5).
–  Common genetic variants within pathways of dopamine/noradrenaline, serotonin and 
neurite outgrowth genes showed association to hyperactivity/impulsivity symptoms 
of ADHD, but not to inattention symptoms (chapter 6).
–  Dopaminergic, noradrenergic, and serotonergic genetic variants are not in the top-re-
sults of GWAS of ADHD. However, aggregating their effects resulted in a finding of 
association with ADHD symptoms (chapter 6).
–  Using an aggregated phenotypic and/or genetic measure can increase the power to 
detect association (chapter 5 and chapter 6).
–  Multivariate analysis of structural brain data identified a component that differs be-
tween participants with ADHD and participants without ADHD consisting of frontal, 
pre- and post-central gyrus, and occipital areas (chapter 7).
–  Candidate genes, selected based on prior association to ADHD status, were not asso-
ciated with a multivariate structural imaging component that differed between ADHD 
cases and controls (chapter 7).
–  Multivariate/joint analyses of genetic or imaging data can identify differences between 
groups that will not be detected with univariate analyses (chapter 6 and chapter 7).
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Summary
Attention-deficit/hyperactivity disorder (ADHD) is a common and complex neurodevelop-
mental disorder characterized by developmentally inappropriate inattentiveness, and/or 
increased impulsivity and hyperactivity. The underlying etiology of ADHD remains largely 
unknown. Two types of evidence about the nature of ADHD are the starting points of this 
thesis. First, ADHD is considered to be a disorder of brain development. Widespread alter-
ations in brain structure and brain function are reported on a group level for participants 
with ADHD compared to controls. However, findings on brain volumetric differences in 
ADHD are inconsistent and mostly studied in small samples. Second, ADHD is highly 
heritable, with heritability estimates of 76%. ADHD is (in most affected individuals) a 
multifactorial disorder in which multiple genetic factors and environmental factors play 
a role. Most of the genetic factors have a small effect size and are thought to interact with 
each other and with environmental factors, making the identification of these factors dif-
ficult. Although some ADHD-related genetic risk factors are identified, finding additional 
ones remains challenging. As ADHD runs in families, it can be of interest to investigate 
familiality. Familial means that a trait is more common within families than between 
families (i.e. due to shared genetic and/or shared environmental factors). 
My overall aim in this research project is to gain further insight into the genetic underpin-
nings and brain correlates of ADHD, the latter serving as a possible link between genetic 
risk factors and the clinical phenotype. 
PART 1  Structural brain variation in ADHD
In part 1 of this thesis I focus on the question which structural brain phenotypes show 
familial links with ADHD and might be useful in molecular genetic studies of ADHD. 
Chapters 2 and 3 describe volumetric brain differences between study participants with 
ADHD and controls, and the familiality of these differences. 
In chapter 2 total brain volume and subcortical brain volume are measured using an 
automatic segmentation approach. Smaller total brain volume is found for participants 
with ADHD compared to controls. Unaffected siblings show an intermediate total brain 
volume that differs significantly from controls, suggesting familial origins for these al-
terations. The subcortical volumes of the caudate and the putamen are also different 
between participants with ADHD and controls, however only when age is taken into 
account. Younger participants with ADHD have smaller caudate and putamen volumes 
than controls, a difference that disappears around mid-adolescence, due to the decrease 
in volume observed in controls with increasing age. In early adulthood participants with 
ADHD have larger caudate and putamen volume compared to controls.  
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In chapter 3 a hypotheses-free whole-brain voxel-based morphometry study is performed, 
to investigate small-scale volumetric brain changes between study participants with and 
without ADHD. Five clusters in the brain are found for which people with ADHD have 
smaller volumes compared to the controls. These clusters are located in the precentral 
gyrus, medial and orbital frontal cortex, and (para)cingulate cortices. For four of these 
clusters (all except the one in precentral gyrus) the unaffected siblings differ from con-
trols and show an intermediate volume, suggesting familiality of the volume differences. 
To summarize, part 1 of this thesis shows that structural brain differences are present in 
participants with ADHD compared to healthy individuals. By the investigation of unaffect-
ed siblings it is observed that several of these differences are subject to familial influences 
and can be useful in molecular genetics studies of ADHD.
PART 2  Genetics of ADHD
In part 2 of this thesis I focus on the molecular genetic mechanisms involved in ADHD. 
This is done by employing analysis methods that go beyond standard genetic association 
testing. In chapter 4 I use neuropsychological phenotypes in a relatively large sample with 
a wide age-range. In chapters 5 and 6 I study the combined effects of multiple phenotypic 
measures or multiple genetic determinants in an attempt to increase the power to detect 
genetic associations in ADHD.
In chapter 4 I investigate the associations of three functional genetic variants in the 
ADHD risk genes DAT1, DRD4, and 5-HTT with ADHD symptoms and six neurocognitive 
measures. Neuropsychological data of children, adolescents and adults with an age-range 
from 8-25 years and 35-61 years are used. Although the reported effects are modest, and 
results need to be replicated, my analyses show that age can be an important factor in 
genetic association analyses in ADHD. 
In chapter 5 a neuropsychological measure, intra-individual variability (IIV), is construct-
ed based on the observed variation on seven neuropsychological tests performed by the 
participants of our study. The seven measures share common variance, allowing the 
creation of an aggregated measure. The IIV construct is largely independent from other 
cognitive constructs related to ADHD, such as working memory, inhibition or IQ. A linkage 
analysis using the IIV construct as a quantitative trait shows three suggestive linkage 
peaks on chromosome 12, 13 and 17. These loci have earlier been implicated in the risk 
for ADHD (12q24.3 and 17p13.3) and possibly autism (12q24.3).
In chapter 6 candidate gene-sets are investigated for their association to symptoms of 
ADHD. Dopaminergic/noradrenergic, and serotonergic genetic pathways as well as a 
group of genes from the neurite outgrowth network are selected and their effect on ADHD 
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symptoms is examined. The candidate gene-sets are associated with hyperactivity/impul-
sivity symptoms in ADHD, whereas no association to inattention symptoms is observed. 
Also each of the three pathways individually showed an association with hyperactivity/
impulsivity, suggesting that this association is not driven by only one pathway alone.
To summarize, part 2 of this thesis suggests that age might underlie conflicting results in 
genetic analyses in ADHD and that aggregation of phenotypic and/or genetic effects can 
increase the power to detect genetic associations.
PART 3  Brain Imaging Genetics in ADHD
In part 3 of this thesis a brain imaging genetics approach is used to investigate ADHD. 
Chapter 7 describes our study combining genetics and structural brain imaging.
In chapter 7 a multivariate approach is applied to investigate the presence of different 
independent sources of grey matter concentration patterns in the structural brain volume 
data of study participants with ADHD and controls. Based on the assumption that the 
structural brain data we collected is an independent and linear mix of underlying sources, 
or components, I deconstruct the structural brain volumes of participants with ADHD 
and controls into components and compare them between the groups. One component, 
located in frontal, pre- and post-central gyrus, and occipital areas is different between 
participants with ADHD and participants without ADHD, suggesting these brain areas 
to be altered in ADHD. This component is not associated to the ADHD candidate genes 
DAT1, DRD4, DRD5, 5-HTT, HTR1B, or SNAP25.
To summarize, part 3 of this thesis shows the potential for multivariate methods on brain 
imaging and genetic data in ADHD research. A pattern of grey matter volume concen-
tration is found that differs between individuals with ADHD and controls and harbours 
interesting brain areas for ADHD.
Overall, this thesis provides new insights on volumetric brain alterations in ADHD, genetic 
risk variants linked to ADHD traits and provides innovative analysis methods for combin-
ing brain and genetic analyses in terms of brain imaging genetics of ADHD.
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Samenvatting 
ADHD staat voor attention-deficit/hyperactivity disorder, in het Nederlands vertaald als 
aandachtstekort/hyperactiviteits stoornis. ADHD is een veelvoorkomende aandoening 
die wordt gekenmerkt door aandachtsproblemen en/of hyperactief en impulsief gedrag 
leidend tot functionele beperkingen. Aandachtsproblemen zijn bijvoorbeeld problemen 
als vergeetachtigheid, dagdromen, makkelijk afgeleid zijn en moeite hebben om de aan-
dacht langdurig vast te houden. Onder hyperactief gedrag valt bijvoorbeeld rusteloosheid, 
buitensporig veel praten en friemelen. Impulsiviteit wordt gekenmerkt door het vaak on-
derbreken van anderen, het eruit flappen van antwoorden voordat vragen zijn afgemaakt 
en het moeilijk vinden om op je beurt te wachten. 
ADHD is een complexe aandoening waarvan de onderliggende oorzaken nog voor een 
groot gedeelte onbekend zijn. Het huidige onderzoek springt in op twee bevindingen 
in het onderzoek naar ADHD. De eerste is dat we weten dat ADHD gezien wordt als 
een aandoening van het brein. Uit eerdere onderzoeken is naar voren gekomen dat op 
groepsniveau veranderingen in de bouw en het functioneren van de hersenen gevonden 
worden tussen mensen met ADHD en mensen zonder ADHD. De tweede bevinding is dat 
genetische factoren een belangrijke rol spelen in het ontstaan van ADHD. De erfelijkheid 
van ADHD wordt zelfs geschat op 76%. 
Bij de meeste patiënten is ADHD een multifactoriële aandoening. Dit betekent dat zowel 
genetische factoren als omgevingsfactoren een rol spelen in hun aandoening. De gene-
tische factoren die een rol spelen bij multifactoriële aandoeningen hebben elk vaak maar 
een klein effect. Er is een combinatie van meerdere genetische factoren nodig, al dan niet 
samen met het optreden van ongunstige omgevingsfactoren, voordat ADHD daadwerkelijk 
ontstaat. Dit maakt het lastig om de genetische factoren voor ADHD te vinden. Er zijn 
dan ook maar enkele genetische risicofactoren gevonden voor ADHD. En het vinden van 
nieuwe genetische varianten voor ADHD is daarom een behoorlijke uitdaging.
Het doel van het onderzoek dat gerapporteerd wordt in dit proefschrift is om meer inzicht 
te verkrijgen in de genetische factoren voor ADHD door gebruik te maken van geavanceer-
de en innovatieve statistische technieken. Verder is het doel om meer inzicht te krijgen in 
de verschillen in de bouw van de hersenen van personen met ADHD, hun niet-aangedane 
broertjes of zusjes en gezonde controle personen. Inzicht in de verschillen in de bouw 
van de hersenen van personen met ADHD en hun niet-aangedane verwanten kan een 
belangrijke tussenstap zijn om het verband te leggen tussen genetische risicofactoren 
voor ADHD en het klinische fenotype.
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In dit onderzoek is gebruik gemaakt van genetische en structurele MRI data van families 
die mee hebben gedaan aan het IMAGE en/of neuroIMAGE onderzoek. Het IMAGE onder-
zoek is een internationale samenwerking van verschillende landen waarbij de verschil-
lende groepen geïnteresseerd zijn in de genetica van ADHD. In het IMAGE onderzoek zijn 
families verzameld waarvan één van de kinderen ADHD heeft. Data is verzameld van de 
kinderen en van de ouders. Vragenlijsten en testen zijn afgenomen om de ADHD sympto-
men in kaart te brengen in deze families en bloed is afgenomen om ook naar hun DNA te 
kunnen kijken. Het neuroIMAGE onderzoek is een vervolgonderzoek van IMAGE waarbij 
een aantal jaar later gevraagd is of de Nederlandse personen van het IMAGE onderzoek 
nogmaals mee wilden doen aan een onderzoek. Dit keer werden naast vragenlijsten en 
testen ook MRI scans afgenomen. Ook zijn er controle gezinnen toegevoegd waar ook 
DNA van verzameld is in het neuroIMAGE project.
DEEL 1  Structurele hersenverschillen in ADHD
In het eerste deel van dit proefschrift onderzoek ik of de bouw van de hersenen van per-
sonen met ADHD verschilt van die van personen zonder ADHD, en of deze verschillen 
familiaal zijn. Familiaal betekend dat een eigenschap (in dit geval hersenstructuur) meer 
hetzelfde is binnen een familie dan tussen verschillende families. Als dat zo is doet dit 
vermoeden dat er erfelijke invloeden zijn en er dus genetische factoren aan ten grondslag 
liggen, waardoor de eigenschap interessant kan zijn voor genetische onderzoek. In hoofd-
stuk 2 en 3 beschrijf ik de structurele hersenverschillen die we vinden als we personen 
met ADHD vergelijken met personen zonder ADHD. Doordat we ook broertjes en zusjes 
hebben onderzocht van personen met ADHD, die zelf geen ADHD hebben, kunnen we 
kijken of deze verschillen familiaal zijn. 
In hoofdstuk 2 meten we het totale hersenvolume en het volume van verschillende sub-
corticale hersengebieden van de personen met ADHD en zonder ADHD en hun niet-aan-
gedane broertjes en zusjes. We vinden dat mensen met ADHD een kleiner hersenvolume 
hebben dan mensen zonder ADHD. De niet-aangedane broertjes en zusjes hebben een 
hersenvolume dat hier tussenin valt, en wel significant verschillend is van de personen 
zonder ADHD uit andere families. Dit suggereert dat het hersenvolume onder invloed 
staat van familiale en zeer waarschijnlijk genetische factoren. We vinden ook verschillen 
tussen mensen met ADHD en mensen zonder ADHD in de subcorticale hersengebieden 
namelijk de nucleus caudatus en het putamen, maar dit is alleen terug te vinden als 
we ook kijken naar de leeftijd van de personen. In de jongere personen vinden we dat 
mensen met ADHD een kleiner volume hebben in de nucleus caudatus en het putamen, 
maar dit verschil verdwijnt rond het midden van de adolescentie. Dit is het gevolg van 
een beginnende afname in het volume van deze gebieden met een toenemende leeftijd in 
personen zonder ADHD. In de vroege volwassenheid hebben deze gebieden in personen 
met ADHD dus juist een groter volume vergeleken met de personen zonder ADHD. 
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In hoofdstuk 3 is een hypothese vrije methode gebruikt waarbij we naar het hele brein 
kijken. Dit is mogelijk door het brein op te delen in kleine kubussen, ook wel voxels 
genoemd, en per voxel te kijken of er een volume verschil is tussen de twee groepen. 
Hiermee zijn we opnieuw op zoek gegaan naar verschillen tussen personen met ADHD en 
personen zonder ADHD. We vinden 5 verschillende gebieden waarbij het volume kleiner 
is bij personen met ADHD. Deze gebieden liggen in de precentrale gyrus, de mediale en 
orbitofrontale cortex, en in (para)cingulate cortices. Voor vier van de vijf gebieden (alleen 
de precentrale gyrus niet) vinden we dat de niet-aangedane broertjes en zusjes een volume 
laten zien dat tussen de aangedane en niet-aangedane personen ligt. Dit suggereert dat 
ook deze verschillen familiaal zijn.
Het eerste deel van dit proefschrift toont aan dat er verschillen zijn in de bouw en het 
volume van de hersenen in personen met ADHD als deze vergeleken worden met personen 
zonder ADHD. Ook wordt gevonden dat voor sommige van deze verschillen leeftijd- en 
ontwikkelingsfactoren een rol spelen. Doordat we ook naar niet-aangedane broertjes en 
zusjes hebben kunnen kijken kunnen we aantonen dat deze verschillen familiaal zijn en 
van belang kunnen zijn voor genetisch onderzoek naar ADHD.
DEEL 2  De genetica van ADHD
In het tweede gedeelte van dit proefschrift ligt de focus op de genetische risicofactoren 
die van invloed zijn op het ontstaan van ADHD. Hiervoor heb ik gebruik gemaakt van 
complexe analyse methoden. In hoofdstuk 4 worden neuropsychologische testen gebruikt 
als ADHD-gerelateerde maten bij een grote groep mensen met een grote verscheidenheid 
aan leeftijden. In hoofdstuk 5 en 6 wordt de genetica van ADHD bestudeerd door ver-
schillende genetische factoren of verschillende gedragskenmerken samen te voegen in 
de hoop zo meer informatie te verkrijgen.
In hoofdstuk 4 bestudeer ik de link van 3 verschillende genetische risicofactoren in de 
ADHD-risicogenen DAT1, DRD4 en 5-HTT met ADHD symptomen en zes verschillende 
neurocognitieve maten. Hiervoor worden gegevens gebruikt van kinderen, adolescenten 
en volwassenen met een groot leeftijdsbereik (van 8-25 jaar en van 35-61 jaar). Ondanks 
dat de effecten van de genetische varianten op gedragmaten klein zijn, en onze resultaten 
gerepliceerd moeten worden, is een belangrijke conclusie van deze studie dat leeftijd 
een belangrijke – en tot nu toe wellicht onderbelichte – factor is in genetische associatie 
studies naar ADHD.
 
In hoofdstuk 5 maken we een gecombineerd fenotype, namelijk intra-individuele variabili-
teit (IIV). Deze maat is gebaseerd op de variabiliteit van de reacties in zeven verschillende 
neuropsychologische taken. Deze maat is interessant voor ADHD omdat kinderen met 
ADHD meer variabel zijn in de manier waarom ze reageren op neuropsychologische taken. 
Zo zien we dat controle kinderen vaak ongeveer binnen dezelfde tijd reageren, terwijl 
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kinderen met ADHD vaker de ene keer heel snel reageren en de andere keer erg langzaam. 
Dit verschil is te meten door een “variabiliteits”-maat te maken die weergeeft of iemand 
steeds ongeveer op dezelfde manier reageert, of dat iemand erg verschilt in zijn of haar 
reactie. Deze variabiliteits-maat hebben we samengepakt voor de zeven neuropsycho-
logische taken. Deze gecombineerde score, IIV, is grotendeels onafhankelijk van andere 
ADHD constructen, zoals werkgeheugen, inhibitie of IQ. Vervolgens is een genetische 
koppelingsonderzoek uitgevoerd waarbij we het IIV construct als fenotype nemen en drie 
genetische regio’s vinden die mogelijk een gen/genen voor de gedragsmaat herbergen, 
namelijk op chromosoom 12, 13 en 17. Eerder zijn op deze plekken in het genoom ook 
gebieden gevonden voor ADHD (12q24.3 en 17p13.3) en autisme (12q24.3).
In hoofdstuk 6 kijk ik welke genetische netwerken mogelijk een rol spelen bij ADHD en 
naar hun associatie met ADHD symptomen. De netwerken die ik selecteer zijn het dopa-
mine/noradrenaline-netwerk, het serotonine-netwerk en een groep van genen die een 
rol spelen bij neuronale uitgroei. Deze genetische netwerken laten een associatie zien 
met de hyperactiviteit/impulsiviteitssymptomen van ADHD, maar niet met de aandachts-
problemen in ADHD. Deze associatie wordt niet veroorzaakt door slechts één van de drie 
netwerken, want als ze getest worden is er associatie met hyperactiviteits/impulsiviteits 
symptomen voor elk van de drie netwerken.
Deel 2 van dit proefschrift toont aan dat leeftijd een mogelijke verklaring kan vormen 
voor de inconsistente bevindingen die gedaan worden in genetische associatie studies bij 
ADHD en dat het combineren van verschillende metingen of effecten van verschillende 
genetische varianten er voor kan zorgen dat we genetische associaties in ADHD makke-
lijker kunnen vinden.
DEEL 3  Hersenmaten gecombineerd met genetica in ADHD
In het derde deel van dit proefschrift kijk ik of we de kennis uit de voorgaande delen 
kunnen samenvoegen. In hoofdstuk 7 is een techniek gebruikt om tegelijkertijd naar 
genetica en naar hersenverschillen te kijken bij ADHD.
Met een multivariate methode is getest of we patronen kunnen vinden in de structurele 
MRI scans. De achterliggende gedachte is dat de complexe gegevens in de data van een 
structureel MRI onderzoek vereenvoudigd kan worden tot een aantal verschillende rela-
tief onafhankelijke onderliggende componenten. Een aantal verschillende componenten 
zijn gevonden, en één van deze componenten laat een verschil zien tussen personen met 
ADHD en personen zonder ADHD. Deze component bestaat uit verschillende gebieden in 
het brein, namelijk frontale gebieden, pre- en post centrale gyri, en occipitale gebieden. 
Deze component is echter niet geassocieerd met de ADHD genen DAT1, DRD4, DRD5, 
5-HTT, HTR1B, of SNAP25.
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Het derde gedeelte van dit proefschrift toont dat er potentie is voor geavanceerde multi-
variate methoden die genetica en gegevens over de hersenen samenvoegen in onderzoek 
naar ADHD. Een multivariate methode op structurele hersendata laat een patroon in de 
hersenen zien dat verschillend is tussen mensen met ADHD en mensen zonder ADHD.
De studies beschreven in dit proefschrift geven nieuwe inzichten in de verschillen in de 
hersenen in ADHD, genetische risicofactoren voor ADHD symptomen en het biedt ver-
nieuwende analyse methoden voor het combineren van brein data en genetische data in 
het onderzoek naar ADHD.
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